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Abstract 
 
Objective 
Cause-of-death distributions are important for prioritising interventions. We estimated 
proportions, risks, and numbers of deaths (with uncertainty) for programme-relevant causes of 
neonatal death for 194 countries for 2000-2013, differentiating between the early (days 0-6) 
and late (days 7-27) neonatal periods.  
 
Methods 
For 65 high-quality VR countries, we used the observed early and late neonatal proportional 
cause distributions. For the remaining 129 countries, we used multinomial logistic models to 
estimate the early and late proportional cause distributions.  We used separate models, with 
different inputs, for low and high neonatal mortality countries. We applied these cause-specific 
proportions to United Nations’ neonatal death estimates by country/year to estimate cause-
specific risks and numbers of deaths. 
 
Findings 
Of the 2.76 million neonatal deaths in 2013, 0.99 (uncertainty: 0.70-1.31) million (35.7%) were 
estimated to be from preterm complications, 0.64 (uncertainty: 0.46-0.84) million (23.4%) from 
intrapartum-related complications, and 0.43 (0.22-0.66) million (15.6%) from sepsis. Preterm 
(40.8%) and intrapartum-related (27.0%) complications accounted for the majority of early 
neonatal deaths while infections caused nearly half of late neonatal deaths.  In every region, 
preterm was the leading cause of neonatal death, with the highest risks in Southern Asia (11.9 
per 1000 livebirths) and Sub-Saharan Africa (9.5).  
 
Conclusion 
The neonatal cause-of-death distribution differs between the early and late periods, and varies 
with NMR level and over time. To reduce neonatal deaths, this knowledge must be incorporated 
into policy decisions. The Every Newborn Action Plan provides stimulus for countries to update 
national strategies and include high-impact interventions to address these causes.   
 
Words: 250 
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Introduction 
Most of the 2.76 million neonatal (first month of life) deaths in 2013 occurred from preventable 
causes (1). While the global neonatal mortality rate (NMR) is decreasing, its rate of reduction 
has been substantially slower than the decreases in under-5 and maternal mortality (2, 3).  
Neonatal deaths now constitute 44% of all deaths in children under 5 years old (1).  Many 
countries are unlikely to meet the child mortality target of the 4th Millennium Development Goal 
(MDG) by 2015, at least partly because of inadequate neonatal mortality reductions (4).  The 
Every Newborn Action Plan, launched in June 2014 (5), provides a stimulus to accelerate 
progress by implementing effective cause-specific interventions that can rapidly reduce 
neonatal mortality.   
 
Understanding the neonatal cause-of-death (COD) distribution is important for identifying 
appropriate interventions and program priorities. Such a distribution should be as local as 
possible (national or even subnational in large countries), current, and distinguish 
programmatically relevant causes. Moreover, separate COD estimates are required for the early 
(days 0-6) and late (days 7-27) neonatal periods since both our understanding of pathology and 
empirical data suggest that the COD distribution differs substantially between these periods (6, 
7).  Around three-quarters of neonatal deaths occur during the early period (8), and most 
interventions to prevent these deaths need to be delivered within a very short window of time.  
 
For countries with high-quality vital registration (VR) data by cause and age at death, such data 
provide the information needed to determine policies and priorities. VR data quality is 
dependent on the completeness of reporting and the quality of cause-of-death coding (9, 10). 
Unfortunately, high-quality VR data are available for only about one-third of countries (11), 
which account for only about 4% of neonatal deaths.  Thus, statistical modeling remains 
necessary to estimate cause-of-death distributions in the majority of countries.   
 
Systematic estimates of neonatal deaths classified into programmatically relevant cause 
categories were first published in 2005, for the year 2000 (12), by the Child Health 
Epidemiology Research Group (CHERG). These estimates were developed using  data from high-
quality VR systems and from research studies in high mortality/low resource settings in which 
high-quality VR data were lacking. Updated neonatal cause-of-death estimates using this 
approach were subsequently published for 2008 (13) and 2010 (14).   
 
The current work goes beyond these previous exercises by estimating neonatal causes of death 
separately for the early and late neonatal periods, and by adding injuries as a distinct cause for 
low mortality countries.  The separation of early and late neonatal deaths is an important 
advance which will aid policy makers and programme managers.  The input data have also been 
updated and modifications made to the modelling strategy, particularly for the split of neonatal 
infections between pneumonia and sepsis.  
 
Here, we present global, regional, and national estimates (with uncertainty ranges) of 
proportions, risks, and numbers of deaths for key programmatically relevant neonatal causes of 
death by the early and late neonatal periods for 194 countries for 2000-2013.   
 
Methods 
Overview of cause-of-death estimation  
We divided 194 countries into three groups based on the quality of their VR data and their child 
mortality rates (appendix A).  Different methods were used to estimate the proportional cause-
of-death (COD) distributions for countries in each group (figure 1). For the 65 countries with 
high-quality VR data, the proportional cause distribution from 2000-2013 was obtained directly 
from the country’s VR data. For the 49 countries without high-quality VR but with low child 
mortality, this distribution was estimated using a multi-cause model (“low mortality model”) 
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with input data from high-quality VR countries.  For the high-quality VR countries and low 
mortality model, we used seven cause categories: complications of preterm birth (“preterm”), 
intrapartum-related complications (“intrapartum”), congenital disorders, pneumonia, sepsis 
and other severe infections (“sepsis”), injuries, and other causes (panel 1).  For the 80 countries 
with inadequate VR and high child mortality, we used studies that identified neonatal COD in 
high mortality settings as input data in a separate multi-cause model (“high mortality model”).  
The eight cause categories for this model were preterm, intrapartum, congenital disorders, 
pneumonia, diarrhea, neonatal tetanus, sepsis, and other causes (panel 1).  In appendix B, we 
detail the methodological differences between this work and previous estimates.  
 
[appendix A: countries in the 3 models]   
[appendix B: key methodological differences between this work and previous estimates] 
[figure 1: flowchart of methods]  
 
Data inputs 
Cause-of-death data from vital registration 
For the 65 high-quality VR countries, we obtained publicly available VR cause-of-death data by 
the early and late neonatal periods from the World Health Organization (WHO) for years 2000 
and later.  We mapped the reported causes of death to our cause categories (appendix C).  We 
then generated a proportional cause distribution by dividing the number of deaths attributed to 
each cause by the total deaths across the seven causes.  To create a full time series, we imputed 
the cause-specific proportions for years with missing VR data (appendix D). The imputed 
proportions were only used as estimates for the high-quality VR countries; the low mortality 
model input dataset only included the non-imputed data.  
 
[appendix C: ICD 9/10 to CHERG conversion codes]   
[appendix D: table with information about the VR input data] 
 
Cause-of-death data from high mortality setting studies 
The high mortality model input data consisted of neonatal COD distribution data from studies in 
high mortality settings. We updated a previously developed database of neonatal COD studies 
(15) by conducting an extensive literature review for relevant research published from January 
2011 to May 2013 (appendix E).  For each study, we extracted COD data and, when necessary, 
re-categorized the causes into our cause categories.  While we included injuries as a separate 
category in the low mortality model, the study data lacked enough information on injuries for 
separate estimation in the high mortality model.  We recorded deaths separately by early or late 
neonatal period whenever possible. 
 
[appendix E: study data inclusion criteria]   
[appendix F: full study list with relevant info]   
  
Covariate data 
We chose for investigation covariates that we believed might partly predict variation in the COD 
distribution across countries.  We could only use covariates for which national time series are 
publically available.  The covariates were used in two ways: 1) as inputs into the multinomial 
models, and 2) as predictor variables to which the final model coefficients were applied to 
estimate the national proportional cause distributions.  We used national-level covariates as 
inputs to the low mortality model since the input COD data are national, and, whenever 
possible, local-level data extracted from the studies for the high mortality model.  When local-
level data were unavailable, we used subnational- or national-level covariate data instead.  For 
the predictions, we used national-level covariate data, with the exception of India for which we 
used state-level data to produce state-level estimates.  We applied the same rules for imputing 
missing covariate data as for the VR data (appendix D). For prediction purposes, we restricted 
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covariate values to the input data ranges, and performed a sensitivity analysis without this 
restriction.   
 
Statistical modelling  
All statistical analyses were done using Stata (version 12).  For each model, a baseline cause was 
chosen; this cause was preterm for the low mortality model (the most common cause) and 
intrapartum for the high mortality model (reported in all studies).  Our overall estimation 
process had two stages.  First, we selected covariates.  Then, we estimated the log of the ratio of 
each of the other causes to the baseline cause (the “log-cause ratio”) as a function of the selected 
covariates using a multinomial logistic regression model.  For both the low and high mortality 
models, we ran separate models for the early and late neonatal periods. Since not all studies in 
the high mortality model reported deaths by period, we included the studies reporting only 
overall neonatal deaths in both the early and late high mortality models, and included a binary 
covariate for period in these models.   
 
Covariate selection for models 
For each of the four models, we used a previously developed jackknife procedure (14) to select 
the set of covariates that minimized the out-of-sample prediction error for each log-cause ratio 
separately.  First, we determined if the relationship between each covariate and log-cause ratio 
in the input data was best represented by a linear, quadratic, or restricted cubic spline 
relationship. We did this by choosing the covariate relationship which yielded the smallest chi-
squared statistic (sum of the squared differences between observed and expected deaths 
divided by expected deaths) for the given log-cause ratio.  We then selected the covariate with 
the smallest chi-squared statistic as the first covariate in the model. Finally, we added one 
covariate at a time, retaining it in the model only if the chi-squared statistic decreased and 
cycling through all the remaining covariates again.  In this way, we selected a set of covariates 
for each non-baseline cause in each model.  
 
Multi-cause models 
The multi-cause multinomial logistic regression models fit the data for all causes 
simultaneously. Each input observation received a weight inversely proportional to the square 
root of the total deaths contributed by that observation. This weighting is intermediate between 
giving equal weight to each death and equal weight to each study or country year in the input 
data.  We made assumptions about the cause category into which deaths from an unreported 
cause would have been assigned (appendix G). The coefficient values from the multinomial 
logistic regression models were applied to the country- and year-specific national level 
predictor covariates to estimate the proportional cause distribution for each modelled country 
from 2000-2013.  
 
[appendix G: assumptions about missing causes in the high mortality model input data] 
 
Estimation of cause-specific deaths and risks  
We applied our estimated cause fractions to the neonatal deaths and live births estimated for 
each country from 2000-2013 by the Inter-agency Group for Child Mortality Estimation (IGME) 
(1).  We split the overall neonatal deaths from IGME into early and late neonatal deaths.  For 
high-quality VR countries, we took this split directly from the data.  For the other countries, we 
assumed that 74% of neonatal deaths occurred during the early period and 26% in the late 
period based on previous work (8).  We also performed a sensitivity analysis in which we 
assumed the early proportion was 65% or 85% instead of 74% (appendix H).  To determine the 
number of deaths by cause, neonatal period, and year for each country, we applied the cause-
specific proportions derived from the VR data (for high-quality VR countries) or the relevant 
models to the period-specific neonatal deaths for each country and year. We then divided these 
by the relevant country-specific live births to obtain the risk (per 1,000 live births) for each 
cause by neonatal period and year.   
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[appendix H: sensitivity analysis assuming 65% or 85% for proportion of early neonatal deathsl] 
 
 
Uncertainty estimation 
For the modelled estimates, we generated uncertainty estimates by drawing 1,000 bootstrap 
samples with replacement from the input data and re-running the multi-cause models to 
produce new proportional cause distributions. We took the 2.5th and 97.5th percentile values for 
each cause as the uncertainty bounds.  For the high-quality VR data, we developed uncertainty 
estimates by assuming a Poisson distribution for the number of deaths (i.e. the standard error 
equaled the square root of the reported number of deaths).   
 
Results 
Data inputs 
The high-quality VR input dataset, which was also used in the low mortality model, included 65 
countries with 1,267,404 neonatal deaths and 665 country-years for each neonatal period from 
2000-2013.  Of these deaths, 75.8% occurred in the early period. Preterm and congenital were 
the most common causes during both neonatal periods (figure 2a).  
 
The high mortality model input dataset included 112 data points consisting of 98,222 deaths 
from 36 countries (figure 1).  This includes the addition of nearly 4100 neonatal deaths from 15 
new studies, representing 10 countries across five MDG regions.  The overall dataset had 31 
observations for the early period, 18 for the late period, and 63 for the overall neonatal period.  
Seventy-eight observations had missing information on one or more cause, with pneumonia and 
diarrhoea being the causes most commonly unreported (appendix G). Preterm and intrapartum 
were the most common causes of death during the early period, while infections (sepsis and 
pneumonia) dominated during the late period (figure 2b).   
 
[figures 2a and 2b: box and whisker plots of the proportional cause distributions for the VR and 
high mortality model input data] 
 
While most covariate values were within the ranges of the input data, a few prediction 
covariates had values substantially outside the input data range, especially in the low mortality 
model (appendix I). Notable examples were Monaco with an average GNI about 3.5 times larger 
than the maximum input data and Egypt with female literacy and ANC coverage 15-20 
percentage points below the input ranges. While we capped the prediction covariate data to the 
input ranges in the analysis, a sensitivity analysis without these caps suggested that the decision 
to cap or not had minimal influence on the results (appendix J).    
 
[appendix I: comparison of the input and prediction datasets in the multinomial models] 
[appendix J: sensitivity analysis when prediction data is not restricted to ranges of the input data] 
 
Statistical modelling  
Covariate selection for models 
The model equations varied substantially in their performance, from 0% reduction in the chi-
squared statistic (injuries, low mortality model, late period) to 87% reduction (diarrhea, high 
mortality model, early period) (appendix K). Overall, equations in the high mortality model 
appeared to have better performance, with an average of 50% reduction in residuals across the 
equations compared to an average of 30% in the low mortality model equations.   
 
[appendix K: selected covariates and their performance for each cause equation]   
 
Multi-cause models 
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Model regression coefficients are in appendix L. 
 
[appendix L: Regression coefficients for the models] 
  
Cause-specific deaths and risks  
Globally, the leading causes of neonatal death in 2013 were preterm (35.7%), intrapartum 
(23.4%), and sepsis (15.6%), accounting for 2.1 (uncertainty range: 1.4-2.8) of the 2.8 million 
neonatal deaths (table 1). There is little difference in these numbers when the proportion of 
early deaths is assumed to be 65% or 85% instead of 74% for modelled countries (appendix H).   
The proportional cause distribution varied by both neonatal period and NMR level. In the early 
period, preterm (40.8%) and intrapartum (27.0%) accounted for the majority of deaths while in 
the late neonatal period nearly half of all deaths occurred from infectious causes (sepsis, 
pneumonia, tetanus, and diarrhoea) (table 1). The proportion of deaths from congenital 
disorders was relatively stable across the periods. Higher NMR and lower income were 
associated with a higher proportion of deaths attributable to intrapartum and infectious causes 
(appendix M). The variation between regions appears to largely reflect NMR differences 
between regions. In low mortality settings, injuries accounted for less than 1% of neonatal 
deaths, and this fraction increased slightly from the early to late period (appendix M). See 
appendix N for model-specific results and appendix O for country-specific results.  
 
[table 1: global cause-specific proportions and number of neonatal deaths]. 
[appendix M: results by NMR level and income category].   
[appendix N: proportions/risk by high-quality VR, low mortality model, and high mortality model].   
[appendix O: country-specific results of proportions, risk, and number of deaths] 
 
Globally, risks for all causes have been decreasing as the global NMR decreases over time. The 
risk of death from each cause is substantially higher in higher mortality settings, even for causes 
that dominate proportionally in low mortality settings (e.g. preterm and congenital disorders).  
The risks of death due to preterm, intrapartum, and sepsis are 10, 36, and 34 times greater in 
settings with NMR≥30 compared to NMR≤5.  In every MDG region, preterm is the leading cause 
of neonatal death, with the highest risks in Southern Asia (11.9 per 1000 live births) and Sub-
Saharan Africa (9.5) (figure 3). While the absolute risks of death due to intrapartum and 
preterm have been falling in the early period, they have decreased less in the late period.  Risk 
of tetanus has declined in both periods (figure 4).    
 
 [figure 3: stacked bars of risk by region for 2013] 
 [figure 4: global area chart of time trends from 2000-2013 by neonatal period] 
 
Discussion 
We developed systematic, globally comparable estimates of programmatically relevant neonatal 
causes of death. Our current estimates go beyond our previous estimates in providing separate 
decompositions for the early and late neonatal periods.  The proportional neonatal cause 
distribution varies with a number of factors, including the early versus late neonatal periods, 
NMR level, and over time. To reduce neonatal deaths, such variations must be understood, and 
this knowledge must be incorporated into decisions regarding the selection of appropriate 
interventions. With the launch of the Every Newborn Action Plan in June, this is a particularly 
opportune time for affecting such change within countries.  
 
The three leading categories of causes of neonatal death (preterm, intrapartum, and infections) 
are the same for the early and late neonatal periods, but their distribution is very different 
between the two periods.  Globally, in the early period, preterm and intrapartum account for 
nearly 68% of deaths while infections (pneumonia, sepsis, tetanus, and diarrhea) account for 
around 14%.  In the late period, around 34% of deaths are due to intrapartum or preterm while 
roughly 48% are from infections. Intrapartum-related complications are expected to occur in 
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the minutes or hours after birth, and hence cause more deaths during the early period.  
Infections usually take some time to develop, and thus become more common during the late 
period.  
 
Even within each neonatal period, considerable differences exist in the proportional cause 
distribution by NMR level.  Generally, NMR is closely linked to the level of care available to 
neonates. Settings with very low NMR tend to have readily available intensive care for 
newborns, while areas with high NMRs often lack even simple interventions like clean delivery 
kits and resuscitation equipment.  In this analysis, low mortality countries had higher 
proportions of deaths from congenital disorders and lower proportions from intrapartum and 
infections, while the opposite was true in high mortality settings.  While infection deaths 
accounted for 51% of deaths in the late period in high mortality countries, they caused less than 
30% of late neonatal deaths in low mortality countries. This may be because of better access to 
and availability of treatment and infection control in low mortality countries.  
 
We used our model to predict trends in individual causes of death. Our model predicts that 
deaths due to intrapartum-related complications had the largest absolute risk reduction 
between 2000 and 2013, from 7.2 (4.8-9.5) to 4.7 (3.4-6.1) per 1000 live births, possibly 
because of increased coverage of skilled obstetric care.  The largest relative decrease in risk was 
predicted for neonatal tetanus, which dropped by 73% (from 1.1 [0.3-2.8] to 0.3 [0.1-0.9]) 
between 2000 and 2013. This may be due to increases in clean deliveries, facility birth, cord 
care, and tetanus toxoid vaccination (a predictor in the model), as well as contextual changes in 
maternal education and social norms. Additionally, a few countries in the low mortality model 
eliminated neonatal tetanus after 2000. Since tetanus is not estimated in the low mortality 
model, we may thus be underestimating the relative decline in risk.   
 
The smallest predicted relative decrease in risk was for congenital (13% drop; from 2.4 [1.4-
4.1] to 2.1 [1.3-3.3]). While the predicted risk of death due to preterm complications fell by 2.4 
per 1,000 live births between 2000 and 2013 (from 9.6 [6.7-12.8] to 7.2 [5.1-9.5]), this 
represented the second smallest relative decrease (25%), despite the existence of simple and 
cost-effective interventions such as antenatal corticosteroids and Kangaroo Mother Care (8, 16). 
In addition to prematurity, there is also evidence that babies that are small-for-gestational age 
(SGA) are at higher risk of death (17).   
 
Broadly, our results are similar to those from 2010 (14), with the exception that we estimate 
substantially fewer pneumonia deaths than before. This is likely due to improvements to the 
estimation approach, namely the inclusion of additional studies that split pneumonia from 
sepsis and the inclusion of pneumonia directly in the multinomial model (appendix B).   
 
We used the low mortality model to estimate the proportional cause distribution in China due to 
its low NMR (18.8 in 2000, 7.7 in 2013), obtaining around 14.4% of neonatal deaths attributable 
to intrapartum-related complications. Others have also estimated the neonatal COD distribution 
in China and their results differ somewhat from ours, most notably with higher proportions of 
intrapartum-related deaths (18, 19).  Our approach differs in three important ways: 1) we used 
multi-cause instead of single-cause models, 2) we estimated results for the early and late 
neonatal periods separately, and 3) we included input data from outside of China.  We believe 
the first two are advantages in our work, while using China-only data is an advantage of the 
other models.  The global COD distribution changes little when we apply the WHO COD 
proportions (20) for China instead of ours, with the biggest differences in 2013 being 
intrapartum-related and other deaths increasing by about 2 percentage points.  Alternative COD 
distributions for China are shown in Appendix P for comparison.   
 
[appendix P: Comparison of different China estimates] 
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Although the quantity and quality of data has improved in recent years, enormous data gaps still 
exist. We now have nearly 100,000 deaths and over 90 studies in the high mortality model 
compared to <14,000 deaths and <60 studies when we produced the estimates in 2005 (12).  
However, while we used the high mortality model for 80 countries, the inputs only included 
data from 36 countries. Many of these studies were relatively small, and few were nationally 
representative.  We could include data from only 13 Sub-Saharan African countries, the region 
with the highest risk of neonatal death. Excluding a large South African dataset, the studies from 
these countries contribute only 4,000 deaths to our database. It is an unfortunate reality that we 
know the least about the areas with the highest burdens.  
 
As with all such modeling exercises, our estimates should be viewed as an interim measure to 
help policymakers, particularly in settings with little or no data currently. It is important  to 
distinguish estimates from data and to recognize that not all estimates are “equal”. We used UN-
IGME estimates of the NMR and total number of neonatal deaths in each country. The UN-IGME 
estimates of all-cause mortality in each country are derived from data for that country and 
therefore can be said to “track” mortality in each country. For most countries, our cause-specific 
estimates are not based on data from that country, but from a model bringing together data 
from many countries. The model then predicts the cause-of-death distribution, and changes in 
the cause-of-death distribution, in individual countries based on covariate values for the 
individual country. Some countries contribute little or no input data to the modeling process. 
For example, only 24 deaths in our input data come from Nigeria, one of the most populous 
countries.  Our estimates should not therefore be interpreted as “tracking” changes in causes –
of-death for the majority of countries, but rather as predictions of what might be occurring in 
countries. To track changes in burden due to specific causes of death requires each country to 
collect representative and consistent data on cause of death on a continuing basis. We 
emphasise once again that our estimates are not a panacea for actual data collection and should 
not be an excuse for a failure to collect data. 
 
Fortunately, rapid but sensible improvements in data collection are possible.  Recent examples 
of countries like South Africa improving their data systems to the point where their VR data is 
considered high quality are encouraging. In table 2, we provide a set of proposals for improving 
the counting of births and neonatal deaths.  As data systems improve, regression-based models 
should be replaced by reliable local COD data.   
 
[table 2: recommendations for data improvements based on neonatal mortality level] 
 
The validity of our estimates relies on the quality of the input/prediction data, and our 
modelling techniques.  Quality is of particular concern for verbal autopsy studies, in which the 
reported cause distributions depend heavily on the case definitions and causal hierarchies used 
to attribute deaths (10). Accurate cause attribution using VA will always be problematic for 
causes that are difficult to distinguish, such as sepsis and pneumonia, or difficult to identify, 
such as internal congenital abnormalities. The potential lack of comparability between different 
VA studies can affect the ability of our model to predict variation between settings.  By following 
standardized methods when conducting VA studies, some of these problems can be partially 
alleviated (21). Additionally, regression-based models inherently depend on the relationship 
between outcome variables and covariates, which should ideally come from the same 
population and time period. While we sought to include as much local covariate information as 
possible for the input studies, 52% of the total covariate information came from national data 
instead of from local/regional data.   Finally, when re-categorizing reported VA causes of death 
(panel 1), we had to make choices, for example placing deaths reported as being due to “very 
low birth weight” into the preterm complication category. This may introduce a degree of 
misclassification as some “very low birth weight” deaths may be attributable to congenital 
abnormalities. We made those choices that we believed would introduce the least 
misclassification, but until VA methods improve, this will continue to be a challenge.  Similar 
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issues exist in ICD coding, but are more common in VA studies because of the limited and lower 
quality information collected.   
 
Even high-quality VR data can have problems.  Unfortunately, ICD-10 codes are not ideal for 
neonatal causes, particularly because several programmatically relevant causes are relegated to 
the often-unused fourth digit in the codes.  Codes for the upcoming ICD-11 revision are 
currently being drafted, providing the opportunity to develop more appropriate, clinically 
relevant coding for neonatal causes.  Additionally, ICD coding practices can vary between and 
even within countries and over time (22, 23). Such variations reduce our model’s ability to 
predict true variation in causes of death. Other issues in VR coding include changes during the 
transition between ICD revisions, differences in relegating certain causes to non-specific/ill-
defined cause categories, and the assumption inherent in our exclusion of such codes that the 
deaths attributed to them are a random sample of all deaths.  Finally, the availability and quality 
of VR data in a country may change over time, especially in countries with newly emerging 
surveillance systems. Developing consistent time trend estimates given such changes remains a 
challenge.   
   
We used multinomial models because they naturally allow proportional cause distributions to 
sum to one, so that the sum of cause-specific deaths equals total deaths. Single-cause models 
require post-hoc adjustments to retain this property, but there may be limited information on 
which to base such adjustments. An important concern for both types of model, however, is the 
attribution of death to a single cause. This does not allow for co-morbidities, which are a 
frequent occurrence in neonatal deaths, and may thus underestimate the impact of a given 
cause.  
 
Given the considerable variations in health systems and contextual factors within individual 
countries, sub-national neonatal COD estimates are needed and should be a target for future 
estimation exercises and data collection.  National-level estimates like ours aim to ascertain the 
average causal distribution for a country, which can help guide national priorities, but may 
mask subnational variation.  Some countries are beginning to collect the necessary information 
for sub-national estimates.  For example, our national India estimates were produced by 
aggregating state-level estimates.  In the future, we also hope to further differentiate causes 
within the current broad categories like congenital disorders. However, such differentiation 
may only be possible for VR-based models, as VA-based data generally lack the detail needed to 
do this.  Finally, we strongly believe that the production of such estimates should be 
transparent. In accordance with this, the datasets and Stata code we used for this analysis are 
available on the WHO Global Health Observatory website. 
 
Neonates constitute an important component of the unfinished agenda of MDG-4, and reducing 
preventable neonatal deaths will be essential to achieve the “grand convergence” to which the 
global community now aspires (24). The Every Newborn Action Plan, which calls for all countries 
to reduce their NMRs to 10 or fewer deaths per 1000 live births by 2035, provides fresh 
impetus for ending preventable newborn deaths (5),  and a future in which every baby has an 
equal chance of survival. 
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Panel 1: Definitions for the neonatal period and causes of death 
 
Neonatal period definitions 
Neonatal period: days 0-27, or first month after birth 
Early neonatal period: days 0-6, or first week after birth 
Late neonatal period: days 7-27, or weeks 2-4 after birth 
 
Neonatal causes of death  
 Case definitions for neonatal causes of death 
Used in VR and sought in study data Accepted in study data 
Preterm 
complications 
Neonatal deaths from one or more of the 
following: 
- specific complications of preterm birth like 
surfactant deficiency (Respiratory Distress 
Syndrome), intraventricular haemorrhage, 
necrotizing enterocolitis 
- immaturity (<34 weeks) at which level 
preterm specific complications occur for the 
majority of babies 
- neonatal death with birth weight < 2,000 g 
where gestational age is unknown 
- “Prematurity” 
- “Very low birth weight” 
Intrapartum-
related 
complications 
Neonatal death due to: 
- neonatal encephalopathy with criteria 
suggestive of intrapartum events 
- early neonatal death in a term baby with no 
congenital malformations and a specific 
history of acute intrapartum insult or 
obstructed labor 
- “Birth asphyxia” with 
Apgar-based definition but 
excluding preterm infants 
- Fits and/or coma in the 
first two days of life in a 
term baby 
- Acute intrapartum 
complications 
Congenital 
disorders 
- Neonatal death due to major or lethal 
congenital abnormalities 
- Specific abnormality listed (e.g. neural tube 
defect, cardiac defect) 
Congenital abnormality or 
malformation 
Sepsis 
Neonatal deaths due to sepsis/septicaemia, 
meningitis, or neonatal infection 
Neonatal infection 
Pneumonia 
Neonatal deaths due to pneumonia or acute 
respiratory tract infection 
Pneumonia 
Neonatal 
tetanus 
Neonatal deaths due to tetanus 
Spasms and poor feeding 
after age of 3 days 
Diarrhoea Neonatal deaths due to diarrhoea --- 
Injuries Neonatal deaths due to injuries N/A 
Other 
Specific causes not included in the above-
listed causes, including:  
- neonatal jaundice 
- haemorrhagic disease of the newborn 
- term baby dying due to in-utero growth 
restriction 
- injuries (in study data only) 
Author grouping of “other” 
(not unknown) 
Notes: 1) This table is slightly modified from Lawn (25), which adapted it from Wigglesworth (26, 27) 
and NICE (27); 2) specific ICD codes for causes of death in the VR data are included in appendix C.   
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Figure 1: Flowchart of modelling methods 
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Figure 2: The proportional cause distribution of neonatal deaths by neonatal period for 
the input data in the a) low mortality model (one observation per country by averaging 
across years) and b) high mortality model.   
a) 
 
b)  
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Figure 3: Cause-specific risk of neonatal death by MDG region in 2013 
 
 
 
 
 
Figure 4: Global cause-specific risks of death from 2000-2013 for the early and 
late neonatal periods 
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Table 1: Global cause-specific proportions, risk, and numbers of neonatal deaths 
(with uncertainty ranges) in 2013 
 Early neonatal 
period 
Late neonatal 
period 
Overall neonatal  
period 
% # of deaths in 
thousands 
(uncertainty) 
% # of deaths in 
thousands 
(uncertainty) 
% # of deaths in 
thousands 
(uncertainty) 
Risk 
 
Preterm 40.8 834.8 
(608.1-1083.5) 
21.2 152.1 
(91.0-229.0) 
35.7 986.9 
(699.1-1312.5) 
7.2 
Intrapartum 27.0 552.7  
(407.6-711.4) 
12.9 92.1 
(54.8-133.4) 
23.4 644.8 
(462.4-844.7) 
4.7 
Congenital 10.6 217.0 
(140.9-325.9) 
10.2 72.8 
(42.5-124.5) 
10.5 289.8 
(183.3-450.4) 
2.1 
Sepsis 8.0 163.7 
(62.4-271.6) 
37.2 266.7 
(156.5-393.2) 
15.6 430.4 
(218.9-664.8) 
3.1 
Pneumonia 4.8 98.9 
(48.8-200.3) 
5.2 37.6  
(21.5-58.7) 
4.9 136.4 
(70.3-259.0) 
1.0 
Diarrhoea 0.3 6.7  
(0-57.4) 
1.4 10.0  
(3.2-25.6) 
0.6 16.6 
(3.2-83.0) 
0.1 
Tetanus 1.0 21.1 
(7.4-53.2) 
3.8 27.1 
(8.1-67.2) 
1.7 48.2 
(15.5-120.4) 
0.3 
Other 7.3 149.9 
(72.7-250.3) 
8.1 57.9 
(26.3-117.2) 
7.5 207.8 
(99.0-367.4) 
1.5 
Notes: 1) diarrhoea and tetanus were estimated only for the 80 high mortality model countries; 2) injuries 
are included within the “other” category; 3) risk is per 1,000 live births.  
 
 
  
Page 18 
 
Table 2: Recommendations for data improvements based on neonatal mortality level 
Neonatal mortality rate  
(per 1,000 live births) 
< 5 5 – <15 15 – <30 ≥30 
Main data collection 
platforms  
1. Full coverage vital 
registration (VR) 
2. National perinatal and 
maternal mortality audit  
3. Strong Health Management 
Information Systems (HMIS) 
1. VR usually full coverage, 
quality may be lacking 
2. Audit may not be full 
coverage 
3. HMIS may be high coverage 
but inconsistent quality 
1. Limited to no VR  
2. Usually dependent on 5 yearly national surveys and HMIS 
Counting all births and neonatal deaths 
Counting all births  Consistent counting of all live birth and any birth over 500 g/22 weeks, noting if singleton or multiple birth 
Comparable definitions  
to count neonatal deaths 
Reporting all deaths in live born babies using perinatal death certificates where possible (no gestational age or weight cut off) 
Specify early neonatal (day 0, days 1–6) and late neonatal (days 7–27) deaths separately  
Collecting more detailed 
data 
1. VR using specific neonatal death certificates with birth weight and 
gestational age 
2. Improved cause coding in ICD-11 with clinically-relevant codes  
3. Health facility surveillance with detailed dataset 
4. Crosslink VR and health facility databases to maximise capture  
5. Analysis to track and target disparities 
1. Develop or enhance sentinel surveillance sites for pregnancy, child and 
other health outcomes (prospective), with a focus on enhancing national 
representativeness and coverage of the poorest 
2. Improve VR systems. Use specific neonatal death certificates 
3. Track urban/rural and other key disparities  
Comparable cause-of-
death categories  
Consensus on a minimum dataset to be collected on all neonatal deaths, with a limited number of programmatically relevant, comparable cause 
categories distinguishable through verbal autopsy, but which can be further specified by clinical data in mid-mortality settings and linked to complex 
classification systems/ICD codes. Include both direct fetal/neonatal causes and maternal condition so can cross tabulate 
Categorising small babies 
(weight and gestational 
age) 
 
All babies to be weighed at birth and weight to be recorded on birth and death certificates 
1. Gestational age to be assessed using routine high-quality early 
pregnancy ultrasound and recorded on birth and death certificates 
2. Track the % of births that are reported <28 weeks (noting that if <3% 
of preterm births are <28 weeks, the system may be under-recording 
preterm births) 
1. Gestational age to be assessed in all babies using simplified clinical 
examination or last menstrual period (LMP) where early pregnancy 
ultrasound is not available 
2. Improved technology and low-cost assessment tools are required to 
increase reliability 
Notes: 1) This table is adapted from the “Every Newborn: beyond survival” article published in the Lancet (3) 
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Appendix A: Country groupings by estimatation method 
The 194 countries in this analysis were separated into 3 groups based on the quality if their vital registration 
(VR) data and under-5 mortality rates (U5MR).  U5MR was used instead of the neonatal mortality rate 
(NMR) in order to be consistent with researchers working in parallel to develop estimates for children 1-59 
months old.  We kept the same country groupings as the previous work (1), with the exception of a few 
countries (see “changes to country groupings” in Appendix B). 
 
As defined in the previous work (1), countries were considered to have high-quality VR data if they 1) had 
80% or higher coverage, 2) did not have excessive use of non-specific/ill-defined VR codes, and 3) provided 
sufficient details in the coding such that the deaths could be grouped in the programmatically-relevant 
categories used in this work.  Countries that lacked high-quality VR data were included in the low mortality 
model if their U5MR from 2000-2010 was ≤35 (per 1,000 live births) and in the high mortality model if it 
their U5MR was >35.   
  
High-quality VR – 65 countries 
Antigua and Barbuda, Argentina, Australia, Austria, Bahamas, Bahrain, Barbados, Belgium, Belize, 
Brazil, Bulgaria, Chile, Colombia, Costa Rica, Croatia, Cuba, Czech Republic, Denmark, Dominica, 
Estonia, Finland, France, Germany, Greece, Grenada, Guyana, Hungary, Iceland, Ireland, Israel, Italy, 
Japan, Kuwait, Latvia, Lithuania, Luxembourg, Macedonia (TFYR of), Malta, Mauritius, Mexico, 
Montenegro, Netherlands, New Zealand, Norway, Panama, Poland, Republic of Korea, Republic of 
Moldova, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Serbia, 
Singapore, Slovakia, Slovenia, South Africa, Spain, Suriname, Sweden, Trinadad and Tobago, United 
Kingdom, United States, Uruguay, Venezuela 
 
Low mortality model – 49 countries 
Albania, Andorra, Armenia, Belarus, Bosnia and Herzegovina, Brunei Darussalam, Canada, Cabo Verde, 
China, Cook Islands, Cyprus, Ecuador, Egypt, El Salvador, Fiji, Georgia, Hondorus, Jamaica, Jordan, 
Lebanon, Libya, Malaysia, Maldives, Monaco, Nicaragua, Niue, Oman, Palau, Paraguay, Peru, Portugal, 
Qatar, Russian Federation, Samoa, San Marino, Saudi Arabia, Seyechelles, Sri Lanka, Switzerland, 
Syrian Arab Republic, Thailand, Tongo, Tunisia, Turkey, Tuvalu, Ukraine, United Arab Emirates, 
Vanuatu, Vietnam 
 
High mortality model – 80 countries 
Afghanistan, Algeria, Angola, Azerbaijan, Bangladesh, Benin, Bhutan, Bolivia, Botswana, Burkina Faso, 
Burundi, Cambodia, Cameroon, Central African Republic, Chad, Comoros, Congo, Cote d’Ivoir, 
Democratic People’s Republic of Korea, Democratic Republic of the Congo, Djibouti, Dominican 
Republic, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guinea, Guinea-
Bissau, Haiti, India, Indonesia, Iran, Iraq, Kazakhstan, Kenya, Kiribati, Kyrgyzstan, Lao People’s 
Democratic Republic, Lesotho, Liberia, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, 
Micronesia, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Niger, Nigeria, 
Pakistan, Papau New Guinea, Philippines, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, 
Solomon Islands, Somalia, South Sudan, Sudan, Swaziland, Tajikistan, Timor-Leste, Togo, 
Turkmenistan, Uganda, United Republic of Tanzania, Uzbekistan, Yemen, Zambia, Zimbabwe 
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Appendix B: Key methodological differences between current and previous estimates  
Some key methological changes since the last round of neonatal cause-of-death estimates are described 
below.  
 
Early/late neonatal period estimates 
We are now reporting the results by the early and late neonatal periods.  As described in the paper, we run 4 
separate models (early and late separately for both the low and high mortality models).   
 
Changes to country groupings 
Since the last iteration of this work, we have included Kuwait, Macedonia, Montenegro, Republic of Korea, 
and Saint Lucia in the high-quality VR countries instead of the low mortality model.  We made this change 
because VR time series data became avaible from the WHO for these countries recently.  Additionally, due 
to improved vital registration data collection in South Africa, we have now included South Africa in the 
group of high-quality VR countries instead of the high mortality model.   
 
Covariate selection  
Previously (1), we allowed the relationship between each covariate and the log of the cause/baseline cause 
ratio to be described either linearly or quadratically.  In this work, we also included the possibility of a 
restricted cubic spline relationship to include potentially more accurate non-linear relationships.  We also 
included more covariates to the low mortality model than were previously used.  
 
Additional cause categories within the multinomial 
In the low mortality model, we added injuries as a separate cause, while in the previous work injuries was 
included in the “other” category.  In the high mortality model, we included sepsis, pneumonia, and tetanus as 
separate cause categories.  In the previous work, the high mortality model included a broader “infections” 
category that included sepsis and pneumonia, and these were then split separately using the results from the 
multinomial.  Additionally, in the previous work tetanus was estimated using a single-cause, but now is a 
part of the multinomial itself.   
 
Indian estimates 
Similar to the 2010 estimates (1), we produced national Indian estimates by aggregating state-level estimates.  
For the 2010 estimates, we had developed a separate multinomial using only Indian studies/surveys for the 
input data.  This time, however, we estimated the state-level proportional cause distribution for each Indian 
state/year within the overall high mortality model.  We did this because there were not enough Indian studies 
that reported sepsis and pneumonia separately in order to estimate these causes in an India-only multinomial, 
and because the cause-of-death distribution between Indian studies and non-Indian studies appeared to be 
quite similar.    
 
Table S1 contains an overview of how the methods have changed since the first Child Health Epidemiology 
Research Group (CHERG) neonatal estimates were published in 2005 for the year 2000.   
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Table S1: Methodological differences between the current and previous estimates 
Publication 
year 
2005 2010 2012 Current 
Estimation 
year(s) 
2000 2008 2000-2010 2000-2013 
Goal of 
estimation 
Nonatal cause-of-death 
distribution for 193 
countries in 2000 
 
Neonatal cause-of-
death distribution for 
193 countries in 2008 
 
Neonatal cause-of-
death distribution for 
193 countries from 
2000-2010 
 
Neonatal cause-of-death 
distribution for 194 
countries from 2000-
2013 by early and late 
periods 
Countries in 
each model 
VR: 45 
Low mortality: 37 
High mortality: 111 
VR: 73 
Low mortality: 37 
Low/high averaged: 22 
High mortality: 61 
VR: 61 
Low mortality: 51 
High mortality: 81 
VR: 65 
Low mortality: 49 
High mortality: 80 
Thresholds 
for classifying 
countries into 
high-quality 
VR, low 
mortality 
model, or 
high 
mortality 
model 
- High quality VR = 
>90% coverage 
- Low mort model = 
countries without high-
quality VR data and 
NMR<10 (or NMR<15 
in WHO 
EURO/AMRO regions) 
- High mort model = 
remaining countries 
 
- High quality VR = 
>80% coverage 
- Low mort model = 
countries without high-
quality VR and 
NMR<15 
- averaged model = 
countries without high-
quality VR and NMR 
between 15-20: 
low/high mortality 
models averaged  
- High mort model = 
countries without high-
quality VR data and 
NMR>20 
- High quality VR = 
>80% coverage + 
quality criteria (e.g. 
limited non-
specific/implausible 
codes) 
- Low mort model = 
countries without 
adequate VR and with 
U5MR≤35 from 
2000-2010. 
- High mort model = 
countries without 
adequate VR and with 
U5MR>35 from 
2000-2010. 
- High quality VR = 
>80% coverage + 
quality criteria (e.g. 
limited non-
specific/implausible 
codes) 
- Low mort model = 
countries without 
adequate VR and with 
U5MR≤35 from 2000-
2013. 
- High mort model = 
countries without 
adequate VR and with 
U5MR>35 from 2000-
2013. 
Input data 
High mortality model: 
13685 deaths 
Low mortality model: 
96,797 deaths 
High mortality model: 
23,220 deaths 
Low mortality model: 
1,005,478 deaths  
High mortality model: 
56,890 deaths 
Low mortality model: 
1,013,599 deaths 
High mortality model: 
98,222 deaths 
Low mortality 
model:1,267,404 deaths  
Covariate 
selection 
-High mortality model: 
expert opinion on 
which covariates may 
be associated with 
outcomes 
-Low mortality model: 
forward stepwise with 
5% sig. level 
Same covariates used 
as previous round 
-High and low 
mortality models: 
jackknife procedure to 
minimize out-of-
sample prediction 
error.   
- Allowed relationship 
between covariate and 
outcome to be linear 
or quadratic 
-High and low mortality 
models: jackknife 
procedure to minimize 
out-of-sample prediction 
error.   
- Allowed relationship 
between covariate and 
outcome to be linear, 
quadratic, or spline 
Multinomial 
model 
All causes in 
multinomial 
Infections in 
multinomial with 
sepsis/pneumonia split 
done after; tetanus as 
single-cause 
Infections in 
multinomial with 
sepsis/pneumonia 
split done after; 
tetanus as single-
cause 
All causes included in 
multinomial 
Causes 
Preterm, Intrapartum, 
Congenital, Infection, 
Diarrhoea, Tetanus, 
Other 
Preterm, Intrapartum, 
Congenital, Sepsis, 
Pneumonia, Diarrhoea, 
Tetanus, Other 
Preterm, Intrapartum, 
Congenital, Sepsis, 
Pneumonia, 
Diarrhoea, Tetanus, 
Other 
Preterm, Intrapartum, 
Congenital, Sepsis, 
Pneumonia, Diarrhoea, 
Tetanus, Other (+  
injuries for VR and low 
mortality model 
countries) 
Uncertainty Jackknife Jackknife Bootstrap Bootstrap 
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Differences in global estimates between previous Child Health Epidemiology Reference Group 
(CHERG) estimates and this round are shown in table S2.  Since time trends are a recent addition, we 
have compared the data reported in the earlier studies with the relevant year from our current work.  
For example, the paper published in 2005 had estimates for 2000, so we have compared the 2000 
predictions from that paper and our work.   
 
Table S2: Comparison of estimated proportions between 
current and previous estimates 
 Percentages from 
previous work (%) 
Percentages from 
current work (%) 
2000 estimates (2) 
Preterm  27.9 (0.19-0.35) 33.1 (23.1-44.0) 
Intrapartum 22.8 (0.15-0.27) 24.8 (16.4-32.8) 
Infections 26.0 (0.17-0.31) 21.5 (10.5-35.9) 
Congenital 7.4 (0.06-0.12) 8.3 (5.0-14.2) 
Tetanus 6.5 (0.05-0.20) 3.8 (1.0-9.7) 
Diarrhoea 2.8 (0.02-0.10) 0.9 (0.1-4.7) 
Other 6.6 (0.05-0.16) 7.6 (3.8-13.2) 
2008 estimates (3) 
Preterm  28.9 (20.1-34.0) 34.6 (24.4-46.2) 
Intrapartum 22.8 (15.7-27.9) 23.8 (16.8-31.5) 
Sepsis 14.6 (10.0-20.6) 16.0 (8.2-24.7) 
Pneumonia 10.8 (7.4-15.2) 5.5 (2.8-10.4) 
Congenital 7.6 (5.7-10.7) 9.6 (6.2-15.0) 
Tetanus 1.7 (0.9-2.3) 2.1 (0.6-5.5) 
Diarrhoea 2.2 (1.6-5.9) 0.7 (0.1-3.6) 
Other 11.4 (8.9-24.7) 7.7 (3.7-13.2) 
2010 estimates (1) 
Preterm  30.2 (25.6-37.1) 35.0 (24.6-46.9) 
Intrapartum 20.1 (17.1-24.5) 23.6 (16.8-31.0) 
Sepsis 11.0 (7.0-15.4) 16.0 (8.2-24.7) 
Pneumonia 9.1 (5.8-13.1) 5.2 (2.7-10.0) 
Congenital 7.6 (5.8-10.2) 10.1 (6.4-15.6) 
Tetanus 1.6 (0.6-7.7) 1.8 (0.5-4.8)  
Diarrhoea 1.4 (0.5-4.2) 0.6 (0.2-3.3) 
Other 5.1 (3.2-7.9) 7.6 (3.7-13.2)   
Notes: 1) Intrapartum-related conditions were previously referred to 
as “birth asphyxia”; 2) infections include sepsis and other severe 
infections as well as pneumonia, which in recent years have been 
estimated separately.  To compare with previous estimates, however, 
these are included in the aggregate infection category for estimates.   
 
Note that these estimates are not necessarily directly comparable.  One reason for this is that UN-IGME 
updates their NMR, U5MR, and IMR time series each year, and so the values estimated for 2008 in one year 
may be different from those from another year.  Since our model includes these as covariates, the covariate 
values for the same year may be different for these values, which could affect the proportions.  But as is seen 
in Table S2, the previous and current estimates generally fall within each other’s uncertainty bounds.   
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Appendix C:  Mapping from ICD codes to cause categories used in this work for VR data 
 
Here we have included the mapping from the 9
th
 and 10
th
 International Classification of Diseases (ICD-9 and 
ICD-10) to the 7 programatically relevant cause categories we used in our work for the VR data.   
 
Table S3: Mapping between ICD codes and cause categories used in this work 
 ICD-10 codes ICD-9 codes 
Complications of 
preterm birth 
P01.0-P01.1, P07, P22, P25-
P28, P52, P61.2, P77 
434.9, 518.1-518.9, 761.0-761.1, 765, 
769-770.0, 770.2-770.9, 772.1, 774.2, 
776.6, 777.5-777.6, 786.3 
Intrapartum-related 
complications 
P01.7-P02.1, P02.4-P02.6, 
P03, P07, P10-P15, P20-P21, 
P24, P50, P90-P91 
348.1-348.9, 437.1-437.9, 723.4, 
761.7-762.1, 762.4-762.6, 763, 767-
768, 770.1, 772.2, 779.0-779.2 
Congenital disorders 
D55-D68.9, E01-E07, E70-
E84, G10-G99, H, I, K, L, M, 
N, P35, P76, Q 
056, 240-243, 245-259, 272-277, 
279.3-286, 288.2, 303, 330-348.0, 349-
426, 429-434.0, 435-437.0, 438-451, 
520-723.0, 724-728, 731-759, 775.2, 
777.0, 795.2 
Sepsis and other 
severe infections 
A00-A35, A38-A99, B, G00-
G09, P36-P39 
000-031, 034-055, 057-134, 136-139, 
320-326, 491, 730, 771, 780.6, 785.4 
Pneumonia A36-A37, J, P23 032-033, 460-490, 492-518.0 
Injuries S, V, W, X, Y 800-999 
Other 
C, D00-D54.9, D69-D99, 
E00, E08-E69, E85-E99, P00, 
P01.2-P01.6, P02.2-P02.3, 
P02.7-P02.9, P04-P06, P08, 
P29, P51, P53-P61.1, P61.3-
P74, P78, P80-P83, P93-P94 
135, 140-239, 244, 260-271, 278-
279.2, 287-288.1, 288.3-289, 427, 452-
459, 760, 761.2-761.6, 762.2-762.3, 
762.7-762.9, 764, 766, 772.0, 772.3-
774.1, 774.3-775.1, 775.3-776.5, 
776.7-776.9, 778.0, 779.5-779.6 
 
We excluded the following ICD codes as non-specific/ill-defined: 
1) ICD-10 – F, O, P92, P95-96, R 
2) ICD-9 – 295.4, 305.6, 205.9, 308.9, 311.0, 317.0, 319.0, 779.3, 779.8-799 (except for 780.6, 785.4, 786.3, 
and 795.2 as mentioned above) 
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Appendix D:  Details of the high-quality VR data used in the low mortality model 
Below is a table describing the missing data years for the high-quality VR countries.  This data was used as 
is for the low mortality model input dataset (i.e. no imputation of missing data).  For the high-quality VR 
country estimates, we imputed data for the years with missing data.  For years with missing data that were 
between years with existing data, we used linear interpolation to impute the missing proportions.  For years 
that were before the earliest or after the latest available data year, we applied the proportions from the 
nearest year with available data to the missing data.  None of the 7 causes we modelled for low mortality 
countries were missing in these data. The full dataset can be found at the WHO Global Health Observatory 
(www.who.int/gho).   
 
Table S4: List of years with missing data for high-quality VR countries 
Country Years with  
missing data 
Country Years with  
missing data 
Country Years with  
missing data 
Antigua and 
Barbuda 
2010-2012 Germany 2012 Panama 2010-2012 
Argentina 2011-2012 Greece 2012 Poland 2012 
Australia 2005, 2012 Grenada 2000, 2011-
2012 
Republic of Korea 2012 
Austria 2012 Guyana 2000, 2009-
2012 
Republic of 
Moldova 
none 
Bahamas 2009-2012 Hungary 2012 Romania 2012 
Bahrain 2010-2012 Iceland 2010-2012 Saint Kitts and 
Nevis 
2009-2012 
Barbados 2009-2012 Ireland 2000-2006, 
2011-2012 
Saint Lucia 2000-2001, 
2007, 2009-2012 
Belgium 2000-2002; 
2010-2012 
Israel 2011-2012 Saint Vincent and 
the Grenadines 
2011-2012 
Belize 2008-2012 Italy 2004-2005, 
2011-2012 
Serbia 2012 
Brazil 2011-2012 Japan 2012 Singapore 2012 
Bulgaria 2012 Kuwait 2000, 2012 Slovakia 2011-2012 
Chile 2010-2012 Latvia 2011-2012 Slovenia 2011-2012 
Colombia 2010-2012 Lithuania 2011-2012 South Africa 2000-2005, 
2008, 2010-2012 
Costa Rica 2010-2012 Luxembourg 2012 Spain 2012 
Croatia 2012 Macedonia 
(TYFR of) 
2001-2004, 
2011-2012 
Suriname 2010-2012 
Cuba 2011-2012 Malta 2012 Sweden 2011-2012 
Czech 
Republic 
2012 Mauritius 2012 Trinadad and 
Tobago 
2003, 2009-2012 
Denmark 2000, 2010-
2012 
Mexico 2011-2012 United Kingdom 2011-2012 
Dominica 2011-2012 Montenegro 2000-2004, 
2010-2012 
United States 2011-2012 
Estonia 2009, 2012 Netherlands 2012 Uruguay 2002-2003, 
2005-2006, 
2010-2012 
Finland 2012 New Zealand 2010-2012 Venezuela 2008-2012 
France 2010-2012 Norway 2012   
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Appendix E:  Inclusion criteria for studies in the high mortality model input dataset  
For this work, we used the same criteria for selecting new studies to include in the input dataset as used in 
previous iterations of this work (4).  The criteria are as follows: 
 
 Publication in 1980 or later 
 Study set in one of nine (of a total of 14) subregions with no or few countries with >90% VR coverage 
 Community-based study or hospital based in populations with over 90% hospital delivery and defined 
catchment population 
 Case ascertainment: follow up of newly born infants from birth to at least 7 or 28 days 
 Number of deaths with known cause ≥ 20 
 Study duration ≥ 12 months 
 Included four or more of the eight selected programme relevant causes of neonatal death 
 Deaths of unknown cause ≤ 25% of total deaths 
 Cause attribution based on skilled clinical investigation, post mortem, or verbal autopsy 
 Case definitions specified and comparable with other studies 
 
Our search strategy involved doing a literature review in ten databases for articles published between 
January 2011 and May 2013.  Previous searches covered periods from 1980 to December 2010.  The 
databases we searched were Pubmed, Embase, Web of Knowledge, Medline, Global Health, Popline, and 
region-specific indices (LILACS, Africa-Wide Information, Western Pacific Region, Eastern Mediterranean, 
IndMed).   
 
Our search covered the following areas (including variations, alternatives, and MESH for these terms): 
Cause-specific (one or more of these): haemorrhage, jaundice, abnormality, malformation, neural tube 
defect, sudden infant daeath syndrome, congenital malformations, congenital abnormalities, necrotic, 
respiratory distress, prematurity, preterm birth, asphyxia, tetanus, sepsis, birth injury, intrapartum, birth, 
cause, fetal alcohol syndrome, rubella, diarrhea, dysentery, cholera, gastroenteritis, digestive tract infection, 
pneumonia, respiratory infections, bronchitis, croup, meningitis, encephalitis, meningococcal 
AND 
Age group (one or more of these): infant/newborn, neonatal, perinatal  
AND  
Mortality terms (one or more of these): death, mortality, fatality 
AND 
High mortality countries/regions: Argentina, Bolivia, Brazil, Brasil, Chile, Colombia, Ecuador, French 
Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Mexico, Belize, Costa Rica, El Salvador, 
Guatemala, Honduras, Nicaragua, Puerto Rico, Panama, West Indies, Antigua, Bahamas, Barbados, Cuba, 
Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Antilles, Anguilla, Saint 
Kitts, St Kitts, Saint Lucia, St Lucia, Saint Vincent, St Vincent, Trinidad, Tobago, Virgin Islands, 
Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Borneo, Brunei, Cambodia, East Timor, 
Indonesia, Laos, Malaysia, Mekong Valley, Myanmar, Burma, Philippines, Singapore, Thailand, Vietnam, 
Bangladesh, Bhutan, India, Nepal, Pakistan, Sri Lanka, China, Korea, Macao, Mongolia, Taiwan, 
Afghanistan, Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, Turkey, 
United Arab Emirates, Yemen, Fiji, New Caledonia, Papua New Guinea, Vanuatu, Micronesia, Melanesia, 
Guam, Palau, Polynesia, Samoa, Tonga, Armenia, Azerbaijan, Georgia, Albania, Estonia, Latvia, Lithuania, 
Bosnia, Herzegovina, Serbia, Bulgaria, Belarus, Croatia, Czech Republic, Hungary, Macedonia, Moldova, 
Montenegro, Poland, Romania, Russia, Bashkiria, Dagestan, Slovakia, Slovenia, Ukraine, Cameroon, 
Central African Republic, Chad, Congo, "Democratic Republic of the Congo", Equatorial Guinea, Gabon, 
Burundi, Djibouti, Eritrea, Ethiopia, Kenya, Rwanda, Somalia, Sudan, Tanzania, Uganda, Angola, 
Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia, Zimbabwe, Benin, 
Burkina Faso, Cote d'Ivoire, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia,  Mali, Mauritania, Niger, 
Nigeria, Senegal, Sierra Leone, Togo, Algeria, Egypt, Libya, Morocco, Tunisia, Comoros, Madagascar, 
Mauritius, Reunion, Seychelles, developing country, third world country, less developed, sub-Saharan, 
Caribbean, Pacific Islands, Mexico, Latin America, South America,  Indian Ocean Islands, Central America, 
Asia, Africa, Far East 
AND  
NOT “case reports”, editorial, comment, practice guideline  
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Appendix F:  Details of the study data for the high mortality model input dataset 
Below is a table describing the studies and surveys included in the high mortality model input dataset.  New 
studies have an asterisk (*) in front of the author name.  While most studies were included in the dataset as a 
single observation, those stratified by neonatal period or in other ways (e.g. setting location) were included 
as multiple observations.  The full dataset can be found at the WHO Global Health Observatory 
(www.who.int/gho).   
 
Table S5: Details of the high mortality model input dataset   
First author Year 
published 
Country Additional 
strata 
Median 
data year 
# of causes 
reported 
# of deaths 
used in 
analysis 
Adazu (5) 2005 Kenya  2002 5 75 
Aguilar (6) 1998 Bolivia  1995 8 79 
*Akgun (7) 2012 Turkey  2003 4 34 
Aleman (8) 1998 Nicaragua  1993 6 72 
Anand (9) 2000 India  1993 8 50 
Asling-Monemi 
(10) 
 2003 Nicaragua  1995 6 56 
Awasthi (11) 1998 India  1994 7 286 
Baiden (12) 2006 Ghana  1999 4 1001 
Balci (13) 2008 Turkey early/late 2006 5 68 
Bang (14) 1999 India  1994 6 36 
*Bapat (15) 2012 India early/late 2006 5 102 
Baqui (16) 2006 India early/late not given 7 477 
Barros (17) 1987 Brazil  1982 7 113 
Barros (18) 2008 Brazil  2004 8 54 
Bassani (19) 2010 India  2002 7 10892 
Bezzaoucha (20) 2010 Algeria early/late 2003 5 2167 
Bhatia (21) 1989 Bangladesh  1982 7 513 
Bhutta (22) - Pakistan  2001 7 152 
Campbell (23) 2004 Egypt  2000 7 103 
Chowdhury (24) 1996 Bangladesh  1983 5 474 
Chowdhury (25) 2005 Bangladesh early/late 1992 5 43 
Chowdhury (26)  2010 Bangladesh   2004  8 332 
Darmstadt (27) 2010 Bangladesh time periods 2002 7 56 
Darmstadt (27) 2010 Bangladesh time periods 2005 7 125 
Datta (28) 1988 India  not given 8 163 
Deribew (29) 2007 Ethiopia  2005 8 45 
*DHS (30) 2005 Bangladesh  2002 8 302 
*DHS (31) 2006 Honduras  2004 7 142 
*DHS (32) 2007 Nepal  2004 8 220 
*DHS (33) 2008 Pakistan  2006 8 1484 
*DHS (34) 2009 Mozambique  2007 5 718 
Djaja (35) 2003 Indonesia  2001 8 178 
Dommisse (36) 1991 South Africa early/late 1988 7 276 
Edmond (37) 2008 Ghana early/late 2004 5 582 
Ekanem (38) 1994 Nigeria  1991 7 24 
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Table S5: Details of the high mortality model input dataset   
First author Year 
published 
Country Additional 
strata 
Median 
data year 
# of causes 
reported 
# of deaths 
used in 
analysis 
El-Zibdeh (39) 1988 Saudi Arabia  1983 7 78 
Fantahun (40) 1998 Ethiopia  1992 7 47 
Fauveau (41) 1990 Bangladesh  1982 8 201 
Fikree (42) 2002 Pakistan  1992 8 497 
Fonseka (43) 1994 Sri Lanka  1987 7 253 
Garenne (44) 2007 Morocco time periods 1987 8 109 
Garenne (44) 2007 Morocco time periods 1987 8 329 
*Gill (45) 2011 Zambia  2007 7 58 
Gomes (46) 1997 Brazil early/late 1991 6 138 
Greenwood (47) 1987 Gambia  1982 8 32 
Halder (48) 2009 Bangladesh  2007 8 49 
Hinderaker (49) 2003 Tanzania early/late 1995 5 71 
Jehan (50) 2009 Pakistan early/late 2004 5 49 
Karabulut (51) 2009 Turkey early/late 2006 6 178 
Khalique (52) 1993 India early/late 1990 8 21 
Khan (53) 1993 Pakistan  1986 7 80 
*Khanal (32) 2011 Nepal early/late 2006 5 183 
Khanjanasthiti 
(54) 
1984 Thailand  not given 8 22 
Kishan (55) 1988 Libya  1984 6 245 
*Krishnan (56) 2012 India time periods 1983 5 154 
*Krishnan (56) 2012 India time periods 2003 5 106 
Leach (57) 1999 Gambia  1992 8 130 
Liu (58) 1985 China  1980 7 956 
Lucas (59) 1996 Sri Lanka  1993 6 120 
Manandhar 
(60) 
2010 Nepal  2007 5 640 
*Matendo (61) 2011 Congo  2005 6 56 
Matijasevich (62) 2008 Brazil time periods 1982 4 115 
Matijasevich (62) 2008 Brazil time periods 1993 4 88 
Matijasevich (62) 2008 Brazil time periods 2004 4 47 
Mendieta (63) 2001 Paraguay  1996 6 3638 
Nandan (64) 2005 India  2001 8 299 
*Nga (65) 2012 Viet Nam  2009 7 225 
Pattison (66) 2013 South Africa  2006 7 45848 
Perry (67) 2003 Bangladesh  1997 8 102 
Perry (67) 2003 Haiti  1997 8 28 
Phukan (68) 1998 India  1994 7 101 
Pison (69) 1993 Senegal  1987 6 26 
Pratinidhi (70) 1986 India  1982 7 135 
Rahman (71) 1989 Bangladesh early/late 1985 7 69 
Rajindrajith (72) 2009 Sri Lanka  1999 6 17946 
*RHS (31) 1997 Honduras  1994 7 121 
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Table S5: Details of the high mortality model input dataset   
First author Year 
published 
Country Additional 
strata 
Median 
data year 
# of causes 
reported 
# of deaths 
used in 
analysis 
*RHS (31) 2002 Honduras  1999 7 143 
Samms-Vaughan 
(73) 
1990 Jamaica  1986 7 885 
Schumacher (74) 2002 Guinea  1998 8 94 
Settel (75) 2004 Tanzania location 2000 8 75 
Settel (75) 2004 Tanzania location 2000 8 119 
Settel (75) 2004 Tanzania location 2000 8 124 
Shah (76) 2010 India  2006 8 22 
Sharifzadeh (77) 2008 Iran  2005 7 87 
Shrivastava (78) 2001 India early/late 1995 8 895 
Singhal (79) 1990 India early/late 1984 7 50 
Sivagnanasundram 
(80) 
1985 Sri Lanka early/late 1982 8 46 
Tikmani (81) 2010 Pakistan  2005 7 41 
*Turnbull (82) 2011 Zambia  2008 6 35 
Vaid (83) 2007 India early/late 2000 8 102 
Waiswa (84) 2010 Uganda  2007 7 58 
Walraven (85) 2003 Gambia  2000 6 70 
Woods (86) 2001 South Africa  2001 7 253 
Yassin (87) 2000 Egypt  1994 8 39 
 
Appendix G: Assumptions about missing causes in the high mortality model input data  
Of the 112 observations in the high mortality model input data, 34 had no causes missing, 37 had one cause missing, 13 
had two causes missing, 23 had three causes missing, and 5 had four causes missing.  No observations were missing 
data for the “intrapartum” or “other” cause categories.  For the other causes, the assumptions we made about the cause 
category into which any deaths from an unreported cause would have been assigned are shown in table S6.   
 
Table S6: Assumptions about missing causes in the high 
mortality model input data 
 # of observations with 
this cause missing 
If missing, 
assumed to be in… 
Preterm 1 Other 
Congenital 13 Other 
Sepsis 3 Other 
Pneumonia 62 Sepsis 
Diarrhoea 42 Sepsis 
Tetanus 31 Sepsis 
Notes: 1) observations with sepsis missing were also missing all 
other infection categories (diarrhea, pneumonia, tetatanus) 
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Appendix H:  Sensitivity analysis assuming 65% and 85% for early period proportion 
Based on previous work (88), we assumed that 74% and 26% of neonatal deaths occurred in the 
early and late periods, respectively, for countries without adequate VR data.  The three-
quarters/one-quarter split is quite consistent across countries, including ones with widely varying 
contexts (88).  However, to test how this affected our results, we estimated the global cause-of-
death distribution for the overall neonatal period if the proportion of early neonatal deaths was 65% 
or 85% instead of 74%.  The results are shown in table S7.   
 
Table S7: Global cause-specific proportions and numbers of neonatal deaths in 2013 
assuming different proportions of early neonatal deaths 
 Assuming 74% deaths 
in early neonatal 
period (current 
method)* 
Assuming 65% deaths 
in early neonatal 
period* 
Assuming 85% deaths 
in early neonatal 
period* 
% # of deaths in 
thousands 
(uncertainty) 
% # of deaths 
in 
thousands  
% # of deaths 
in thousands  
Preterm 35.7 986.9 
(699.1-1312.5) 
34.0 939.8 37.8 1044.4 
Intrapartu
m 
23.4 644.8 
(462.4-844.7) 
22.1 610.4 24.9 686.9 
Congenital 10.5 289.8 
(183.3-450.4) 
10.4 288.1 10.6 291.8 
Sepsis 15.6 430.4 
(218.9-664.8) 
18.2 501.5 12.4 343.6 
Pneumoni
a 
4.9 136.4 
(70.3-259.0) 
5.0 137.0 4.9 135.8 
Diarrhoea 0.6 16.6 
(3.2-83.0) 
0.7 19.3 0.5 13.4 
Tetanus 1.7 48.2 
(15.5-120.4) 
2.0 55.0 1.4 39.8 
Other 7.5 207.8 
(99.0-367.4) 
7.6 209.8 7.4 205.4 
* this split is only applied to countries for which modelled estimates are needed – the split for 
countries with high-quality VR data is taken from the data as is.  Additional notes: 1) diarrhoea 
and tetanus were estimated only for the 80 high mortality model countries; and 2) injuries are 
included within the “other” category.   
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Appendix I:  Comparison of input and prediction covariates in the multinomial models 
 
Table S8a: Comparison of input and prediction covariates in the low and high 
mortality models  
 Input data Prediction data 
 Mean 
(SD) 
Median  
(IQR) 
Range  
(min-
max) 
Mean 
(SD) 
Median 
(IQR) 
Range 
(min-
max) 
Low mortality model 
NMR 
6.2 
(4.3) 
4.7  
(2.8-8.8) 
1.1-24.4 
9.2  
(4.5) 
9.1  
(5.4-12.4) 
1.1-22.5 
IMR 
9.6 
(7.2) 
7.0  
(4.2-13.6) 
1.8-49.9 
15.0  
(7.7) 
15.1  
(8.4-20.6) 
2.2-35.9 
U5MR 
11.4 
(8.8) 
8.2  
(5.0-15.6) 
2.3-76.9 
17.8  
(9.3) 
17.6 
(9.9-24.3) 
3.0-44.8 
LBW 
7.3 
(2.5) 
7.0  
(5.7-8.2) 
3.8-23.2 
8.7  
(3.6) 
8.4  
(6.3-10.2) 
0.0-22.3 
GNI 
21026 
(13292
) 
18130 
(11021- 
30090) 
1490-
67970 
20450 
(38356) 
7302 
(4450-
19600) 
1400-
327346 
GFR 
0.055 
(0.018) 
0.050 
(0.040-
0.065) 
0.033-
0.119 
0.076 
(0.029) 
0.075 
(0.050-
0.096) 
0.032-
0.171 
GINI 
37.6 
(9.7) 
34.3 
(30.9-45.3) 
24.2-67.4 
39.3 
(7.7) 
39.4 
(32.6-42.1) 
25.6-69.2 
ANC 
96.7 
(4.3) 
97.9 
(96.3-99.4) 
71.3-100 
93.6 
(7.2) 
96.3 
(90.3-98.9) 
52.9-
100.0 
DPT 
94.2 
(5.6) 
96.0 
(93.0-98.0) 
62.0-99.0 
93.1 
(8.6) 
96.0  
(92.0-98.0) 
41.0-99.0 
femlit 
93.0 
(4.7) 
92.4 
(90.7-97.0) 
70.3-99.8 
87.8 
(9.0) 
90.1  
(81.9-93.5) 
50.6-99.7 
High mortality model 
NMR 
33.0 
(15.9) 
30.2 
(18.8-47.2) 
10.5-70.1 
30.2 
(10.2) 
29.7 
(21.8-37.3) 
8.8-55.1 
IMR 
62.1 
(30.0) 
58.7 
(35.7-81.6) 
14.7-142.0 
60.3 
(24.9) 
57.2 
(40.0-76.5) 
14.4-
141.3 
U5MR 
88.6 
(45.8) 
89.1 
(52.9-125.4) 
17.1-227.0 
89.2 
(45.1) 
83.0 
(52.0-116.7) 
16.3-
231.5 
LBW 
18.9 
(11.3) 
15.9 
(10.6-27.6) 
2.5-50.0 
14.2 
(6.7) 
12.8 
(10.2-16.7) 
4.2-35.6 
GFR 
0.127 
(0.043) 
0.118 
(0.092-
0.158) 
0.057-
0.235 
0.140 
(0.046) 
0.145 
(0.101-
0.175) 
0.054-
0.246 
ANC 
67.5 
(26.5) 
73.9 
(50.0-92.0) 
5.0-98.3 
78.6 
(18.5) 
84.1 
(71.0-92.7) 
16.1-
100.0 
DPT 
67.9 
(24.6) 
73.5 
(60.5-83.5) 
0.0-99.0 
76.3 
(18.5) 
80.0 
(66.0-91.0) 
3.0-99.0 
BCG 
78.8 
(23.9) 
87.0 
(73.0-93.0) 
0.0-100.0 
85.1 
(14.2) 
90.0 
(78.0-96.0) 
24.0-99.0 
PAB 63.3 68.0 0.0-98.5 76.0 79.7 24.0-97.0 
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(25.0) (51.4-83.5) (13.1) (68.2-85.0) 
femlit 
51.9 
(24.7) 
48.7 
(34.6-77.3) 
4.0-94.0 
62.2 
(23.6) 
61.8 
(43.9-83.6) 
9.4-100.0 
SBA 
48.7 
(33.1) 
45.3 
(18.9-83.7) 
0.0-100.0 
60.1 
(25.3) 
60.2 
(42.0-82.0) 
5.6-100.0 
Region 
 
East Asia and Pacific: n = 4 
Europe and Central Asia: n = 5 
Latin America/Caribbean: n = 16 
Middle East and North Africa: n = 8 
South Asia: n = 52 
Sub-Saharan Africa: n = 26 
High income: n = 1 
East Asia and Pacific: n = 14 
Europe and Central Asia: n = 6 
Latin America/Caribbean: n = 4 
Middle East and North Africa: n = 6 
South Asia: n = 5 
Sub-Saharan Africa: n = 44 
High income: n = 0 
  
Notes: 1) bolded values are those outside the input data range; 2) these do not include Indian states (see table S8b 
for comparison of Indian state data); 3) SD = standard deviation, IQR = interquartile range; 4) region was only 
included as a covariate in the high mortality model; 5) covariate acronyms are as follows: NMR = neonatal mortality 
rate (per 1,000 live births); IMR = infant mortality rate (per 1,000 live births); U5MR = under-5 mortality rate (per 
1,000 live births); LBW = low birth weight rate (%); GNI = gross national income; GFR = general fertility rate; GINI = 
gini coefficient; ANC = antenatal care (%); DPT = diphtheria/pertussis/tetanus vaccine (%); femlit = female literacy 
(%); BCG = Bacille Calmette-Guerin vaccine (%); PAB = Protected at birth (against neonatal tetanus) (%); SBA = 
skilled birth attendance (%).   
 
Table S8b table is similar the table above, but the prediction data is now for Indian states.  In the 
analysis, we predicted the proportional cause-of-death distribution at the state-level for India and 
aggregated the estimates to develop national estimates.   
 
Table S8b: Comparison of high mortality model input covariates and 
covariates for Indian states 
 High mortality model input 
data 
Indian state-level prediction 
data 
 Mean 
(SD) 
Median  
(IQR) 
Range  
(min-
max) 
Mean 
(SD) 
Median 
(IQR) 
Range 
(min-
max) 
NMR 
33.0 
(15.9) 
30.2 
(18.8-47.2) 
10.5-70.1 
26.8 
(11.6) 
26.8 
(18.1-33.9) 
6.3-59.9 
IMR 
62.1 
(30.0) 
58.7 
(35.7-81.6) 
14.7-
142.0 
40.2 
(17.3) 
38.8 
(27.1-52.2) 
9.2-95.5 
U5M
R 
88.6 
(45.8) 
89.1 
(52.9-
125.4) 
17.1-
227.0 
54.9 
(25.2) 
51.0 
(36.1-72.5) 
11.8-
122.0 
LBW 
18.9 
(11.3) 
15.9 
(10.6-27.6) 
2.5-50.0 
20.4 
(8.4) 
21.0  
(15.0-26.0) 
0.0-43.0 
GFR 
0.127 
(0.043) 
0.118 
(0.092-
0.158) 
0.057-
0.235 
0.089 
(0.007) 
0.088 
(0.083-
0.096) 
0.080-
0.103 
ANC 
67.5 
(26.5) 
73.9 
(50.0-92.0) 
5.0-98.3 
77.8 
(13.2) 
75.2  
(70.1-88.8) 
33.1-99.5 
DPT 
67.9 
(24.6) 
73.5 
(60.5-83.5) 
0.0-99.0 
68.9 
(14.4) 
70.6 
(61.2-78.1) 
30.2-96.9 
BCG 
78.8 
(23.9) 
87.0 
(73.0-93.0) 
0.0-100.0 
87.2 
(10.9) 
89.7 
(85.0-96.1) 
45.4-99.5 
PAB 
63.3 
(25.0) 
68.0 
(51.4-83.5) 
0.0-98.5 
72.6 
(15.5) 
76.9 
(60.6-85.4) 
31.3-97.1 
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femli
t 
51.9 
(24.7) 
48.7 
(34.6-77.3) 
4.0-94.0 
62.9 
(14.7) 
63.8 
(52.7-70.3) 
35.4-94.0 
SBA 
48.7 
(33.1) 
45.3 
(18.9-83.7) 
0.0-100.0 
59.8 
(16.8) 
59.4 
(48.1-70.0) 
25.5-99.6 
   
Notes: 1) bolded values are those outside the input data range; 2) the region covariate was “Southern 
Asia” for all states; 3) SD = standard deviation, IQR = interquartile range; 4) covariate acronyms are in the 
footnotes of table S5a.  
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Appendix J:  Sensitivity analysis – uncapped prediction covariate values  
As noted in the paper, we capped the predication covariate values to the min/max of the input covariate 
values in both the low and high mortality models to avoid predicting on covariates outside fo the input data 
range.  Capping the prediction data will tend to “shrink” the predicted cause distribution towards that seen in 
the input data. Here, we present the results of a sensitivity analysis in which we ran the low and high 
mortality models without the caps on the covariate values.   
 
Low mortality model 
Table S9a: Low mortality model sensitivity analysis of uncapped prediction covariate 
values for 2013 
 Early Late 
 % of 
deaths 
(capped) 
% of  
deaths 
(uncapped) 
Difference  % of 
deaths 
(capped) 
% of  
deaths 
(uncapped) 
Difference  
Preterm 43.0 44.2 +1.2 27.9 27.7 -0.2 
Intrapartum 15.8 16.5 +0.7 9.0 9.2 +0.2 
Congenital 21.8 19.1 -2.7 27.6 27.4 -0.2 
Sepsis 5.8 6.1 +0.3 17.6 17.9 +0.3 
Pneumonia 2.9 3.0 +0.1 9.9 9.8 -0.1 
Injuries 0.7 0.7 0 1.5 1.5 0 
Other 10.1 10.4 +0.3 6.7 6.6 -0.1 
   
Notes: 1) the “capped” analysis is the main analysis presented in the paper; the “uncapped” is the sensitivity analysis.   
 
Excluding countries with few deaths (<50), the key differences (greater than 5 percentage point difference) 
in countries were:  
 1) Egypt (both periods, 2000-2006) – intrapartum was 5-9 percentage points higher in the sensitivity 
      analysis 
 2) Syria (xxx periods, 2012-2013) – sepsis was 9-11 percentage points higher and congenital was 6 
     percentage points lower in the sensitivity analysis 
 3) Honduras (early period, 2000) – injuries was 8 percentage points higher in the sensitivity              
      analysis  
 4) Jordan (early period, 2000) – injuries was 5 percentage points higher in the sensitivity analysis 
 
High mortality model 
Table S9b: High mortality model sensitivity analysis of uncapped prediction covariate 
values 
 Early Late 
% of 
deaths 
(capped) 
% of  
deaths 
(uncapped) 
Difference  % of 
deaths 
(capped) 
% of  
deaths 
(uncapped) 
Difference  
Preterm 40.6 40.6 0 20.3 20.3 0 
Intrapartum 28.8 28.7 -0.1 13.5 13.5 0 
Congenital 9.0 9.0 0 7.6 7.6 0 
Sepsis 8.3 8.3 0 40.0 40.1 +0.1 
Pneumonia 5.2 5.2 0 4.7 4.7 0 
Tetanus 1.2 1.2 0 4.4 4.3 -0.1 
Diarrhoea 0.4 0.4 0 1.6 1.6 0 
Other 6.7 6.7   0 7.9 7.9 0 
   
Notes: 1) the “capped” analysis is the main analysis presented in the paper; the “uncapped” is the sensitivity analysis.   
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In the early period, both Niger (2000, “other”) and Kazhakstan (2013, “congenital”) were 2 percentage 
points higher in the sensitivity analysis.  No other countries had more than a one percentage point difference 
between the sensitivity versus main analysis.   
Appendix K: Selected covariates in model equations and performance of the equations 
The following table lists the covariates that were selected for each of the four models, as well as the 
performance of each equation in reducing the out-of-sample residuals.  The % reduction in residuals were 
calculated based on comparing the chi-squared statistic (sum of the squared differences between the 
observed and expected deaths divided by expected deaths) of the final equation compared to the null model 
with no covariates (see main paper for further methods).  While for some causes our models seemed to 
explain the majority of variation in the input data, for others the models performed less well. The 
poorer performance for some causes may be due to a number of factors, including the limited range of 
covariates available for inclusion, inaccurate measurement of included covariates, or the possibility 
that there is no pattern that can be predicted based on the input data.  
 
Table S10: Selected covariates in equations of the low and high mortality models and % 
reduction in residuals 
 Early neonatal period Late neonatal period 
Selected covariates1 % reduction 
in residuals 
Selected covariates1 % reduction 
in residuals 
Low mortality model 
Intrapartum: 
Preterm 
L: femlit 16% S: femlit, DPT 21% 
Congenital: 
Preterm 
L: GINI, DPT, femlit 
S: IMR, U5MR, LBW 
62% L: NMR, DPT 10% 
Sepsis: 
Preterm 
L: GNI, GINI, ANC 
S: IMR, DPT 
66% 
L: femlit, GINI 
Q: IMR 
S: DPT 
67% 
Pneumonia: 
Preterm 
L: GNI 25% 
L: GNI 
S: ANC 
40% 
Injuries: 
Preterm 
Q: GFR 17% none 0% 
Other: 
Preterm 
Q: GFR 
19% 
 
L: LBW 
Q: DPT 
S: NMR 
16% 
High mortality model 
Preterm: 
Intrapartum 
L: BCG, PAB, SBA, DPT 
S: LBW, GFR 
47% 
S: LBW, PAB, GFR 
B: reg_SSA 
61% 
Congenital: 
Intrapartum 
L: LBW 
Q: NMR, U5MR 
S: BCG 
B: period 
77% 
Q: SBA, U5MR 
B: period, reg_SSA 
71% 
Sepsis: 
Intrapartum 
L: LBW 
Q: BCG 
B: period, reg_SA 
81% 
Q: PAB 
S: LBW 
B: period 
13% 
Pneumonia: 
Intrapartum 
L: U5MR, LBW 
B: period 
16% Q: PAB 23% 
Diarrhoea: 
Intrapartum 
L: DPT, GFR 
Q: NMR 
B: period, reg_SA, 
reg_SSA 
87% 
L: DPT, BCG, GFR, 
femlit 
S: LBW 
B: reg_LAC 
45% 
Tetanus: 
Intrapartum 
L: PAB, ANC, NMR 
B: period 
86% 
L: NMR, IMR, U5MR, 
PAB 
B: period 
44% 
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Other: 
Intrapartum 
S: GFR 
B: reg_SSA 
6% 
S: GFR 
B: period, reg_SSA 
49% 
  
Notes: 1) L = linear; Q = quadratic; S = restricted cubic spline; B = binary; 2) reg_SSA = sub-Saharan Africa, reg_SA = 
South Asia, reg_LAC = Latin America and the Caribbean; 3) see the “notes” at the end of table S7a for the other 
covariate acronym definitions. 
Appendix L:  Regression coefficients for the low and high mortality models 
The following table includes the regression coefficients from the multinomial regressions for the two models 
used in this work.   
 
Table S11: Regression coefficients for the low and high mortality models 
 Early neonatal period Late neonatal period 
Coveraites with regression 
coefficients 
Covariate with regression 
coefficients 
Low mortality model 
Intrapartum: 
Preterm 
femlit (-0.018); const (0.572) 
femlit_S1 (-0.030); femlit_S2 (-
0.025); femlit_S3 (0.134); DPT_S1 
(0.002); DPT_S2 (0.006); DPT_S3 
(0.064); const (1.173) 
Congenital: 
Preterm 
GINI (-0.008); DPT (0.015); femlit 
(0.004); IMR_S1 (-1.669); IMR_S2 
(11.454); IMR_S3 (-13.670); 
U5MR_S1 (1.417); U5MR_S2 (-
9.443); U5MR_S3 (13.523); 
LBW_S1 (0.185); LBW_S2 (-1.133); 
LBW_S3 (2.726); const 
NMR (-0.039); DPT (0.007); const 
(-0.307) 
Sepsis: 
Preterm 
GNI (-2.6x10-5); GINI (0.025); ANC 
(0.029); IMR_S1 (-0.274); IMR_S2 
(2.647); IMR_S3 (-4.009); DPT_S1 
(-0.013); DPT_S2 (0.034); DPT_S3 
(-0.555); const (-3.267) 
femlit (-0.009); GINI (0.031); 
DPT_S1 (-0.026); DPT_S2 (0.062); 
DPT_S3 (-1.125); IMR (0.049); 
IMR_Q (-0.001); const (0.643) 
Pneumonia: 
Preterm 
GNI (-6.7x10-5); const (-2.078) 
GNI (-4.8x10-5); ANC_S1 (0.072); 
ANC_S2 (-0.205); ANC_S3 (2.250); 
const (-6.979) 
Injuries: 
Preterm 
GFR (-104.414); GFR_Q (763.714); 
const (-0.903) 
const (-2.942) 
Other: 
Preterm 
GFR (103.863); GFR_Q (-908.192); 
const (-4.231) 
LBW (0.029); NMR_S1 (-0.212); 
NMR_S2 (1.117); NMR_S3 (-
1.514); DPT (-0.090); DPT_Q 
(0.001); const (2.433) 
High mortality model 
Preterm: 
Intrapartum 
BCG (0.007); PAB (-0.007); SBA 
(0.010); DPT (-0.004); LBW_S1 
(0.028); LBW_S2 (-0.006); GFR_S1 
(-11.980); GFR_S2 (14.787); const 
(0.602) 
LBW_S1 (0.038); LBW_S2 (-
0.054); PAB_S1 (-0.011); PAB_S2 
(0.000); GFR_S1 (-21.739); GFR_S2 
(19.502); reg_SSA (0.305); const 
(2.764) 
Congenital: 
Intrapartum 
LBW (0.009); NMR (-0.073); 
NMR_Q (0.001); U5MR (-0.022); 
U5MR_Q (0.000); BCG_S1 (0.004); 
BCG_S2 (0.003); early (0.223); 
const (0.364) 
SBA (-0.021); SBA_Q (0.000); 
U5MR (-0.021); U5MR_Q (0.000); 
late (0.739); reg_SSA (-0.186); 
const (-0.070) 
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Sepsis: 
Intrapartum 
LBW (0.013); BCG (0.022); BCG_Q 
(0.000); early (-0.765); reg_SA 
(0.253); const (-2.303) 
PAB (0.019); PAB_Q (0.000); 
LBW_S1 (0.023); LBW_S2 (-
0.018); late (1.510); const (-1.708) 
Pneumonia: 
Intrapartum 
U5MR (0.006); LBW (0.009); early 
(-0.674); const (-1.713) 
PAB (-0.029); PAB_Q (0.000); 
const (-0.092) 
Diarrhoea: 
Intrapartum 
DPT (-0.005); GFR (12.725); NMR 
(0.282); NMR_Q (-0.003); early (-
1.725); reg_SA (-0.226); reg_SSA (-
1.491); const (-8.746) 
DPT (-0.003); BCG (-0.011); GFR (-
3.800); femlit (-0.022); LBW_S1 
(0.139); LBW_S2 (-0.192); const (-
1.332) 
Tetanus: 
Intrapartum 
PAB (-0.011); ANC (-0.018); NMR 
(0.043); early (-0.985); const (-
1.642) 
NMR (0.038); IMR (-0.010); U5MR 
(0.011); PAB (-0.020); late 
(0.839); const (-2.186) 
Other: 
Intrapartum 
GFR_S1 (-22.942); GFR_S2 
(33.572); reg_SSA (-0.746); const 
(0.824) 
GFR_S1 (-25.195); GFR_S2 
(25.625); late (0.474); reg_SSA 
(0.317); const (1.317) 
  
Notes: 1) reg_SSA = sub-Saharan Africa, reg_SA = South Asia, reg_LAC = Latin America and the Caribbean; 2) see the 
“notes” at the end of table 1 for covariate acronym definitions; 3) while most regression coefficients have been 
rounded to the third decimal place in this table, GNI has been rounded to the 6th decimal place because the GNI 
values are on the order of thousands instead of the much smaller values of the other coefficients.   
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Appendix M:  Results by NMR level and World Bank income category 
Table S12a: Cause-specific proportions (median with IQR) and risk (with uncertainty) for 2013 by NMR level  
 Median proportion (with IQR) by NMR level  Total risk (with uncertainty) by NMR level  
<5 5 to <15 15 to <30 30+ <5 5 to <15 15 to <30 30+ 
      Early neonatal period  
Preterm 0.35 (0.29-
0.45) 
0.31 (0.26-
0.42) 
0.27 (0.15-
0.35) 
0.25 (0.16-
0.37) 
1.1 (1.0-
1.2) 
2.9 (2.5-
3.4) 8.4 (5.4-11.8) 
11.0 (8.6-
13.1) 
Intrapartu
m 
0.10 (0.07-
0.14) 
0.13 (0.09-
0.18) 
0.18 (0.15-
0.32) 
0.22 (0.15-
0.34) 
0.3 (0.2-
0.3) 
1.3 (1.1-
1.6) 5.4 (3.7-7.5) 9.3 (7.3-10.9) 
Congenital 0.31 (0.24-
0.38) 
0.24 (0.20-
0.29) 
0.11 (0.08-
0.14) 
0.05 (0.05-
0.07) 
0.6 (0.5-
0.7) 
1.5 (1.1-
1.9) 1.9 (1.1-3.1) 1.7 (1.1-2.7) 
Sepsis 0.05 (0.02-
0.11) 
0.10 (0.06-
0.21) 
0.11 (0.09-
0.43) 
0.23 (0.09-
0.45) 
0.1 (0.0-
0.1) 
0.5 (0.3-
0.6) 1.7 (0.5-3.0) 2.4 (0.9-3.8) 
Pneumoni
a 
0.01 (0.00-
0.02) 
0.04 (0.02-
0.07) 
0.05 (0.04-
0.06) 
0.05 (0.05-
0.07) 
0.0 (0.0-
0.0) 
0.2 (0.1-
0.3) 0.9 (0.4-1.9) 2.0 (1.1-3.7) 
Tetanus 
--- 
0.00 (0.00-
0.00) 
0.01 (0.00-
0.02) 
0.03 (0.01-
0.06) --- 
0.0 (0.0-
0.0) 0.2 (0.0-0.5) 0.6 (0.2-1.3) 
Diarrhoea 
--- 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.01 (0.00-
0.01) --- 
0.0 (0.0-
0.0) 0.0 (0.0-0.4) 0.2 (0.0-1.7) 
Other 0.10 (0.06-
0.14) 
0.08 (0.06-
0.10) 
0.07 (0.05-
0.09) 
0.06 (0.04-
0.07) 
0.3 (0.3-
0.4) 
0.7 (0.5-
0.9) 1.4 (0.5-2.6) 1.6 (0.9-2.8) 
Total 
--- --- --- --- 
2.4 (2.0-
2.7) 
7.1 (5.6-
8.7) 
19.9 (11.6-
30.8) 
28.8 (20.1-
40.0) 
 Late neonatal period  
Preterm 0.42 (0.32-
0.50) 
0.42 (0.38-
0.46) 
0.35 (0.33-
0.41) 
0.37 (0.33-
0.40) 
0.2 (0.2-
0.3) 
0.6 (0.5-
0.8) 1.6 (0.8-2.6) 1.7 (1.1-2.4) 
Intrapartu
m 
0.14 (0.11-
0.17) 
0.18 (0.15-
0.22) 
0.32 (0.26-
0.35) 
0.34 (0.33-
0.36) 
0.1 (0.0-
0.1) 
0.2 (0.2-
0.3) 0.9 (0.5-1.4) 1.5 (1.0-2.1) 
Congenital 0.26 (0.21-
0.31) 
0.22 (0.18-
0.25) 
0.12 (0.09-
0.15) 
0.06 (0.05-
0.07) 
0.3 (0.2-
0.3) 
0.6 (0.5-
0.7) 0.6 (0.2-1.2) 0.5 (0.2-1.0) 
Sepsis 0.03 (0.02- 0.07 (0.05- 0.09 (0.08- 0.09 (0.07- 0.1 (0.1- 0.6 (0.4- 2.7 (1.5-4.3) 4.3 (2.7-5.8) 
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0.05) 0.08) 0.10) 0.10) 0.1) 0.8) 
Pneumoni
a 
0.00 (0.00-
0.02) 
0.03 (0.02-
0.04) 
0.05 (0.04-
0.06) 
0.07 (0.06-
0.08) 
0.0 (0.0-
0.0) 
0.2 (0.1-
0.3) 0.3 (0.2-0.5) 0.5 (0.3-0.8) 
Tetanus 
--- 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.01 (0.01-
0.02) --- 
0.0 (0.0-
0.0) 0.2 (0.1-0.6) 0.7 (0.2-1.6) 
Diarrhoea 
--- 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) --- 
0.0 (0.0-
0.0) 0.1 (0.0-0.4) 0.2 (0.1-0.3) 
Other 0.11 (0.06-
0.14) 
0.08 (0.05-
0.11) 
0.06 (0.04-
0.09) 
0.04 (0.03-
0.07) 
0.1 (0.0-
0.1) 
0.2 (0.1-
0.3) 0.6 (0.2-1.3) 0.7 (0.3-1.5) 
Total 
--- --- --- --- 
0.8 (0.5-
0.9) 
2.4 (1.8-
3.2) 7.0 (3.5-12.3) 
10.1 (5.9-
15.5) 
  Overall neonatal period  
Preterm 0.32 (0.27-
0.40) 
0.27 (0.19-
0.30) 
0.15 (0.14-
0.18) 
0.16 (0.15-
0.18) 
1.3 (1.2-
1.4) 
3.5 (3.0-
4.1) 9.9 (6.2-14.4) 
12.7 (9.6-
15.6) 
Intrapartu
m 
0.07 (0.04-
0.09) 
0.09 (0.07-
0.11) 
0.15 (0.12-
0.16) 
0.15 (0.14-
0.16) 
0.3 (0.2-
0.4) 
1.6 (1.2-
2.0) 6.3 (4.2-8.8) 
10.8 (8.3-
13.0) 
Congenital 0.36 (0.30-
0.39) 
0.27 (0.23-
0.32) 
0.09 (0.07-
0.13) 
0.05 (0.04-
0.06) 
0.8 (0.7-
1.0) 
2.1 (1.5-
2.7) 2.5 (1.3-4.2) 2.1 (1.3-3.7) 
Sepsis 0.10 (0.07-
0.13) 
0.21 (0.16-
0.28) 
0.43 (0.38-
0.47) 
0.45 (0.40-
0.46) 
0.2 (0.1-
0.2) 
1.1 (0.7-
1.4) 4.4 (2.0-7.3) 6.7 (3.6-9.7) 
Pneumoni
a 
0.01 (0.00-
0.03) 
0.06 (0.04-
0.09) 
0.05 (0.05-
0.06) 
0.05 (0.05-
0.05) 
0.0 (0.0-
0.1) 
0.4 (0.3-
0.6) 1.2 (0.5-2.5) 2.5 (1.4-4.5) 
Tetanus 
--- 
0.00 (0.00-
0.00) 
0.02 (0.01-
0.03) 
0.05 (0.04-
0.09) --- 
0.0 (0.0-
0.0) 0.4 (0.1-1.1) 1.3 (0.4-2.9) 
Diarrhoea 
--- 
0.00 (0.00-
0.00) 
0.01 (0.00-
0.01) 
0.01 (0.01-
0.02) --- 
0.0 (0.0-
0.0) 0.2 (0.0-0.8) 0.3 (0.1-2.0) 
Other 0.10 (0.06-
0.13) 
0.09 (0.07-
0.10) 
0.07 (0.06-
0.09) 
0.06 (0.06-
0.07) 
0.4 (0.3-
0.4) 
1.0 (0.6-
1.3) 2.0 (0.7-3.9) 2.3 (1.2-4.3) 
Total 
--- --- --- --- 
3.0 (2.5-
3.5) 
9.7 (7.3-
12.1) 
26.9 (15.0-
43.0) 
38.7 (25.9-
55.7) 
Notes: 1) no high mortality model countries had an NMR<5 so there were no tetanus/diarrhoea estimates for this NMR category; 2) injuries are included in the “other” category; 
3) risk uncertainty estimates assume no uncertainty in live birth estimates. 
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Table S12b: Cause-specific proportions (median with IQR) and risk (with uncertainty) for 2012 by World Bank income level  
 Median proportion (with IQR) by income level  Total risk (with uncertainty) by income level  
High Upper-
middle 
Lower-
middle 
Low High Upper-
middle 
Lower-
middle 
Low 
      Early neonatal period  
Preterm 0.42 (0.31-
0.46) 
0.42 (0.38-
0.46) 
0.39 (0.34-
0.42) 
0.34 (0.31-
0.38) 
1.2 (1.1-
1.3) 
2.9 (2.5-
3.3) 8.8 (6.0-11.8) 7.3 (5.5-9.3) 
Intrapartu
m 
0.14 (0.11-
0.19) 
0.17 (0.14-
0.23) 
0.26 (0.19-
0.34) 
0.34 (0.31-
0.37) 
0.3 (0.3-
0.4) 
1.4 (1.1-
1.7) 5.2 (3.7-7.1) 7.0 (5.4-8.4) 
Congenital 0.27 (0.22-
0.31) 
0.22 (0.14-
0.25) 
0.15 (0.09-
0.19) 
0.09 (0.07-
0.13) 
0.7 (0.6-
0.8) 
1.4 (1.0-
1.8) 1.8 (1.0-2.9) 1.9 (1.3-2.9) 
Sepsis 0.03 (0.02-
0.05) 
0.06 (0.05-
0.08) 
0.08 (0.07-
0.09) 
0.09 (0.08-
0.10) 
0.1 (0.1-
0.1) 
0.5 (0.3-
0.7) 1.6 (0.5-2.9) 1.8 (0.6-2.8) 
Pneumoni
a 
0.00 (0.00-
0.01) 
0.03 (0.02-
0.04) 
0.04 (0.04-
0.05) 
0.06 (0.05-
0.07) 
0.0 (0.0-
0.0) 
0.3 (0.2-
0.4) 0.9 (0.4-2.0) 1.3 (0.6-2.4) 
Tetanus 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.01 (0.01-
0.01) 
0.0 (0.0-
0.0) 
0.0 (0.0-
0.1) 0.2 (0.1-0.6) 0.3 (0.1-0.7) 
Diarrhoea 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.0 (0.0-
0.0) 
0.0 (0.0-
0.1) 0.1 (0.0-0.6) 0.1 (0.0-0.8) 
Other 0.11 (0.06-
0.17) 
0.08 (0.05-
0.11) 
0.07 (0.04-
0.10) 
0.05 (0.04-
0.08) 
0.3 (0.3-
0.4) 
0.7 (0.5-
0.9) 1.4 (0.5-2.4) 1.3 (0.6-2.5) 
Total 
--- --- --- --- 
2.6 (2.4-
3.0) 
7.2 (5.6-
9.0) 
20.0 (12.2 
30.3) 
21.0 (14.1-
29.8) 
Late neonatal period 
Preterm 0.30 (0.23-
0.37) 
0.27 (0.21-
0.30) 
0.18 (0.15-
0.27) 
0.15 (0.14-
0.18) 
0.3 (0.2-
0.3) 0.6 (0.5-0.7) 1.6 (0.9-2.5) 1.3 (0.7-1.9) 
Intrapartu
m 
0.07 (0.04-
0.10) 
0.09 (0.07-
0.11) 
0.13 (0.10-
0.15) 
0.15 (0.14-
0.16) 
0.1 (0.0-
0.1) 0.2 (0.2-0.3) 0.9 (0.5-1.4) 1.1 (0.7-1.5) 
Congenital 0.37 (0.32-
0.39) 
0.27 (0.22-
0.31) 
0.14 (0.08-
0.23) 
0.06 (0.05-
0.08) 
0.3 (0.3-
0.3) 0.6 (0.5-0.7) 0.6 (0.3-1.1) 0.5 (0.2-1.1) 
Sepsis 0.11 (0.08-
0.15) 
0.20 (0.15-
0.32) 
0.38 (0.24-
0.46) 
0.45 (0.40-
0.47) 
0.1 (0.1-
0.2) 0.6 (0.4-0.8) 2.7 (1.5-4.1) 3.2 (1.9-4.5) 
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Pneumoni
a 
0.01 (0.00-
0.02) 
0.05 (0.04-
0.08) 
0.05 (0.05-
0.07) 
0.05 (0.05-
0.05) 
0.0 (0.0-
0.0) 0.2 (0.1-0.3) 0.3 (0.2-0.5) 0.4 (0.2-0.6) 
Tetanus 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.01 (0.00-
0.03) 
0.03 (0.02-
0.05) 
0.0 (0.0-
0.0) 0.0 (0.0-0.1) 0.3 (0.1-0.7) 0.3 (0.1-0.7) 
Diarrhoea 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.01 (0.01-
0.02) 
0.0 (0.0-
0.0) 0.0 (0.0-0.0) 0.1 (0.0-0.3) 0.1 (0.0-0.3) 
Other 0.10 (0.06-
0.14) 
0.09 (0.07-
0.10) 
0.08 (0.07-
0.09) 
0.07 (0.06-
0.07) 
0.1 (0.1-
0.1) 0.2 (0.1-0.3) 0.6 (0.2-1.2) 0.5 (0.2-1.3) 
Total 
--- --- --- --- 
0.9 (0.7-
1.0) 2.4 (1.8-3.2) 
7.1 (3.7-
11.8) 7.4 (4.0-11.9) 
Overall neonatal period  
Preterm 0.33 (0.28-
0.45) 
0.34 (0.27-
0.43) 
0.30 (0.18-
0.39) 
0.25 (0.15-
0.34) 
1.4 (1.3-
1.6) 3.5 (3.0-4.1) 
10.4 (6.9-
14.3) 8.5 (6.2-11.2) 
Intrapartu
m 
0.10 (0.07-
0.15) 
0.13 (0.09-
0.17) 
0.16 (0.13-
0.26) 
0.19 (0.15-
0.34) 
0.4 (0.3-
0.5) 1.7 (1.3-2.0) 6.1 (4.2-8.5) 8.1 (6.1-9.9) 
Congenital 0.31 (0.24-
0.38) 
0.24 (0.16-
0.28) 
0.15 (0.09-
0.22) 
0.07 (0.06-
0.11) 
1.0 (0.8-
1.2) 2.0 (1.5-2.5) 2.3 (1.3-4.0) 2.4 (1.5-3.9) 
Sepsis 0.06 (0.02-
0.12) 
0.09 (0.06-
0.20) 
0.11 (0.08-
0.38) 
0.19 (0.09-
0.45) 
0.2 (0.1-
0.3) 1.1 (0.8-1.5) 4.3 (2.0-7.0) 5.0 (2.6-7.3) 
Pneumoni
a 
0.00 (0.00-
0.02) 
0.04 (0.03-
0.05) 
0.05 (0.04-
0.06) 
0.05 (0.05-
0.06) 
0.0 (0.0-
0.1) 0.5 (0.3-0.7) 1.3 (0.6-2.6) 1.6 (0.9-3.0) 
Tetanus 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.02 (0.01-
0.03) 
0.0 (0.0-
0.0) 0.1 (0.0-0.2) 0.5 (0.2-1.3) 0.6 (0.2-1.4) 
Diarrhoea 0.00 (0.00-
0.00) 
0.00 (0.00-
0.00) 
0.00 (0.00-
0.01) 
0.00 (0.00-
0.01) 
0.0 (0.0-
0.0) 0.0 (0.0-0.1) 0.2 (0.0-0.9) 0.2 (0.0-1.1) 
Other 0.10 (0.06-
0.14) 
0.08 (0.06-
0.11) 
0.07 (0.05-
0.09) 
0.06 (0.05-
0.07) 
0.4 (0.3-
0.5) 1.0 (0.6-1.3) 2.0 (0.8-3.6) 1.9 (0.8-3.8) 
Total 
--- --- --- --- 
3.4 (2.8-
4.2) 
9.9 (7.5-
12.4) 
27.1 (16.0-
42.2) 
28.3 (18.3-
41.6) 
Notes: 1) injuries are included in the “other” category; 2) risk uncertainty estimates assume no uncertainty in live birth estimates. 
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Appendix N:  Cause-specific results by estimation method 
Here, we present the results by estimation method (i.e. high-quality VR data, low mortality model, and high 
mortality model).  Table S14 includes the cause-specific proprtions, risks, and numbers of deaths by 
estimation method, and Figures S1a-c show the 2000-2013 time trends in cause-specific risks by neonatal 
period for each estimation method. 
 
Table S14: Cause-specific proportions, risks, and numbers of deaths 
(with uncertainty) in 2013 by estimation method  
 Early period Late period 
 
% 
# of deaths in 
1000s 
(uncertainty) 
Risk % 
# of deaths in 
1000s 
(uncertainty) 
Risk 
High-quality VR countries 
Preterm 41.
5 35.9 (34.0-37.7) 1.7 
25.
9 7.3 (6.4-8.2) 0.3 
Intrapartu
m 
16.
1 13.9 (12.8-15.0) 0.7 7.5 2.1 (1.7-2.6) 0.1 
Congenita
l 
20.
2 17.5 (16.1-18.8) 0.8 
26.
4 7.5 (6.6-8.4) 0.4 
Sepsis 
7.3 6.3 (5.6-7.0) 0.3 
21.
3 6.0 (5.4-6.7) 0.3 
Pneumoni
a 2.2 1.9 (1.5-2.2) 0.1 6.8 1.9 (1.6-2.3) 0.1 
Injuries 
0.5 0.4 (0.3-0.6) 
<0.0
5 1.6 0.4 (0.3-0.6) 
<0.0
5 
Other 12.
3 10.6 (9.7-11.5) 0.5 
10.
5 3.0 (2.5-3.5) 0.1 
Total 100 86.4 4.1 100 28.2 1.3 
Low mortality model countries 
Preterm 43.
0 80.8 (68.8-91.8) 2.6 
27.
9 18.4 (16.0-22.2) 0.6 
Intrapartu
m 
15.
8 29.7 (22.3-36.5) 0.9 9.0 5.9 (3.4-8.1) 0.2 
Congenita
l 
21.
8 41.0 (30.3-57.1) 1.3 
27.
6 18.2 (15.9-21.6) 0.6 
Sepsis 
5.8 11.0 (7.0-14.5) 0.4 
17.
6 11.6 (7.6-14.8) 0.4 
Pneumoni
a 2.9 5.4 (3.5-8.3) 0.2 9.9 6.5 (4.1-9.7) 0.2 
Injuries 
0.7 1.2 (0.9-1.8) 
<0.0
5 1.5 1.0 (0.8-1.3) 
<0.0
5 
Other 10.
1 19.0 (13.8-23.3) 0.6 6.7 4.4 (2.6-7.4) 0.1 
Total 100 188.1 6.0 100 66.1 2.1 
High mortality model countries 
Preterm 40.
6 
718.1 (505.3-
954.0) 8.4 
20.
3 
126.4 (68.6-
198.6) 1.5 
Intrapartu
m 
28.
8 
509.2 (372.6-
659.9) 6.0 
13.
5 
84.0 (49.7-
122.7) 1.0 
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Congenita
l 9.0 
158.6 (94.5-
250.0) 1.9 7.6 47.1 (20.0-94.6) 0.6 
Sepsis 
8.3 
146.5 (49.7-
250.2) 1.7 
40.
0 
249.0 (143.6-
371.7) 2.9 
Pneumoni
a 5.2 
91.5 (43.8-
189.7) 1.1 4.7 29.2 (15.8-46.7) 0.3 
Tetanus 1.2 21.1 (7.4-53.2) 0.2 4.4 27.1 (8.1-67.2) 0.3 
Diarrhoea 0.4 6.7 (0-57.4) 0.1 1.6 10.0 (3.2-25.6) 0.1 
Other 
6.7 
118.6 (48.1-
213.1) 1.4 7.9 
49.1 (20.2-
104.5) 0.6 
Total 100 1770.2 20.8 100 622.0 7.3 
 
Notes: 1) risk is per 1,000 live births 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: Cause-specific risk from 2000-2013 by neonatal period for: a) high-quality VR countries, b) 
low mortality model countries, and c) high mortality model countries. Important note: the y-axes (risk) are 
different on the 3 graphs due to the very different mortality risks between these estimation categories.   
 
a) 
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b)  
 
 
 
c)  
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Appendix O: Country-specific proportions, risks, and number of deaths for 2013 
 
The following pages (pages 19-83) contain estimates of the proportions, risks, and numbers of deaths in 2013 for 194 countries.  The estimation technique (high-
quality VR, low mortality model, and high mortality model) is listed below the country name in the left-most column.  In the table, the low mortality model is called 
“low mort model” and the high mortality model is called “high mort model”.  The estimates are given by the early (days 0-6), late (days 7-27) and overall (days 0-27) 
neonatal periods.  As noted in the paper, injuries were only estimated for high-quality VR and low mortality model countries, while diarrhoea and tetanus were only 
estimated for high mortality model countries.     
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) in 2013 for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Afghanista
n 
(high mort 
model) 
 
Early 
 
prop 0.33 0.33 0.06 0.1 0.07 0.02 0.01 --- 0.08 1 
risk 8.8 8.9 1.6 2.7 1.8 0.6 0.4 --- 2 26.9 
num 89.3 90.5 16.3 26.9 18 6.5 4 --- 20.6 272.1 
 (67.7-117.4) (69.1-114.5) (11.7-27.2) (8.7-45.3) (9.7-34.3) (2.8-15.2) (0.0-39.2) --- (10.1-31.0)  
Late 
 
prop 0.15 0.16 0.05 0.46 0.05 0.06 0.02 --- 0.05 1 
risk 1.4 1.5 0.5 4.4 0.5 0.6 0.2 --- 0.4 9.4 
num 14.2 15 5 44.4 5.1 5.9 1.6 --- 4.5 95.6 
 (8.1-24.2) (9.4-22.2) (2.7-10.6) (27.5-65.8) (2.9-8.1) (2.1-13.5) (0.5-3.4) --- (1.8-13.7)  
Overall 
 
prop 0.29 0.28 0.06 0.19 0.06 0.04 0.02 0 0.07 1 
risk 10.7 10.4 2.1 6.9 2.3 1.4 0.6 0 2.5 36.9 
num 110.6 108.1 21.4 71.9 24 14.3 5.9 0 25.7 381.9 
 (82.8-149.3) (81.3-140.0) (14.4-38.1) (35.9-108.5) (13.2-43.9) (5.4-32.7) (0.5-42.6) (0.0-0.0) (12.2-45.9)  
Albania 
(low mort 
model) 
 
Early 
 
prop 0.39 0.13 0.28 0.06 0.03 --- --- 0.01 0.11 1 
risk 2.2 0.7 1.5 0.3 0.1 --- --- 0 0.6 5.5 
num 0.9 0.3 0.7 0.1 0.1 --- --- 0 0.3 2.4 
 (0.8-1.2) (0.3-0.4) (0.5-0.9) (0.1-0.2) (0.1-0.1) --- --- (0.0-0.0) (0.2-0.3)  
Late 
 
prop 0.3 0.08 0.32 0.14 0.08 --- --- 0.02 0.07 1 
risk 0.6 0.2 0.6 0.3 0.1 --- --- 0 0.1 1.9 
num 0.2 0.1 0.3 0.1 0.1 --- --- 0 0.1 0.8 
 (0.2-0.3) (0.1-0.1) (0.2-0.3) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.37 0.12 0.29 0.08 0.04 0 0 0.01 0.1 1 
risk 2.9 0.9 2.2 0.6 0.3 0 0 0.1 0.7 7.7 
num 1.2 0.4 0.9 0.3 0.1 0 0 0 0.3 3.3 
 (1.1-1.6) (0.3-0.5) (0.8-1.3) (0.2-0.4) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.5)  
Algeria 
(high mort 
model) 
 
Early 
 
prop 0.36 0.25 0.22 0.07 0.03 0 0 --- 0.08 1 
risk 3.7 2.6 2.2 0.7 0.3 0 0 --- 0.8 10.3 
num 36 25.1 22.1 6.7 2.8 0.2 0 --- 8 101 
 (24.2-44.7) (16.9-30.9) (11.7-28.6) (2.1-10.3) (1.1-5.9) (0.1-0.6) (0.0-0.2) --- (3.3-10.4)  
Late 
 
prop 0.14 0.12 0.27 0.32 0.04 0.01 0 --- 0.08 1 
risk 0.5 0.4 1 1.2 0.2 0 0 --- 0.3 3.6 
num 5 4.4 9.6 11.5 1.6 0.3 0.1 --- 3 35.5 
 (2.7-7.5) (2.5-6.0) (4.4-13.3) (5.4-16.6) (0.9-2.4) (0.1-0.9) (0.0-0.2) --- (1.5-4.6)  
Overall 
 
prop 0.3 0.22 0.23 0.13 0.03 0 0 0 0.08 1 
risk 4.3 3.1 3.2 1.9 0.5 0.1 0 0 1.1 14.1 
num 42.5 30.6 32.3 18.8 4.6 0.6 0.2 0 11.4 141 
 (27.7-54.1) (20.0-37.9) (16.9-42.2) (7.9-27.4) (2.0-8.9) (0.2-1.6) (0.0-0.5) (0.0-0.0) (4.9-15.8)  
* prop = proportion; num = number of deaths (in 100s).   
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Andorra 
(low mort 
model) 
 
Early 
 
prop 0.38 0.13 0.37 0.02 0 --- --- 0.01 0.1 1 
risk 0.4 0.1 0.4 0 0 --- --- 0 0.1 1 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.3 0.08 0.39 0.1 0 --- --- 0.02 0.11 1 
risk 0.1 0 0.1 0 0 --- --- 0 0 0.4 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.36 0.11 0.38 0.04 0 0 0 0.01 0.1 1 
risk 0.5 0.2 0.6 0.1 0 0 0 0 0.2 1.5 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Angola 
(high mort 
model) 
 
Early 
 
prop 0.33 0.34 0.06 0.08 0.1 0.02 0.01 --- 0.07 1 
risk 11.5 11.6 1.9 2.8 3.3 0.7 0.2 --- 2.3 34.5 
num 105.3 106.5 17.7 25.7 30.6 6 2.2 --- 21.4 315.4 
 (73.9-140.0) (77.2-131.3) (9.4-30.2) (9.9-41.9) (15.9-60.0) (2.0-15.8) (0.0-21.1) --- (10.8-38.4)  
Late 
 
prop 0.15 0.15 0.04 0.42 0.05 0.11 0.01 --- 0.07 1 
risk 1.9 1.8 0.5 5.1 0.6 1.3 0.1 --- 0.9 12.1 
num 17 16.5 4.2 46.4 5.6 12.3 0.9 --- 7.9 110.8 
 (9.4-24.6) (9.9-22.9) (1.6-9.1) (27.0-67.3) (3.2-8.6) (2.2-32.4) (0.2-2.6) --- (3.4-19.8)  
Overall 
 
prop 0.29 0.28 0.05 0.17 0.09 0.05 0.01 0 0.07 1 
risk 13.9 13.4 2.5 7.9 4 2.2 0.3 0 3.2 47.4 
num 126.2 121.7 22.7 71.7 36.7 20.3 3 0 29 431.4 
 (88.0-168.3) (88.8-155.4) (10.9-42.4) (36.4-108.7) (18.7-71.4) (4.5-53.1) (0.2-22.6) (0.0-0.0) (14.4-57.6)  
Antigua 
and 
Barbuda 
(high-
quality VR) 
 
Early 
 
prop 0 0 0 0 0 --- --- 0 1 1 
risk 0 0 0 0 0 --- --- 0 1.3 1.3 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.33 0.67 0 0 0 --- --- 0 0 1 
risk 1.3 2.5 0 0 0 --- --- 0 0 3.8 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.25 0.5 0 0 0 0 0 0 0.25 1 
risk 1.3 2.6 0 0 0 0 0 0 1.3 5.2 
num 0 0 0 0 0 0 0 0 0 0.1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s).   
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Argentina 
(high-
quality VR) 
 
Early 
 
prop 0.49 0.08 0.27 0.08 0.02 --- --- 0 0.06 1 
risk 2.5 0.4 1.4 0.4 0.1 --- --- 0 0.3 5.1 
num 17.4 3 9.5 3 0.5 --- --- 0.1 2.2 35.9 
 (16.6-18.3) (2.7-3.4) (8.9-10.1) (2.6-3.3) (0.4-0.7) --- --- (0.1-0.2) (2.0-2.5)  
Late 
 
prop 0.34 0.05 0.3 0.2 0.03 --- --- 0.01 0.06 1 
risk 0.7 0.1 0.6 0.4 0.1 --- --- 0 0.1 2 
num 4.7 0.7 4.2 2.7 0.5 --- --- 0.2 0.8 13.7 
 (4.2-5.1) (0.6-0.9) (3.8-4.6) (2.4-3.0) (0.3-0.6) --- --- (0.1-0.3) (0.6-1.0)  
Overall 
 
prop 0.45 0.08 0.28 0.11 0.02 0 0 0.01 0.06 1 
risk 3.3 0.6 2 0.8 0.1 0 0 0 0.5 7.3 
num 23 3.9 14.2 5.9 1.1 0 0 0.3 3.2 51.5 
 (21.7-24.2) (3.4-4.4) (13.2-15.2) (5.2-6.5) (0.8-1.3) (0.0-0.0) (0.0-0.0) (0.2-0.5) (2.7-3.7)  
Armenia 
(low mort 
model) 
 
Early 
 
prop 0.4 0.12 0.26 0.06 0.03 --- --- 0.01 0.11 1 
risk 2.8 0.9 1.8 0.4 0.2 --- --- 0 0.8 7 
num 1.1 0.3 0.7 0.2 0.1 --- --- 0 0.3 2.7 
 (1.0-1.3) (0.3-0.4) (0.5-0.9) (0.1-0.2) (0.1-0.1) --- --- (0.0-0.0) (0.2-0.4)  
Late 
 
prop 0.33 0.07 0.31 0.14 0.06 --- --- 0.02 0.08 1 
risk 0.8 0.2 0.8 0.3 0.1 --- --- 0 0.2 2.5 
num 0.3 0.1 0.3 0.1 0.1 --- --- 0 0.1 1 
 (0.3-0.3) (0.1-0.1) (0.3-0.3) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.1)  
Overall 
 
prop 0.38 0.11 0.27 0.08 0.04 0 0 0.01 0.1 1 
risk 3.8 1.1 2.7 0.8 0.4 0 0 0.1 1 10 
num 1.6 0.5 1.1 0.3 0.2 0 0 0 0.4 4.2 
 (1.4-1.8) (0.4-0.6) (0.9-1.3) (0.2-0.5) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.3-0.5)  
Australia 
(high-
quality VR) 
 
Early 
 
prop 0.3 0.2 0.27 0.02 0 --- --- 0 0.21 1 
risk 0.6 0.4 0.5 0 0 --- --- 0 0.4 2 
num 2 1.3 1.8 0.1 0 --- --- 0 1.3 6.5 
 (1.7-2.3) (1.1-1.5) (1.5-2.0) (0.0-0.2) (0.0-0.0) --- --- (0.0-0.0) (1.1-1.6)  
Late 
 
prop 0.32 0.08 0.37 0.08 0.03 --- --- 0 0.12 1 
risk 0.1 0 0.1 0 0 --- --- 0 0 0.4 
num 0.4 0.1 0.4 0.1 0 --- --- 0 0.1 1.2 
 (0.3-0.5) (0.0-0.2) (0.3-0.6) (0.0-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.2)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.31 0.18 0.29 0.03 0.01 0 0 0 0.19 1 
risk 0.8 0.5 0.7 0.1 0 0 0 0 0.5 2.5 
num 2.4 1.4 2.3 0.2 0 0 0 0 1.5 8 
 (2.0-2.9) (1.2-1.7) (1.9-2.7) (0.1-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (1.2-1.8)  
* prop = proportion; num = number of deaths (in 100s).  
 Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Austria 
(high-
quality VR) 
 
Early 
 
prop 0.33 0.17 0.34 0.03 0 --- --- 0.01 0.13 1 
risk 0.6 0.3 0.6 0 0 --- --- 0 0.2 1.8 
num 0.5 0.3 0.5 0 0 --- --- 0 0.2 1.5 
 (0.4-0.6) (0.2-0.4) (0.4-0.7) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.3 0.03 0.54 0.05 0 --- --- 0 0.08 1 
risk 0.1 0 0.2 0 0 --- --- 0 0 0.5 
num 0.1 0 0.2 0 0 --- --- 0 0 0.4 
 (0.0-0.2) (0.0-0.0) (0.1-0.3) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.32 0.14 0.38 0.03 0 0 0 0.01 0.12 1 
risk 0.8 0.3 0.9 0.1 0 0 0 0 0.3 2.4 
num 0.6 0.3 0.7 0.1 0 0 0 0 0.2 2 
 (0.4-0.8) (0.2-0.4) (0.5-1.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.4)  
Azerbaijan 
(high mort 
model) 
 
Early 
 
prop 0.46 0.2 0.14 0.06 0.03 0 0 --- 0.11 1 
risk 5.4 2.4 1.7 0.7 0.3 0 0 --- 1.3 11.8 
num 9.3 4.1 2.9 1.1 0.5 0.1 0 --- 2.3 20.3 
 (7.3-12.6) (3.1-5.5) (2.0-3.9) (0.5-1.8) (0.2-1.1) (0.0-0.2) (0.0-0.1) --- (0.5-4.1)  
Late 
 
prop 0.22 0.1 0.22 0.28 0.04 0.01 0 --- 0.13 1 
risk 0.9 0.4 0.9 1.2 0.1 0 0 --- 0.5 4.1 
num 1.6 0.7 1.6 2 0.3 0.1 0 --- 0.9 7.1 
 (1.0-2.5) (0.5-1.0) (0.8-2.4) (1.2-3.2) (0.1-0.4) (0.0-0.2) (0.0-0.0) --- (0.3-1.7)  
Overall 
 
prop 0.4 0.18 0.16 0.12 0.03 0 0 0 0.12 1 
risk 6.6 2.9 2.6 1.9 0.5 0.1 0 0 1.9 16.4 
num 11.3 4.9 4.4 3.2 0.8 0.1 0 0 3.3 28.1 
 (8.7-15.5) (3.7-6.8) (2.7-6.3) (1.6-5.1) (0.4-1.6) (0.0-0.3) (0.0-0.1) (0.0-0.0) (0.9-5.8)  
Bahamas 
(high-
quality VR) 
 
Early 
 
prop 0.31 0.21 0.07 0.03 0.21 --- --- 0 0.17 1 
risk 1.6 1 0.3 0.2 1 --- --- 0 0.9 5 
num 0.1 0.1 0 0 0.1 --- --- 0 0.1 0.3 
 (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Late prop 0.18 0 0.18 0.36 0.27 --- --- 0 0 1 
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 Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.3 0 0.3 0.7 0.5 --- --- 0 0 1.9 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.28 0.15 0.1 0.13 0.23 0 0 0 0.13 1 
risk 2 1.1 0.7 0.9 1.6 0 0 0 0.9 7.1 
num 0.1 0.1 0 0.1 0.1 0 0 0 0.1 0.4 
 (0.0-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Bahrain 
(high-
quality VR) 
 
Early 
 
prop 0.38 0.06 0.5 0 0 --- --- 0 0.06 1 
risk 0.5 0.1 0.7 0 0 --- --- 0 0.1 1.4 
num 0.1 0 0.2 0 0 --- --- 0 0 0.3 
 (0.0-0.2) (0.0-0.0) (0.1-0.2) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.25 0.1 0.3 0.3 0 --- --- 0 0.05 1 
risk 0.2 0.1 0.3 0.3 0 --- --- 0 0 0.9 
num 0 0 0.1 0.1 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.33 0.08 0.42 0.12 0 0 0 0 0.06 1 
risk 0.8 0.2 1.1 0.3 0 0 0 0 0.1 2.5 
num 0.2 0 0.2 0.1 0 0 0 0 0 0.5 
 (0.1-0.3) (0.0-0.1) (0.1-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
Banglades
h (high 
mort model) 
 
Early 
 
prop 0.34 0.26 0.14 0.11 0.04 0.01 0 --- 0.11 1 
risk 6.1 4.7 2.4 2 0.7 0.1 0 --- 2 17.9 
num 192.2 147.5 77.4 61.9 21.1 4 0.7 --- 63 567.7 
 
(155.1-
253.6) (120.3-192.1) (47.3-102.9) (19.4-96.8) (10.2-44.2) (1.4-12.9) (0.0-5.2) --- (21.5-93.8)  
Late 
 
prop 0.24 0.11 0.07 0.4 0.04 0.01 0.02 --- 0.11 1 
risk 1.5 0.7 0.4 2.5 0.3 0.1 0.1 --- 0.7 6.3 
num 47 22.5 14.1 80.2 8.5 2.4 3.3 --- 21.4 199.5 
 (30.6-71.7) (14.1-29.2) (5.7-25.4) (48.3-117.7) (4.2-13.3) (0.7-6.2) (1.1-8.4) --- (7.1-36.8)  
Overall 
 
prop 0.31 0.22 0.11 0.19 0.04 0.01 0.01 0 0.11 1 
risk 7.9 5.6 2.9 4.7 1 0.2 0.1 0 2.8 25.2 
num 246.3 175.1 88.9 145.9 30.7 7 4.2 0 86.9 785 
 
(191.6-
331.7) (137.9-227.6) (51.2-125.4) (71.0-221.0) (15.3-60.2) (2.2-20.1) (1.1-14.7) (0.0-0.0) 
(29.7-
133.5)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Barbados 
(high-
quality VR) 
 
Early 
 
prop 0.29 0.29 0.29 0.07 0 --- --- 0 0.07 1 
risk 1.2 1.2 1.2 0.3 0 --- --- 0 0.3 4.4 
num 0 0 0 0 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.17 0.25 0.33 0 0 --- --- 0 0.25 1 
risk 0.6 0.9 1.2 0 0 --- --- 0 0.9 3.7 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.23 0.27 0.31 0.04 0 0 0 0 0.15 1 
risk 1.9 2.2 2.5 0.3 0 0 0 0 1.3 8.2 
num 0.1 0.1 0.1 0 0 0 0 0 0 0.3 
 (0.0-0.1) (0.0-0.2) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Belarus 
(low mort 
model) 
 
Early 
 
prop 0.36 0.11 0.37 0.05 0.02 --- --- 0.01 0.09 1 
risk 0.6 0.2 0.6 0.1 0 --- --- 0 0.1 1.7 
num 0.6 0.2 0.6 0.1 0 --- --- 0 0.1 1.7 
 (0.5-0.9) (0.1-0.3) (0.4-1.0) (0.1-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.2)  
Late 
 
prop 0.31 0.07 0.39 0.09 0.03 --- --- 0.02 0.09 1 
risk 0.2 0 0.2 0.1 0 --- --- 0 0.1 0.6 
num 0.2 0 0.2 0.1 0 --- --- 0 0.1 0.6 
 (0.2-0.3) (0.0-0.1) (0.2-0.3) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.1)  
Overall 
 
prop 0.36 0.1 0.37 0.06 0.02 0 0 0.01 0.09 1 
risk 0.9 0.2 0.9 0.1 0.1 0 0 0 0.2 2.4 
num 0.9 0.3 0.9 0.1 0.1 0 0 0 0.2 2.5 
 (0.8-1.3) (0.2-0.4) (0.7-1.4) (0.1-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.3)  
Belgium 
(high-
quality VR) 
 
Early 
 
prop 0.35 0.17 0.26 0.03 0 --- --- 0 0.19 1 
risk 0.6 0.3 0.5 0.1 0 --- --- 0 0.3 1.7 
num 0.8 0.4 0.6 0.1 0 --- --- 0 0.4 2.2 
 (0.6-0.9) (0.2-0.5) (0.4-0.7) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.3-0.5)  
Late 
 
prop 0.22 0.11 0.41 0.08 0 --- --- 0.01 0.16 1 
risk 0.1 0.1 0.2 0 0 --- --- 0 0.1 0.6 
num 0.2 0.1 0.3 0.1 0 --- --- 0 0.1 0.8 
 (0.1-0.2) (0.0-0.1) (0.2-0.4) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.2)  
Overall prop 0.31 0.15 0.3 0.05 0 0 0 0 0.18 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.7 0.4 0.7 0.1 0 0 0 0 0.4 2.3 
num 0.9 0.5 0.9 0.1 0 0 0 0 0.5 3 
 (0.7-1.2) (0.3-0.6) (0.6-1.2) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.3-0.7)  
Belize  
(high-
quality VR) 
 
Early 
 
prop 0.28 0.24 0.22 0.07 0.02 --- --- 0 0.17 1 
risk 1.5 1.3 1.2 0.3 0.1 --- --- 0 0.9 5.3 
num 0.1 0.1 0.1 0 0 --- --- 0 0.1 0.4 
 (0.1-0.2) (0.0-0.2) (0.0-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.27 0.14 0.09 0.23 0.23 --- --- 0 0.05 1 
risk 0.7 0.3 0.2 0.6 0.6 --- --- 0 0.1 2.6 
num 0.1 0 0 0 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.28 0.21 0.18 0.12 0.09 0 0 0 0.13 1 
risk 2.3 1.7 1.4 1 0.7 0 0 0 1.1 8.1 
num 0.2 0.1 0.1 0.1 0.1 0 0 0 0.1 0.6 
 (0.1-0.3) (0.0-0.2) (0.0-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.2)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Benin  
(high mort 
model) 
 
Early 
 
prop 0.4 0.33 0.08 0.09 0.06 0.01 0 --- 0.03 1 
risk 8.1 6.6 1.6 1.7 1.2 0.1 0 --- 0.7 19.9 
num 29.2 23.8 5.7 6.2 4.2 0.4 0.1 --- 2.4 72.1 
 (24.3-34.7) (19.3-27.6) (4.3-8.2) (2.6-9.7) (2.2-7.9) (0.2-1.0) (0.0-1.2) --- (1.3-5.9)  
Late 
 
prop 0.13 0.15 0.09 0.47 0.05 0.02 0.02 --- 0.06 1 
risk 0.9 1 0.6 3.3 0.4 0.2 0.2 --- 0.4 7 
num 3.3 3.7 2.2 12 1.4 0.6 0.6 --- 1.5 25.3 
 (1.6-5.9) (2.3-5.0) (0.8-5.1) (7.6-17.0) (0.7-2.3) (0.1-1.6) (0.3-1.0) --- (0.6-3.8)  
Overall 
 
prop 0.33 0.29 0.08 0.19 0.06 0.01 0.01 0 0.04 1 
risk 9.1 7.9 2.2 5.2 1.6 0.3 0.2 0 1.1 27.5 
num 32.3 28.1 7.8 18.5 5.8 1.1 0.7 0 4 98.2 
 (25.6-41.0) (22.0-33.3) (4.9-13.2) (10.5-27.4) (3.1-10.7) (0.3-2.7) (0.3-2.4) (0.0-0.0) (2.0-9.7)  
Bhutan 
(high mort 
model) 
 
Early 
 
prop 0.35 0.26 0.16 0.09 0.03 0 0 --- 0.1 1 
risk 4.7 3.5 2.1 1.2 0.4 0 0 --- 1.4 13.4 
num 0.7 0.5 0.3 0.2 0.1 0 0 --- 0.2 2 
 (0.6-0.9) (0.4-0.7) (0.2-0.4) (0.1-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- (0.1-0.3)  
Late 
 
prop 0.23 0.13 0.11 0.36 0.04 0.01 0.01 --- 0.11 1 
risk 1.1 0.6 0.5 1.7 0.2 0.1 0.1 --- 0.5 4.7 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
num 0.2 0.1 0.1 0.2 0 0 0 --- 0.1 0.7 
 (0.1-0.2) (0.1-0.1) (0.0-0.1) (0.2-0.4) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- (0.0-0.1)  
Overall 
 
prop 0.31 0.23 0.14 0.16 0.04 0.01 0 0 0.11 1 
risk 5.9 4.3 2.6 3.1 0.7 0.1 0.1 0 2 18.8 
num 0.9 0.6 0.4 0.5 0.1 0 0 0 0.3 2.8 
 (0.7-1.2) (0.5-0.9) (0.3-0.6) (0.2-0.7) (0.1-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.1-0.5)  
Bolivia 
(high mort 
model) 
 
Early 
 
prop 0.32 0.3 0.18 0.08 0.04 0 0 --- 0.07 1 
risk 4.3 4 2.4 1.1 0.5 0.1 0 --- 0.9 13.2 
num 11.5 10.8 6.4 2.9 1.3 0.2 0 --- 2.5 35.7 
 (9.5-14.5) (9.0-13.3) (4.5-8.9) (1.1-4.6) (0.6-3.1) (0.1-0.4) (0.0-0.3) --- (1.5-3.5)  
Late 
 
prop 0.15 0.16 0.14 0.39 0.05 0.02 0 --- 0.08 1 
risk 0.7 0.7 0.7 1.8 0.2 0.1 0 --- 0.4 4.7 
num 1.9 2 1.8 4.9 0.7 0.2 0 --- 0.9 12.5 
 (1.4-2.8) (1.4-2.7) (1.0-2.8) (2.9-6.7) (0.4-1.0) (0.1-0.6) (0.0-0.1) --- (0.6-1.7)  
Overall 
 
prop 0.28 0.27 0.16 0.16 0.04 0.01 0 0 0.07 1 
risk 5.2 4.9 3 3 0.8 0.2 0 0 1.3 18.4 
num 13.7 13 7.9 7.9 2 0.4 0.1 0 3.5 48.5 
 (11.0-17.4) (10.5-16.1) (5.3-11.5) (4.0-11.3) (1.1-4.2) (0.1-1.0) (0.0-0.3) (0.0-0.0) (2.0-5.2)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Bosnia and 
Herzegovin
a (low mort 
model) 
 
Early 
 
prop 0.46 0.14 0.22 0.05 0.03 --- --- 0.01 0.09 1 
risk 1.5 0.5 0.7 0.2 0.1 --- --- 0 0.3 3.3 
num 0.5 0.2 0.3 0.1 0 --- --- 0 0.1 1.2 
 (0.5-0.6) (0.1-0.2) (0.2-0.3) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.1)  
Late 
 
prop 0.32 0.07 0.36 0.11 0.05 --- --- 0.02 0.06 1 
risk 0.4 0.1 0.4 0.1 0.1 --- --- 0 0.1 1.1 
num 0.1 0 0.2 0 0 --- --- 0 0 0.4 
 (0.1-0.2) (0.0-0.0) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.13 0.25 0.07 0.04 0 0 0.01 0.08 1 
risk 2 0.6 1.2 0.3 0.2 0 0 0.1 0.4 4.6 
num 0.7 0.2 0.4 0.1 0.1 0 0 0 0.1 1.5 
 (0.6-0.8) (0.2-0.2) (0.3-0.5) (0.1-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.2)  
Botswana 
(high mort 
model) 
Early 
 
prop 0.45 0.27 0.12 0.08 0.04 0 0 --- 0.04 1 
risk 8.3 5 2.2 1.5 0.7 0.1 0 --- 0.7 18.4 
num 3.9 2.4 1.1 0.7 0.3 0 0 --- 0.3 8.8 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
  (3.1-5.1) (1.8-3.1) (0.6-1.6) (0.2-1.2) (0.2-0.7) (0.0-0.1) (0.0-0.1) --- (0.2-1.2)  
Late 
 
prop 0.21 0.12 0.15 0.36 0.04 0.01 0 --- 0.1 1 
risk 1.4 0.8 1 2.3 0.3 0.1 0 --- 0.6 6.5 
num 0.6 0.4 0.5 1.1 0.1 0 0 --- 0.3 3.1 
 (0.3-1.3) (0.2-0.5) (0.1-1.0) (0.6-1.9) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- (0.1-0.8)  
Overall 
 
prop 0.39 0.23 0.13 0.15 0.04 0.01 0 0 0.05 1 
risk 9.7 5.8 3.1 3.9 1 0.2 0 0 1.4 25.1 
num 4.7 2.8 1.5 1.9 0.5 0.1 0 0 0.7 12.1 
 (3.4-6.5) (2.0-3.7) (0.7-2.6) (0.9-3.0) (0.2-1.0) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.3-2.0)  
Brazil  
(high-
quality VR) 
 
Early 
 
prop 0.36 0.18 0.18 0.1 0.01 --- --- 0 0.16 1 
risk 2.4 1.2 1.2 0.7 0.1 --- --- 0 1 6.5 
num 71.2 35.2 34.8 19.9 2.8 --- --- 0.6 30.9 195.4 
 (69.6-72.9) (34.1-36.4) (33.7-36.0) (19.0-20.7) (2.5-3.1) --- --- (0.4-0.7) (29.8-32.0)  
Late 
 
prop 0.2 0.09 0.24 0.28 0.04 --- --- 0.01 0.14 1 
risk 0.4 0.2 0.5 0.5 0.1 --- --- 0 0.3 1.9 
num 11.7 5.3 13.6 16.2 2.2 --- --- 0.6 7.9 57.5 
 (11.1-12.4) (4.8-5.7) (12.9-14.4) (15.5-17.0) (1.9-2.4) --- --- (0.5-0.8) (7.3-8.4)  
Overall 
 
prop 0.33 0.16 0.19 0.14 0.02 0 0 0 0.15 1 
risk 2.9 1.4 1.7 1.3 0.2 0 0 0 1.4 8.8 
num 83.6 40.8 48.8 36.4 5 0 0 1.2 39.1 254.8 
 (81.3-85.9) (39.2-42.4) (46.9-50.7) (34.7-38.1) (4.4-5.6) (0.0-0.0) (0.0-0.0) (0.9-1.5) (37.5-40.7)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Brunei 
Darussala
m (low 
mort model) 
 
Early 
 
prop 0.46 0.15 0.23 0.01 0 --- --- 0.01 0.13 1 
risk 1.8 0.6 0.9 0.1 0 --- --- 0 0.5 3.9 
num 0.1 0 0.1 0 0 --- --- 0 0 0.2 
 (0.1-0.1) (0.0-0.0) (0.1-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.34 0.08 0.37 0.11 0.01 --- --- 0.02 0.07 1 
risk 0.5 0.1 0.5 0.2 0 --- --- 0 0.1 1.4 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.43 0.13 0.27 0.04 0 0 0 0.01 0.12 1 
risk 2.2 0.7 1.4 0.2 0 0 0 0 0.6 5.2 
num 0.1 0 0.1 0 0 0 0 0 0 0.3 
 (0.1-0.2) (0.0-0.1) (0.1-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Bulgaria 
(high-
quality VR) 
 
Early 
 
prop 0.41 0.23 0.25 0.03 0.04 --- --- 0 0.05 1 
risk 1.9 1.1 1.2 0.1 0.2 --- --- 0 0.2 4.7 
num 1.3 0.7 0.8 0.1 0.1 --- --- 0 0.2 3.2 
 (1.1-1.5) (0.6-0.9) (0.6-1.0) (0.0-0.1) (0.1-0.2) --- --- (0.0-0.0) (0.1-0.2)  
Late 
 
prop 0.39 0.09 0.31 0.07 0.04 --- --- 0.01 0.08 1 
risk 0.7 0.2 0.5 0.1 0.1 --- --- 0 0.1 1.7 
num 0.5 0.1 0.4 0.1 0 --- --- 0 0.1 1.2 
 (0.3-0.6) (0.0-0.2) (0.2-0.5) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.2)  
Overall 
 
prop 0.4 0.19 0.27 0.04 0.04 0 0 0.01 0.06 1 
risk 2.7 1.3 1.7 0.3 0.3 0 0 0 0.4 6.6 
num 1.8 0.9 1.2 0.2 0.2 0 0 0 0.3 4.6 
 (1.5-2.2) (0.6-1.1) (0.9-1.5) (0.1-0.3) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.1-0.4)  
Burkina 
Faso  
(high mort 
model) 
 
Early 
 
prop 0.39 0.33 0.08 0.1 0.06 0.01 0 --- 0.05 1 
risk 7.7 6.5 1.5 1.9 1.3 0.1 0 --- 0.9 19.9 
num 51 43.1 10.3 12.6 8.3 0.7 0.3 --- 6 132.4 
 (41.4-63.8) (35.4-52.8) (6.3-16.0) (4.7-20.8) (4.6-16.3) (0.3-1.7) (0.0-2.8) --- (3.7-11.4)  
Late 
 
prop 0.14 0.15 0.05 0.48 0.05 0.03 0.03 --- 0.06 1 
risk 1 1 0.4 3.4 0.4 0.2 0.2 --- 0.5 7 
num 6.6 7 2.5 22.5 2.5 1.3 1.2 --- 3 46.5 
 (3.8-10.2) (4.4-9.5) (0.9-6.2) (14.5-31.7) (1.4-4.0) (0.3-3.6) (0.4-3.0) --- (1.5-6.5)  
Overall 
 
prop 0.32 0.28 0.07 0.2 0.06 0.01 0.01 0 0.05 1 
risk 8.9 7.8 1.9 5.4 1.7 0.3 0.2 0 1.4 27.7 
num 58.3 51.1 12.4 35.7 11.3 2.1 1.5 0 9.2 181.7 
 (45.5-74.6) (40.3-62.6) (6.8-21.5) (19.5-53.5) (6.3-20.7) (0.6-5.9) (0.4-6.5) (0.0-0.0) (5.4-18.3)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Burundi 
(high mort 
model) 
 
Early 
 
prop 0.35 0.35 0.08 0.09 0.06 0.01 0 --- 0.06 1 
risk 7.7 7.7 1.9 2.1 1.3 0.1 0.1 --- 1.2 22.1 
num 33.4 33.3 8 9 5.6 0.6 0.3 --- 5.3 95.6 
 (24.8-45.1) (24.7-43.2) (4.8-13.8) (3.3-14.5) (2.9-11.7) (0.2-1.5) (0.0-3.4) --- (3.2-10.1)  
Late 
 
prop 0.14 0.16 0.06 0.47 0.06 0.03 0.01 --- 0.07 1 
risk 1.1 1.3 0.5 3.6 0.4 0.3 0.1 --- 0.6 7.7 
num 4.7 5.4 2 15.8 1.9 1.1 0.2 --- 2.4 33.6 
 (2.7-7.5) (3.4-7.7) (0.7-5.3) (9.6-23.3) (1.1-3.0) (0.3-2.8) (0.1-0.6) --- (1.3-5.6)  
Overall prop 0.3 0.3 0.08 0.19 0.06 0.01 0 0 0.06 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 9.1 9.1 2.3 5.9 1.8 0.4 0.1 0 1.8 30.5 
num 38.5 38.4 9.8 25.1 7.6 1.8 0.6 0 7.7 129.5 
 (27.3-54.0) (28.2-50.4) (5.2-19.0) (13.1-38.7) (4.0-14.8) (0.6-4.6) (0.1-4.1) (0.0-0.0) (4.3-15.5)  
Cambodia 
(high mort 
model) 
 
Early 
 
prop 0.34 0.29 0.17 0.08 0.04 0 0 --- 0.08 1 
risk 4.4 3.8 2.3 1 0.5 0 0 --- 1 13 
num 16.4 14.2 8.4 3.8 1.8 0.2 0 --- 3.8 48.7 
 (13.9-19.4) (11.7-16.2) (5.9-10.6) (1.5-5.7) (0.9-3.8) (0.1-0.4) (0.0-0.3) --- (2.0-4.9)  
Late 
 
prop 0.16 0.14 0.13 0.42 0.05 0.01 0.01 --- 0.08 1 
risk 0.7 0.6 0.6 1.9 0.2 0.1 0 --- 0.4 4.6 
num 2.8 2.4 2.2 7.2 0.9 0.2 0.1 --- 1.4 17.1 
 (1.7-4.1) (1.5-3.0) (1.1-3.5) (4.4-9.9) (0.5-1.3) (0.1-0.5) (0.1-0.2) --- (0.7-2.2)  
Overall 
 
prop 0.29 0.25 0.16 0.17 0.04 0.01 0 0 0.08 1 
risk 5.4 4.5 2.9 3.1 0.7 0.1 0 0 1.4 18.2 
num 19.4 16.4 10.6 11.2 2.7 0.4 0.2 0 5.1 65.9 
 (15.6-23.7) (13.1-19.4) (6.7-14.3) (5.8-15.9) (1.4-5.1) (0.1-1.0) (0.1-0.5) (0.0-0.0) (2.7-7.1)  
Cameroon 
(high mort 
model) 
 
Early 
 
prop 0.33 0.39 0.08 0.09 0.07 0.01 0 --- 0.04 1 
risk 6.8 8.1 1.6 1.8 1.5 0.2 0.1 --- 0.9 20.9 
num 54.5 64.6 12.8 14.7 11.7 1.4 0.4 --- 6.8 166.8 
 (43.4-75.0) (51.9-81.1) (9.9-23.2) (6.2-24.9) (6.2-23.9) (0.5-3.2) (0.0-3.7) --- (3.7-17.4)  
Late 
 
prop 0.14 0.16 0.06 0.47 0.06 0.03 0.01 --- 0.07 1 
risk 1 1.2 0.4 3.5 0.4 0.2 0.1 --- 0.5 7.3 
num 8.2 9.6 3.4 27.7 3.4 2 0.5 --- 3.9 58.6 
 (4.6-14.3) (6.7-13.8) (1.3-9.1) (18.0-41.3) (2.1-5.3) (0.6-5.7) (0.1-1.1) --- (1.9-10.1)  
Overall 
 
prop 0.28 0.33 0.07 0.19 0.07 0.02 0 0 0.05 1 
risk 8 9.4 2 5.3 1.9 0.4 0.1 0 1.4 28.5 
num 63 73.8 15.6 42 15.2 3.4 0.9 0 10.7 224.6 
 (48.9-88.4) (57.7-96.1) (10.7-31.4) (24.0-65.0) (8.4-29.0) (1.1-8.9) (0.2-4.9) (0.0-0.0) (5.6-26.7)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Canada 
(low mort 
model) 
 
Early 
 
prop 0.46 0.15 0.23 0.03 0 --- --- 0.01 0.12 1 
risk 1.2 0.4 0.6 0.1 0 --- --- 0 0.3 2.5 
num 4.7 1.6 2.3 0.3 0 --- --- 0.1 1.2 10.2 
 (4.2-5.2) (1.3-1.8) (1.9-3.1) (0.2-0.4) (0.0-0.1) --- --- (0.1-0.1) (0.9-1.4)  
Late 
 
prop 0.32 0.08 0.38 0.12 0.01 --- --- 0.02 0.08 1 
risk 0.3 0.1 0.3 0.1 0 --- --- 0 0.1 0.9 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
num 1.1 0.3 1.4 0.4 0 --- --- 0.1 0.3 3.6 
 (1.0-1.3) (0.2-0.4) (1.2-1.5) (0.3-0.5) (0.0-0.1) --- --- (0.1-0.1) (0.2-0.3)  
Overall 
 
prop 0.43 0.14 0.26 0.05 0 0 0 0.01 0.11 1 
risk 1.5 0.5 0.9 0.2 0 0 0 0 0.4 3.4 
num 5.9 1.9 3.6 0.7 0.1 0 0 0.1 1.5 13.7 
 (5.2-6.5) (1.5-2.2) (3.1-4.5) (0.5-0.9) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.1-0.2) (1.1-1.8)  
Cabo 
Verde (low 
mort model) 
 
Early 
 
prop 0.41 0.18 0.19 0.09 0.04 --- --- 0 0.09 1 
risk 3.5 1.5 1.6 0.8 0.3 --- --- 0 0.7 8.4 
num 0.4 0.2 0.2 0.1 0 --- --- 0 0.1 0.9 
 (0.3-0.4) (0.1-0.2) (0.1-0.2) (0.1-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.1)  
Late 
 
prop 0.27 0.1 0.23 0.25 0.08 --- --- 0.01 0.06 1 
risk 0.8 0.3 0.7 0.7 0.2 --- --- 0 0.2 3 
num 0.1 0 0.1 0.1 0 --- --- 0 0 0.3 
 (0.1-0.1) (0.0-0.0) (0.1-0.1) (0.1-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.37 0.16 0.2 0.13 0.05 0 0 0.01 0.08 1 
risk 4.3 1.8 2.3 1.6 0.6 0 0 0.1 0.9 11.6 
num 0.4 0.2 0.2 0.2 0.1 0 0 0 0.1 1.2 
 (0.3-0.6) (0.1-0.3) (0.2-0.3) (0.1-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.1)  
Central 
African 
Republic 
(high mort 
model) 
 
Early 
 
prop 0.35 0.4 0.05 0.05 0.1 0.03 0.01 --- 0.04 1 
risk 11.1 12.6 1.5 1.5 3.1 0.8 0.2 --- 1.1 31.8 
num 17.2 19.5 2.4 2.3 4.8 1.3 0.3 --- 1.7 49.3 
 (11.9-23.9) (12.8-23.5) (1.3-4.0) (0.6-3.7) (2.4-8.0) (0.5-2.5) (0.0-2.6) --- (0.8-4.9)  
Late 
 
prop 0.18 0.15 0.04 0.4 0.05 0.09 0.03 --- 0.06 1 
risk 2 1.6 0.4 4.5 0.6 1 0.4 --- 0.7 11.2 
num 3.2 2.5 0.7 6.9 0.9 1.6 0.6 --- 1.1 17.3 
 (1.7-5.1) (1.5-3.5) (0.3-1.3) (3.8-9.6) (0.5-1.3) (0.4-3.8) (0.2-1.5) --- (0.4-2.7)  
Overall 
 
prop 0.32 0.3 0.05 0.16 0.08 0.04 0.01 0 0.04 1 
risk 13.9 13.1 2.1 7 3.4 1.8 0.4 0 1.7 43.5 
num 21 19.9 3.2 10.6 5.2 2.8 0.6 0 2.6 65.8 
 (14.4-27.2) (13.7-24.3) (1.9-5.4) (5.3-15.4) (2.7-8.8) (0.8-6.2) (0.1-2.7) (0.0-0.0) (1.1-7.2)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Chad 
(high mort 
model) 
Early 
 
prop 0.38 0.31 0.04 0.06 0.08 0.03 0.01 --- 0.08 1 
risk 11.3 9.2 1.3 1.8 2.5 0.8 0.3 --- 2.3 29.5 
num 63.9 52.2 7.3 9.9 14.1 4.7 1.6 --- 12.9 166.6 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
  (48.3-87.3) (40.9-67.2) (4.8-12.1) (3.8-18.1) (8.1-26.7) (2.1-9.6) (0.0-16.5) --- (6.3-25.5)  
Late 
 
prop 0.21 0.13 0.03 0.35 0.05 0.12 0.04 --- 0.07 1 
risk 2.2 1.4 0.3 3.6 0.5 1.2 0.4 --- 0.7 10.3 
num 12.4 7.9 2 20.3 2.9 6.9 2.1 --- 4 58.5 
 (7.1-19.5) (5.1-11.7) (0.9-3.8) (11.4-33.2) (1.6-4.7) (1.5-17.7) (0.9-4.6) --- (1.6-12.3)  
Overall 
 
prop 0.35 0.26 0.04 0.13 0.08 0.06 0.02 0 0.07 1 
risk 14.2 10.4 1.6 5.1 3.1 2.4 0.7 0 2.9 40.4 
num 79 58 9 28.1 17 13.3 3.7 0 16.3 224.3 
 (56.5-109.6) (44.9-77.2) (5.4-15.8) (13.6-49.7) (9.8-30.8) (3.9-31.6) (0.8-20.1) (0.0-0.0) (7.5-35.9)  
Chile  
(high-
quality 
VR) 
 
Early 
 
prop 0.44 0.06 0.37 0.04 0.01 --- --- 0.01 0.07 1 
risk 1.7 0.2 1.4 0.2 0 --- --- 0 0.3 3.9 
num 4.2 0.6 3.5 0.4 0.1 --- --- 0.1 0.7 9.5 
 (3.8-4.6) (0.4-0.7) (3.2-3.9) (0.3-0.5) (0.0-0.1) --- --- (0.0-0.1) (0.5-0.9)  
Late 
 
prop 0.31 0.03 0.45 0.1 0.05 --- --- 0.01 0.05 1 
risk 0.3 0 0.5 0.1 0 --- --- 0 0.1 1 
num 0.8 0.1 1.1 0.2 0.1 --- --- 0 0.1 2.5 
 (0.6-0.9) (0.0-0.1) (0.9-1.3) (0.1-0.3) (0.1-0.2) --- --- (0.0-0.1) (0.1-0.2)  
Overall 
 
prop 0.41 0.05 0.39 0.05 0.02 0 0 0.01 0.07 1 
risk 2.1 0.3 1.9 0.3 0.1 0 0 0 0.4 5 
num 5.1 0.7 4.8 0.7 0.2 0 0 0.1 0.9 12.3 
 (4.5-5.6) (0.4-0.9) (4.2-5.3) (0.4-0.9) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.2) (0.6-1.1)  
China 
(low mort 
model) 
 
Early 
 
prop 0.42 0.15 0.22 0.06 0.03 --- --- 0.01 0.11 1 
risk 2.4 0.8 1.3 0.3 0.2 --- --- 0 0.6 5.7 
num 
449.2 155.5 235.1 63.4 30.3 --- --- 6.8 119.8 
1060.
2 
 (389.5-497.5) (128.2-177.8) (180.6-313.7) (43.9-79.8) (20.3-44.3) --- --- (5.5-8.3) (89.4-140.3)  
Late 
 
prop 0.28 0.08 0.29 0.16 0.12 --- --- 0.01 0.06 1 
risk 0.6 0.2 0.6 0.3 0.2 --- --- 0 0.1 2 
num 102.7 30.7 107.5 61 43.2 --- --- 5.4 22 372.5 
 (91.1-119.8) (22.6-42.0) (97.3-117.8) (44.6-69.9) (28.4-61.5) --- --- (4.3-6.8) (13.2-31.8)  
Overall 
 
prop 0.38 0.13 0.24 0.09 0.05 0 0 0.01 0.1 1 
risk 3.2 1.1 1.9 0.7 0.4 0 0 0.1 0.8 8.2 
num 
583.6 196.9 360.4 136.2 77.9 0 0 13 150.3 
1518.
2 
 
(510.9-650.7) (159.4-233.1) (290.4-455.1) (97.7-164.0) (51.5-112.5) (0.0-0.0) (0.0-0.0) 
(10.3-
16.0) 
(108.1-
183.8)  
* prop = proportion; num = number of deaths (in 100s). 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Colombia 
(high-
quality VR) 
 
Early 
 
prop 0.38 0.14 0.22 0.09 0.03 --- --- 0.01 0.13 1 
risk 2.8 1.1 1.6 0.7 0.2 --- --- 0.1 0.9 7.4 
num 25.7 9.7 14.8 6 1.8 --- --- 0.6 8.4 67 
 (24.7-26.7) (9.1-10.3) (14.1-15.6) (5.5-6.5) (1.5-2.0) --- --- (0.4-0.7) (7.8-9.0)  
Late 
 
prop 0.27 0.07 0.27 0.21 0.07 --- --- 0.01 0.09 1 
risk 0.8 0.2 0.8 0.6 0.2 --- --- 0 0.3 3 
num 7.4 1.9 7.4 5.7 2 --- --- 0.2 2.4 27.1 
 (6.9-8.0) (1.6-2.1) (6.9-8.0) (5.2-6.1) (1.7-2.3) --- --- (0.1-0.3) (2.1-2.8)  
Overall 
 
prop 0.35 0.12 0.24 0.12 0.04 0 0 0.01 0.12 1 
risk 3.7 1.3 2.5 1.3 0.4 0 0 0.1 1.2 10.6 
num 34.1 11.9 23 12.1 3.9 0 0 0.8 11.2 96.9 
 (32.6-35.7) (11.0-12.8) (21.7-24.3) (11.1-13.0) (3.4-4.5) (0.0-0.0) (0.0-0.0) (0.6-1.0) (10.3-12.1)  
Comoros 
(high mort 
model) 
 
Early 
 
prop 0.39 0.34 0.08 0.09 0.06 0.01 0 --- 0.03 1 
risk 8.9 7.7 1.8 2 1.4 0.2 0.1 --- 0.7 22.8 
num 2.2 1.9 0.5 0.5 0.4 0.1 0 --- 0.2 5.7 
 (1.5-2.6) (1.3-2.1) (0.3-0.6) (0.2-0.8) (0.2-0.6) (0.0-0.1) (0.0-0.1) --- (0.1-0.5)  
Late 
 
prop 0.15 0.14 0.06 0.5 0.05 0.03 0.01 --- 0.06 1 
risk 1.2 1.1 0.4 4 0.4 0.2 0.1 --- 0.5 8 
num 0.3 0.3 0.1 1 0.1 0.1 0 --- 0.1 2 
 (0.1-0.4) (0.2-0.4) (0.0-0.3) (0.6-1.3) (0.1-0.1) (0.0-0.1) (0.0-0.1) --- (0.0-0.3)  
Overall 
 
prop 0.33 0.29 0.07 0.2 0.06 0.01 0.01 0 0.04 1 
risk 10.2 9 2.3 6.2 1.9 0.5 0.2 0 1.2 31.4 
num 2.6 2.2 0.6 1.5 0.5 0.1 0 0 0.3 7.8 
 (1.6-3.1) (1.5-2.6) (0.3-0.9) (0.8-2.1) (0.2-0.8) (0.0-0.3) (0.0-0.2) (0.0-0.0) (0.1-0.7)  
Congo  
(high mort 
model) 
 
Early 
 
prop 0.42 0.29 0.14 0.08 0.04 0 0 --- 0.03 1 
risk 6 4.2 2 1.1 0.6 0.1 0 --- 0.4 14.4 
num 9.7 6.8 3.2 1.8 0.9 0.1 0 --- 0.7 23.3 
 (7.8-12.8) (5.4-8.8) (2.3-4.6) (0.7-2.9) (0.5-2.0) (0.0-0.2) (0.0-0.1) --- (0.4-1.8)  
Late 
 
prop 0.13 0.14 0.17 0.42 0.05 0.02 0.01 --- 0.06 1 
risk 0.7 0.7 0.8 2.1 0.2 0.1 0 --- 0.3 5 
num 1.1 1.2 1.4 3.5 0.4 0.1 0.1 --- 0.5 8.2 
 (0.6-1.8) (0.8-1.6) (0.5-2.9) (2.1-5.3) (0.2-0.6) (0.0-0.4) (0.0-0.1) --- (0.2-1.2)  
Overall 
 
prop 0.35 0.25 0.14 0.17 0.04 0.01 0 0 0.04 1 
risk 7 5.1 2.8 3.4 0.9 0.2 0.1 0 0.8 20.2 
num 11.2 8.2 4.4 5.4 1.4 0.3 0.1 0 1.2 32.2 
 (8.7-15.2) (6.3-10.7) (2.7-7.2) (3.0-8.3) (0.7-2.8) (0.1-0.7) (0.0-0.3) (0.0-0.0) (0.6-3.1)  
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* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Cook 
Islands  
(low mort 
model) 
 
Early 
 
prop 0.47 0.18 0.25 0.03 0.01 --- --- 0.01 0.06 1 
risk 1.6 0.6 0.9 0.1 0 --- --- 0 0.2 3.4 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.28 0.1 0.33 0.16 0.05 --- --- 0.01 0.07 1 
risk 0.3 0.1 0.4 0.2 0.1 --- --- 0 0.1 1.2 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.16 0.27 0.07 0.02 0 0 0.01 0.06 1 
risk 2 0.8 1.3 0.3 0.1 0 0 0 0.3 4.8 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Costa Rica 
(high-
quality VR) 
 
Early 
 
prop 0.38 0.13 0.41 0.02 0.01 --- --- 0 0.05 1 
risk 2.2 0.8 2.3 0.1 0 --- --- 0 0.3 5.8 
num 1.6 0.6 1.7 0.1 0 --- --- 0 0.2 4.3 
 (1.4-1.9) (0.4-0.7) (1.5-2.0) (0.0-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.22 0.08 0.47 0.08 0.05 --- --- 0.03 0.07 1 
risk 0.1 0 0.3 0 0 --- --- 0 0 0.6 
num 0.1 0 0.2 0 0 --- --- 0 0 0.5 
 (0.0-0.2) (0.0-0.1) (0.1-0.3) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.37 0.13 0.41 0.03 0.01 0 0 0 0.05 1 
risk 2.4 0.8 2.7 0.2 0.1 0 0 0 0.3 6.5 
num 1.7 0.6 1.9 0.1 0.1 0 0 0 0.2 4.7 
 (1.4-2.0) (0.4-0.8) (1.6-2.3) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.4)  
Cote 
d'Ivoire 
(high mort 
model) 
 
Early 
 
prop 0.35 0.36 0.07 0.09 0.07 0.01 0 --- 0.04 1 
risk 9.8 10.1 1.8 2.5 2 0.3 0.1 --- 1 27.7 
num 73.2 75.1 13.8 18.9 14.8 2.4 0.8 --- 7.6 206.6 
 (58.1-87.3) (59.1-84.3) (9.7-20.7) (7.9-30.1) (7.8-27.5) (0.8-5.6) (0.0-8.0) --- (3.8-18.4)  
Late 
 
prop 0.16 0.15 0.05 0.47 0.05 0.04 0.02 --- 0.06 1 
risk 1.5 1.5 0.5 4.6 0.5 0.4 0.2 --- 0.6 9.8 
num 11.3 10.8 3.4 34.4 3.7 3.2 1.4 --- 4.4 72.6 
 (6.2-17.7) (6.8-14.5) (1.3-8.3) (21.8-45.0) (2.1-5.3) (1.0-7.3) (0.5-3.1) --- (2.0-10.6)  
Overall 
 
prop 0.31 0.29 0.06 0.2 0.06 0.02 0.01 0 0.04 1 
risk 12 11.3 2.4 7.5 2.5 0.8 0.3 0 1.6 38.4 
num 85.6 80.7 17 53.6 17.7 5.7 2.1 0 11.4 273.7 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (66.7-101.6) (62.9-93.0) (9.8-28.3) (28.8-75.8) (9.6-30.9) (1.8-13.2) (0.5-10.4) (0.0-0.0) (5.6-27.7)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Croatia 
(high-
quality VR) 
 
Early 
 
prop 0.21 0.12 0.21 0.03 0.01 --- --- 0 0.41 1 
risk 0.4 0.2 0.4 0.1 0 --- --- 0 0.8 1.9 
num 0.2 0.1 0.2 0 0 --- --- 0 0.3 0.8 
 (0.1-0.3) (0.0-0.2) (0.1-0.3) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.2-0.4)  
Late 
 
prop 0.29 0.04 0.36 0.13 0.02 --- --- 0 0.16 1 
risk 0.3 0 0.3 0.1 0 --- --- 0 0.1 0.9 
num 0.1 0 0.1 0 0 --- --- 0 0.1 0.4 
 (0.0-0.2) (0.0-0.0) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.24 0.1 0.26 0.06 0.01 0 0 0 0.33 1 
risk 0.7 0.3 0.8 0.2 0 0 0 0 1 3 
num 0.3 0.1 0.4 0.1 0 0 0 0 0.4 1.4 
 (0.2-0.5) (0.0-0.2) (0.2-0.5) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.3-0.6)  
Cuba  
(high-
quality VR) 
 
Early 
 
prop 0.31 0.21 0.13 0.14 0.1 --- --- 0.01 0.1 1 
risk 0.6 0.4 0.2 0.3 0.2 --- --- 0 0.2 1.9 
num 0.6 0.4 0.3 0.3 0.2 --- --- 0 0.2 2 
 (0.5-0.8) (0.3-0.6) (0.2-0.4) (0.2-0.4) (0.1-0.3) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.25 0.06 0.31 0.2 0.05 --- --- 0.04 0.09 1 
risk 0.2 0.1 0.3 0.2 0.1 --- --- 0 0.1 1 
num 0.3 0.1 0.3 0.2 0.1 --- --- 0 0.1 1 
 (0.2-0.4) (0.0-0.1) (0.2-0.4) (0.1-0.3) (0.0-0.1) --- --- (0.0-0.1) (0.0-0.1)  
Overall 
 
prop 0.29 0.16 0.19 0.16 0.09 0 0 0.02 0.09 1 
risk 0.9 0.5 0.6 0.5 0.3 0 0 0.1 0.3 3.1 
num 0.9 0.5 0.6 0.5 0.3 0 0 0.1 0.3 3.2 
 (0.7-1.2) (0.3-0.7) (0.4-0.8) (0.3-0.7) (0.1-0.4) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.2-0.4)  
Cyprus 
(low mort 
model) 
 
Early 
 
prop 0.38 0.12 0.34 0.05 0.01 --- --- 0.01 0.09 1 
risk 0.5 0.2 0.5 0.1 0 --- --- 0 0.1 1.3 
num 0.1 0 0.1 0 0 --- --- 0 0 0.2 
 (0.1-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.3 0.07 0.39 0.09 0.02 --- --- 0.02 0.11 1 
risk 0.1 0 0.2 0 0 --- --- 0 0.1 0.5 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.36 0.11 0.35 0.06 0.01 0 0 0.01 0.1 1 
risk 0.7 0.2 0.6 0.1 0 0 0 0 0.2 1.8 
num 0.1 0 0.1 0 0 0 0 0 0 0.2 
 (0.1-0.1) (0.0-0.0) (0.1-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Czech 
Republic 
(high-
quality VR) 
 
Early 
 
prop 0.36 0.14 0.29 0.08 0.02 --- --- 0.02 0.09 1 
risk 0.5 0.2 0.4 0.1 0 --- --- 0 0.1 1.4 
num 0.6 0.2 0.5 0.1 0 --- --- 0 0.1 1.6 
 (0.4-0.7) (0.1-0.3) (0.3-0.6) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.1) (0.1-0.2)  
Late 
 
prop 0.32 0.16 0.17 0.19 0.02 --- --- 0 0.14 1 
risk 0.2 0.1 0.1 0.1 0 --- --- 0 0.1 0.7 
num 0.3 0.1 0.1 0.2 0 --- --- 0 0.1 0.8 
 (0.2-0.4) (0.1-0.2) (0.1-0.2) (0.1-0.2) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.2)  
Overall 
 
prop 0.34 0.15 0.25 0.12 0.02 0 0 0.01 0.11 1 
risk 0.8 0.3 0.5 0.3 0 0 0 0 0.2 2.2 
num 0.9 0.4 0.6 0.3 0 0 0 0 0.3 2.6 
 (0.6-1.2) (0.2-0.6) (0.4-0.9) (0.2-0.5) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.1-0.4)  
Democrati
c People's 
Republic 
of Korea  
(high mort 
model) 
 
Early 
 
prop 0.43 0.21 0.16 0.05 0.02 0 0 --- 0.13 1 
risk 4.7 2.3 1.8 0.6 0.3 0 0 --- 1.4 11 
num 16.9 8.1 6.5 2.1 0.9 0.1 0 --- 5 39.6 
 (12.5-22.8) (5.9-11.5) (4.2-8.9) (0.8-3.4) (0.4-2.2) (0.0-0.2) (0.0-0.1) --- (1.1-9.5)   
Late 
 
prop 0.2 0.1 0.25 0.26 0.04 0.01 0 --- 0.14 1 
risk 0.8 0.4 1 1 0.1 0 0 --- 0.5 3.9 
num 2.8 1.4 3.5 3.7 0.5 0.1 0 --- 2 13.9 
 (1.6-4.8) (0.8-2.1) (1.7-5.3) (1.9-6.3) (0.3-0.9) (0.0-0.3) (0.0-0.1) --- (0.5-3.7)   
Overall 
 
prop 0.37 0.18 0.18 0.11 0.03 0 0 0 0.13 1 
risk 5.7 2.8 2.8 1.7 0.4 0.1 0 0 2 15.5 
num 19.8 9.7 9.7 5.9 1.5 0.2 0 0 7 53.7 
 (14.0-28.0) (7.0-13.5) (5.8-13.8) (2.8-9.8) (0.7-3.1) (0.1-0.5) (0.0-0.1) (0.0-0.0) (1.7-13.3)   
Democrati
c Republic 
of the 
Congo 
(high mort 
Early 
 
prop 0.41 0.33 0.05 0.07 0.07 0.01 0.01 --- 0.05 1 
risk 11.6 9.4 1.4 2 1.9 0.3 0.2 --- 1.5 28.3 
num 316.6 256.6 38.1 54.3 53.1 8.6 4.9 --- 41.8 774.1 
 
(215.9-
380.2) (169.8-288.1) (24.0-64.8) (18.8-79.6) (24.9-90.6) (2.6-19.2) (0.0-43.7) --- (22.2-67.4)   
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
model) 
 Late 
 
prop 0.15 0.16 0.07 0.43 0.05 0.06 0.01 --- 0.07 1 
risk 1.5 1.6 0.7 4.2 0.5 0.6 0.1 --- 0.7 9.9 
num 40.4 43.8 19 115.8 14.8 16.4 2.1 --- 19.8 272 
 (22.1-55.1) (26.6-57.4) (7.2-38.5) (63.0-153.2) (8.1-21.0) (4.3-40.2) (0.5-4.0) --- (9.5-41.3)   
Overall 
 
prop 0.35 0.28 0.05 0.16 0.07 0.03 0.01 0 0.06 1 
risk 13.6 11 2.1 6.1 2.5 1 0.3 0 2.3 38.9 
num 365.3 296.5 55.7 165.2 68.2 28.2 7 0 61 1047.1 
 
(248.1-
439.5) (192.4-348.3) (29.7-100.2) (80.0-221.9) (31.6-115.5) (7.8-64.3) (0.5-41.7) (0.0-0.0) 
(30.4-
108.4)   
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Denmark 
(high-
quality VR) 
 
Early 
 
prop 0.61 0.1 0.08 0.02 0 --- --- 0.02 0.17 1 
risk 1 0.2 0.1 0 0 --- --- 0 0.3 1.6 
num 0.6 0.1 0.1 0 0 --- --- 0 0.2 1 
 (0.5-0.8) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.56 0.04 0.3 0 0 --- --- 0 0.11 1 
risk 0.4 0 0.2 0 0 --- --- 0 0.1 0.8 
num 0.3 0 0.1 0 0 --- --- 0 0.1 0.5 
 (0.2-0.4) (0.0-0.0) (0.1-0.2) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.59 0.08 0.15 0.01 0 0 0 0.01 0.15 1 
risk 1.5 0.2 0.4 0 0 0 0 0 0.4 2.5 
num 1 0.1 0.2 0 0 0 0 0 0.2 1.6 
 (0.7-1.2) (0.0-0.2) (0.1-0.4) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.4)  
Djibouti 
(high mort 
model) 
 
Early 
 
prop 0.42 0.3 0.07 0.07 0.05 0.01 0.01 --- 0.07 1 
risk 9.7 7 1.7 1.7 1.1 0.2 0.1 --- 1.6 23.1 
num 2.3 1.7 0.4 0.4 0.3 0 0 --- 0.4 5.4 
 (1.9-2.8) (1.3-2.0) (0.3-0.7) (0.2-0.6) (0.1-0.5) (0.0-0.1) (0.0-0.3) --- (0.2-0.5)  
Late 
 
prop 0.15 0.14 0.15 0.4 0.05 0.03 0.01 --- 0.07 1 
risk 1.2 1.2 1.3 3.2 0.4 0.2 0.1 --- 0.5 8.1 
num 0.3 0.3 0.3 0.8 0.1 0.1 0 --- 0.1 1.9 
 (0.2-0.4) (0.2-0.4) (0.2-0.5) (0.5-1.0) (0.1-0.1) (0.0-0.1) (0.0-0.0) --- (0.1-0.2)  
Overall 
 
prop 0.35 0.26 0.09 0.16 0.05 0.01 0.01 0 0.07 1 
risk 11.2 8.3 3 5 1.5 0.4 0.2 0 2.2 31.8 
num 2.6 2 0.7 1.2 0.4 0.1 0 0 0.5 7.5 
 (2.2-3.3) (1.5-2.4) (0.5-1.2) (0.6-1.7) (0.2-0.7) (0.0-0.2) (0.0-0.4) (0.0-0.0) (0.3-0.8)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Dominica 
(high-
quality VR) 
 
Early 
 
prop 0.08 0.77 0 0.08 0 --- --- 0 0.08 1 
risk 0.5 5.1 0 0.5 0 --- --- 0 0.5 6.6 
num 0 0.1 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.33 0 0 0.67 0 --- --- 0 0 1 
risk 0.5 0 0 1 0 --- --- 0 0 1.5 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.13 0.63 0 0.19 0 0 0 0 0.06 1 
risk 1 5.2 0 1.6 0 0 0 0 0.5 8.3 
num 0 0.1 0 0 0 0 0 0 0 0.1 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s). 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Dominican 
Republic 
(high mort 
model) 
 
Early 
 
prop 0.42 0.23 0.18 0.06 0.03 0 0 --- 0.08 1 
risk 5.1 2.7 2.1 0.8 0.3 0 0 --- 1 11.9 
num 10.8 5.8 4.5 1.6 0.7 0.1 0 --- 2 25.5 
 (9.3-13.2) (4.7-7.1) (2.8-6.0) (0.6-2.5) (0.3-1.5) (0.0-0.1) (0.0-0.1) --- (0.9-2.9)  
Late 
 
prop 0.17 0.11 0.25 0.33 0.04 0.01 0 --- 0.09 1 
risk 0.7 0.5 1.1 1.4 0.2 0 0 --- 0.4 4.2 
num 1.5 1 2.3 2.9 0.4 0.1 0 --- 0.8 9 
 (1.0-2.4) (0.6-1.3) (1.1-3.4) (1.7-4.5) (0.2-0.6) (0.0-0.2) (0.0-0.1) --- (0.4-1.3)  
Overall 
 
prop 0.36 0.2 0.19 0.13 0.03 0 0 0 0.08 1 
risk 5.9 3.2 3.2 2.2 0.5 0.1 0 0 1.4 16.5 
num 12.7 7 6.9 4.7 1.1 0.1 0 0 2.9 35.4 
 (10.5-15.9) (5.5-8.8) (4.0-9.6) (2.4-7.3) (0.6-2.1) (0.1-0.4) (0.0-0.1) (0.0-0.0) (1.3-4.3)  
Ecuador 
(low mort 
model) 
 
Early 
 
prop 0.45 0.16 0.22 0.07 0.03 --- --- 0.01 0.08 1 
risk 3.5 1.2 1.7 0.5 0.2 --- --- 0 0.6 7.8 
num 11.4 4 5.5 1.7 0.7 --- --- 0.1 1.9 25.4 
 (10.2-14.4) (3.3-5.3) (4.8-7.5) (1.2-2.4) (0.5-1.2) --- --- (0.1-0.2) (1.6-2.6)  
Late 
 
prop 0.27 0.08 0.25 0.24 0.07 --- --- 0.01 0.07 1 
risk 0.7 0.2 0.7 0.6 0.2 --- --- 0 0.2 2.7 
num 2.4 0.7 2.3 2.1 0.6 --- --- 0.1 0.7 8.9 
 (2.1-3.3) (0.6-1.2) (2.0-3.0) (1.6-2.8) (0.3-0.9) --- --- (0.1-0.2) (0.4-1.0)  
Overall prop 0.4 0.14 0.22 0.11 0.04 0 0 0.01 0.08 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 4.3 1.5 2.4 1.2 0.4 0 0 0.1 0.8 10.7 
num 14 4.8 7.7 3.8 1.4 0 0 0.3 2.7 34.7 
 (12.3-17.9) (3.9-6.4) (6.7-10.5) (2.8-5.2) (0.8-2.0) (0.0-0.0) (0.0-0.0) (0.2-0.4) (2.0-3.8)  
Egypt  
(low mort 
model) 
 
Early 
 
prop 0.45 0.22 0.21 0.03 0.04 --- --- 0.01 0.04 1 
risk 3.9 2 1.8 0.3 0.3 --- --- 0.1 0.4 8.7 
num 74.2 37.4 34.7 5.6 6 --- --- 1.3 7.2 166.3 
 (59.5-89.2) (18.3-56.1) (19.0-56.6) (2.6-10.0) (3.6-10.0) --- --- (0.8-2.4) (4.4-12.0)  
Late 
 
prop 0.28 0.15 0.25 0.18 0.04 --- --- 0.01 0.09 1 
risk 0.9 0.5 0.8 0.6 0.1 --- --- 0 0.3 3.1 
num 16.4 8.8 14.4 10.5 2.1 --- --- 0.9 5.4 58.4 
 (13.6-21.7) (0.6-12.1) (11.9-18.8) (5.2-19.0) (0.3-4.5) --- --- (0.6-1.2) (3.5-7.7)  
Overall 
 
prop 0.41 0.21 0.21 0.06 0.04 0 0 0.01 0.06 1 
risk 5 2.5 2.5 0.8 0.4 0 0 0.1 0.7 12 
num 95.7 48.3 49 14.6 8.6 0 0 2.3 13 231.5 
 (77.2-115.8) (19.8-71.6) (30.7-74.7) (7.5-27.0) (4.0-15.3) (0.0-0.0) (0.0-0.0) (1.5-3.8) (8.2-20.3)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
El 
Salvador 
(low mort 
model) 
 
Early 
 
prop 0.42 0.17 0.19 0.07 0.03 --- --- 0 0.1 1 
risk 2 0.8 0.9 0.4 0.2 --- --- 0 0.5 4.8 
num 2.7 1.1 1.2 0.5 0.2 --- --- 0 0.6 6.4 
 (2.3-3.0) (0.7-1.4) (1.0-1.6) (0.4-0.6) (0.1-0.3) --- --- (0.0-0.0) (0.5-0.8)  
Late 
 
prop 0.26 0.09 0.27 0.19 0.12 --- --- 0.01 0.05 1 
risk 0.4 0.2 0.5 0.3 0.2 --- --- 0 0.1 1.7 
num 0.6 0.2 0.6 0.4 0.3 --- --- 0 0.1 2.2 
 (0.5-0.7) (0.1-0.3) (0.5-0.7) (0.3-0.6) (0.2-0.4) --- --- (0.0-0.0) (0.1-0.2)  
Overall 
 
prop 0.38 0.15 0.21 0.11 0.06 0 0 0.01 0.09 1 
risk 2.6 1 1.4 0.7 0.4 0 0 0 0.6 6.7 
num 3.5 1.4 1.9 1 0.5 0 0 0.1 0.8 9.1 
 (3.0-3.9) (0.9-1.7) (1.6-2.5) (0.7-1.2) (0.3-0.8) (0.0-0.0) (0.0-0.0) (0.1-0.1) (0.6-1.0)  
Equatorial 
Guinea 
(high mort 
model) 
 
Early 
 
prop 0.42 0.34 0.06 0.07 0.06 0.01 0 --- 0.03 1 
risk 10.4 8.4 1.4 1.7 1.5 0.2 0.1 --- 0.8 24.6 
num 2.7 2.1 0.4 0.4 0.4 0.1 0 --- 0.2 6.3 
 (1.7-4.2) (1.3-2.9) (0.2-0.7) (0.1-0.7) (0.2-0.8) (0.0-0.1) (0.0-0.3) --- (0.1-0.6)  
Late 
 
prop 0.16 0.16 0.06 0.45 0.05 0.05 0.01 --- 0.06 1 
risk 1.4 1.4 0.5 3.9 0.5 0.4 0.1 --- 0.6 8.6 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
num 0.4 0.4 0.1 1 0.1 0.1 0 --- 0.1 2.2 
 (0.2-0.6) (0.2-0.5) (0.1-0.3) (0.6-1.4) (0.1-0.2) (0.0-0.3) (0.0-0.1) --- (0.1-0.4)  
Overall 
 
prop 0.35 0.3 0.06 0.17 0.06 0.02 0.01 0 0.04 1 
risk 11.7 10.1 1.9 5.7 2.1 0.7 0.2 0 1.4 33.8 
num 3 2.6 0.5 1.5 0.5 0.2 0 0 0.4 8.6 
 (2.0-4.5) (1.7-3.4) (0.3-1.0) (0.8-2.2) (0.3-1.0) (0.1-0.4) (0.0-0.4) (0.0-0.0) (0.2-0.9)  
Eritrea 
(high mort 
model) 
 
Early 
 
prop 0.24 0.37 0.19 0.11 0.05 0.01 0 --- 0.04 1 
risk 3.1 4.8 2.5 1.4 0.7 0.1 0 --- 0.5 13.1 
num 7.1 10.9 5.8 3.2 1.5 0.2 0 --- 1.1 29.7 
 (5.7-10.8) (9.4-15.8) (4.2-8.8) (1.3-5.6) (0.9-3.5) (0.1-0.5) (0.0-0.1) --- (0.6-3.2)  
Late 
 
prop 0.13 0.15 0.07 0.49 0.06 0.01 0.01 --- 0.06 1 
risk 0.6 0.7 0.3 2.3 0.3 0.1 0 --- 0.3 4.6 
num 1.4 1.6 0.7 5.2 0.6 0.1 0.1 --- 0.7 10.4 
 (0.7-2.9) (1.0-2.5) (0.2-2.2) (3.4-8.6) (0.3-1.1) (0.0-0.5) (0.0-0.3) --- (0.3-1.8)  
Overall 
 
prop 0.21 0.31 0.16 0.21 0.05 0.01 0 0 0.04 1 
risk 3.9 5.7 2.8 3.8 1 0.1 0.1 0 0.8 18.2 
num 8.6 12.7 6.3 8.4 2.2 0.3 0.1 0 1.7 40.3 
 (6.3-13.8) (10.5-18.1) (4.2-10.5) (4.6-14.1) (1.1-4.7) (0.1-1.0) (0.0-0.4) (0.0-0.0) (0.9-5.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Estonia 
(high-
quality VR) 
 
Early 
 
prop 0.14 0.29 0.29 0.21 0 --- --- 0 0.07 1 
risk 0.2 0.3 0.3 0.2 0 --- --- 0 0.1 1.1 
num 0 0 0 0 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.14 0 0.43 0.29 0 --- --- 0.14 0 1 
risk 0.1 0 0.2 0.2 0 --- --- 0.1 0 0.6 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.14 0.19 0.33 0.24 0 0 0 0.05 0.05 1 
risk 0.3 0.3 0.6 0.4 0 0 0 0.1 0.1 1.8 
num 0 0 0.1 0.1 0 0 0 0 0 0.3 
 (0.0-0.1) (0.0-0.1) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Ethiopia 
(high mort 
model) 
Early 
 
prop 0.27 0.41 0.11 0.09 0.07 0.02 0 --- 0.04 1 
risk 5.5 8.3 2.2 1.8 1.3 0.4 0 --- 0.8 20.4 
num 168.4 253.5 68.9 55.6 41.3 12.7 1.3 --- 23.1 624.8 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 
 
(117.0-
199.9) (186.4-278.9) (45.5-95.5) (21.6-85.6) (19.9-71.5) (4.5-33.7) (0.0-11.3) --- (10.3-62.8)  
Late 
 
prop 0.18 0.14 0.07 0.44 0.05 0.03 0.04 --- 0.06 1 
risk 1.3 1 0.5 3.2 0.3 0.2 0.3 --- 0.4 7.2 
num 38.9 30.9 14.3 97.2 10.4 6.8 8.3 --- 12.7 219.5 
 (21.7-59.5) (19.4-39.7) (3.6-33.8) (56.2-127.0) (5.8-14.3) (2.3-14.8) (3.2-17.3) --- (4.9-30.8)  
Overall 
 
prop 0.26 0.33 0.09 0.18 0.06 0.03 0.01 0 0.04 1 
risk 7.3 9.3 2.7 5.1 1.7 0.7 0.3 0 1.2 28.4 
num 221.2 282.7 80.7 155.9 52.3 21.6 9.6 0 35.8 859.8 
 
(146.7-
271.1) (209.1-315.1) (48.2-126.2) (79.2-218.8) (26.1-88.1) (7.6-50.7) (3.5-28.6) (0.0-0.0) (15.6-92.2)  
Fiji  
(low mort 
model) 
 
Early 
 
prop 0.43 0.17 0.19 0.09 0.04 --- --- 0.01 0.07 1 
risk 3.3 1.3 1.4 0.7 0.3 --- --- 0 0.6 7.6 
num 0.6 0.2 0.3 0.1 0.1 --- --- 0 0.1 1.4 
 (0.5-0.8) (0.1-0.3) (0.2-0.4) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.1)  
Late 
 
prop 0.28 0.1 0.27 0.21 0.04 --- --- 0.01 0.08 1 
risk 0.8 0.3 0.7 0.6 0.1 --- --- 0 0.2 2.7 
num 0.1 0 0.1 0.1 0 --- --- 0 0 0.5 
 (0.1-0.2) (0.0-0.1) (0.1-0.2) (0.1-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.39 0.15 0.21 0.13 0.04 0 0 0.01 0.08 1 
risk 4.1 1.6 2.1 1.3 0.4 0 0 0.1 0.8 10.4 
num 0.8 0.3 0.4 0.2 0.1 0 0 0 0.1 1.9 
 (0.6-1.0) (0.2-0.4) (0.3-0.6) (0.2-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Finland 
(high-
quality VR) 
 
Early 
 
prop 0.31 0.14 0.37 0.04 0.03 --- --- 0.01 0.1 1 
risk 0.3 0.1 0.4 0 0 --- --- 0 0.1 1 
num 0.2 0.1 0.2 0 0 --- --- 0 0.1 0.6 
 (0.1-0.3) (0.0-0.1) (0.1-0.3) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.37 0 0.32 0.11 0 --- --- 0 0.21 1 
risk 0.1 0 0.1 0 0 --- --- 0 0.1 0.3 
num 0.1 0 0 0 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.32 0.11 0.36 0.05 0.02 0 0 0.01 0.12 1 
risk 0.4 0.2 0.5 0.1 0 0 0 0 0.2 1.4 
num 0.3 0.1 0.3 0 0 0 0 0 0.1 0.9 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (0.1-0.4) (0.0-0.2) (0.2-0.5) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.2)  
France 
(high-
quality VR) 
 
Early 
 
prop 0.27 0.18 0.26 0.05 0 --- --- 0 0.23 1 
risk 0.4 0.3 0.4 0.1 0 --- --- 0 0.4 1.6 
num 3.4 2.3 3.3 0.6 0 --- --- 0.1 3 12.7 
 (3.0-3.8) (2.0-2.6) (3.0-3.7) (0.4-0.7) (0.0-0.1) --- --- (0.0-0.1) (2.6-3.3)  
Late 
 
prop 0.2 0.2 0.36 0.08 0.01 --- --- 0 0.15 1 
risk 0.1 0.1 0.3 0.1 0 --- --- 0 0.1 0.7 
num 1.2 1.1 2 0.5 0 --- --- 0 0.8 5.6 
 (0.9-1.4) (0.9-1.3) (1.7-2.3) (0.3-0.6) (0.0-0.1) --- --- (0.0-0.0) (0.6-1.0)  
Overall 
 
prop 0.25 0.19 0.29 0.06 0 0 0 0 0.21 1 
risk 0.6 0.4 0.7 0.1 0 0 0 0 0.5 2.3 
num 4.5 3.4 5.3 1.1 0.1 0 0 0.1 3.8 18.2 
 (4.0-5.1) (2.9-3.9) (4.7-6.0) (0.8-1.3) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.1) (3.2-4.3)  
Gabon  
(high mort 
model) 
 
Early 
 
prop 0.4 0.31 0.12 0.08 0.05 0 0 --- 0.03 1 
risk 6.8 5.3 2 1.4 0.8 0.1 0 --- 0.5 16.9 
num 3.6 2.8 1.1 0.8 0.4 0 0 --- 0.2 8.9 
 (2.9-4.5) (2.1-3.4) (0.7-1.5) (0.3-1.2) (0.2-0.8) (0.0-0.1) (0.0-0.1) --- (0.1-0.7)  
Late 
 
prop 0.15 0.14 0.13 0.44 0.05 0.02 0.01 --- 0.06 1 
risk 0.9 0.8 0.8 2.6 0.3 0.1 0 --- 0.4 5.9 
num 0.5 0.4 0.4 1.4 0.2 0.1 0 --- 0.2 3.1 
 (0.2-0.8) (0.3-0.6) (0.1-0.9) (0.8-2.0) (0.1-0.2) (0.0-0.2) (0.0-0.0) --- (0.1-0.5)  
Overall 
 
prop 0.36 0.26 0.12 0.17 0.05 0.01 0 0 0.04 1 
risk 8.3 6 2.8 4 1.1 0.2 0.1 0 0.8 23.3 
num 4.3 3.1 1.5 2.1 0.5 0.1 0 0 0.4 12.1 
 (3.2-5.5) (2.4-3.9) (0.8-2.4) (1.0-3.2) (0.3-1.0) (0.0-0.3) (0.0-0.1) (0.0-0.0) (0.2-1.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Gambia 
(high mort 
model) 
 
Early 
 
prop 0.33 0.35 0.1 0.1 0.06 0.01 0 --- 0.05 1 
risk 6.9 7.4 2.1 2 1.2 0.1 0.1 --- 1.1 20.8 
num 5.3 5.7 1.6 1.6 0.9 0.1 0 --- 0.8 16 
 (3.9-7.2) (4.3-7.4) (0.9-2.7) (0.6-2.7) (0.4-1.9) (0.0-0.3) (0.0-0.4) --- (0.5-1.6)  
Late 
 
prop 0.14 0.16 0.06 0.46 0.06 0.03 0.01 --- 0.07 1 
risk 1 1.2 0.5 3.4 0.4 0.2 0.1 --- 0.5 7.3 
num 0.8 0.9 0.4 2.6 0.3 0.2 0.1 --- 0.4 5.6 
 (0.5-1.3) (0.6-1.3) (0.1-0.9) (1.5-3.7) (0.2-0.5) (0.1-0.5) (0.0-0.1) --- (0.2-0.9)  
 52 
 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.27 0.31 0.09 0.2 0.06 0.01 0 0 0.06 1 
risk 7.7 9 2.5 5.7 1.7 0.3 0.1 0 1.6 28.7 
num 5.7 6.7 1.9 4.3 1.3 0.2 0.1 0 1.2 21.4 
 (3.9-8.5) (4.9-8.7) (1.0-3.5) (2.2-6.5) (0.6-2.5) (0.1-0.7) (0.0-0.6) (0.0-0.0) (0.7-2.5)  
Georgia 
(low mort 
model) 
 
Early 
 
prop 0.4 0.12 0.26 0.07 0.03 --- --- 0.01 0.11 1 
risk 2.9 0.9 1.8 0.5 0.2 --- --- 0 0.8 7.2 
num 1.6 0.5 1 0.3 0.1 --- --- 0 0.4 4 
 (1.4-1.9) (0.4-0.6) (0.7-1.3) (0.2-0.4) (0.1-0.2) --- --- (0.0-0.0) (0.3-0.6)  
Late 
 
prop 0.3 0.07 0.29 0.18 0.08 --- --- 0.02 0.07 1 
risk 0.8 0.2 0.7 0.4 0.2 --- --- 0 0.2 2.5 
num 0.4 0.1 0.4 0.3 0.1 --- --- 0 0.1 1.4 
 (0.3-0.5) (0.1-0.1) (0.3-0.4) (0.2-0.3) (0.1-0.2) --- --- (0.0-0.0) (0.1-0.1)  
Overall 
 
prop 0.39 0.11 0.25 0.09 0.05 0 0 0.01 0.1 1 
risk 4 1.1 2.6 0.9 0.5 0 0 0.1 1.1 10.3 
num 2.4 0.7 1.6 0.6 0.3 0 0 0.1 0.6 6.3 
 (2.1-2.8) (0.5-0.9) (1.2-1.9) (0.5-0.7) (0.2-0.5) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.5-0.8)  
Germany 
(high-
quality VR) 
 
Early 
 
prop 0.45 0.11 0.27 0.02 0 --- --- 0.01 0.13 1 
risk 0.8 0.2 0.5 0 0 --- --- 0 0.2 1.7 
num 5.6 1.3 3.3 0.3 0 --- --- 0.2 1.6 12.3 
 (5.1-6.0) (1.1-1.6) (2.9-3.6) (0.2-0.4) (0.0-0.1) --- --- (0.1-0.2) (1.4-1.9)  
Late 
 
prop 0.33 0.07 0.41 0.09 0.01 --- --- 0.02 0.06 1 
risk 0.2 0 0.2 0 0 --- --- 0 0 0.5 
num 1.1 0.2 1.4 0.3 0 --- --- 0.1 0.2 3.4 
 (0.9-1.3) (0.1-0.3) (1.2-1.6) (0.2-0.4) (0.0-0.1) --- --- (0.0-0.1) (0.1-0.3)  
Overall 
 
prop 0.43 0.1 0.3 0.04 0 0 0 0.01 0.12 1 
risk 1 0.2 0.7 0.1 0 0 0 0 0.3 2.3 
num 6.9 1.6 4.8 0.6 0.1 0 0 0.2 1.9 16.1 
 (6.2-7.6) (1.3-2.0) (4.2-5.4) (0.4-0.8) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.1-0.3) (1.5-2.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Ghana  
(high mort 
model) 
 
Early 
 
prop 0.36 0.35 0.09 0.1 0.06 0.01 0 --- 0.03 1 
risk 7.8 7.6 2 2.2 1.3 0.1 0 --- 0.7 21.7 
num 61.6 59.6 15.9 17.3 10 1 0.3 --- 5.3 171 
 (49.9-71.4) (48.7-68.7) (9.3-24.4) (6.1-26.6) (5.2-19.3) (0.3-2.4) (0.0-2.9) --- (2.5-17.4)  
Late prop 0.17 0.15 0.06 0.46 0.05 0.03 0.01 --- 0.07 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 1.3 1.1 0.5 3.5 0.4 0.2 0.1 --- 0.5 7.6 
num 10 8.9 3.9 27.5 3.2 1.6 0.6 --- 4.3 60.1 
 (4.6-18.2) (5.6-11.8) (1.3-9.9) (16.2-38.0) (1.8-4.6) (0.5-3.9) (0.2-1.1) --- (1.4-10.9)  
Overall 
 
prop 0.31 0.3 0.08 0.19 0.06 0.01 0 0 0.04 1 
risk 9.2 8.8 2.5 5.8 1.7 0.4 0.1 0 1.2 29.7 
num 72 69.5 19.6 45.3 13.5 2.8 0.9 0 9.7 233.2 
 (54.6-90.0) (54.3-80.8) (10.3-33.7) (22.7-65.8) (7.1-24.5) (0.9-6.6) (0.2-4.1) (0.0-0.0) (3.9-28.1)  
Greece 
(high-
quality VR) 
 
Early 
 
prop 0.55 0.09 0.3 0.01 0 --- --- 0 0.05 1 
risk 0.9 0.2 0.5 0 0 --- --- 0 0.1 1.7 
num 1 0.2 0.5 0 0 --- --- 0 0.1 1.8 
 (0.8-1.2) (0.1-0.2) (0.4-0.7) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.45 0.1 0.43 0 0 --- --- 0 0.02 1 
risk 0.5 0.1 0.5 0 0 --- --- 0 0 1.1 
num 0.5 0.1 0.5 0 0 --- --- 0 0 1.1 
 (0.4-0.7) (0.0-0.2) (0.4-0.6) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.51 0.09 0.35 0 0 0 0 0 0.04 1 
risk 1.4 0.3 1 0 0 0 0 0 0.1 2.8 
num 1.6 0.3 1.1 0 0 0 0 0 0.1 3.2 
 (1.3-2.0) (0.2-0.5) (0.8-1.4) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.2)  
Grenada 
(high-
quality VR) 
 
Early 
 
prop 0.33 0.33 0.08 0.08 0 --- --- 0 0.17 1 
risk 1.7 1.7 0.4 0.4 0 --- --- 0 0.8 5 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0 0 0.5 0.5 0 --- --- 0 0 1 
risk 0 0 0.4 0.4 0 --- --- 0 0 0.8 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.29 0.29 0.14 0.14 0 0 0 0 0.14 1 
risk 1.7 1.7 0.9 0.9 0 0 0 0 0.9 6 
num 0 0 0 0 0 0 0 0 0 0.1 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Guatemala 
(high mort 
Early 
 
prop 0.26 0.33 0.23 0.08 0.04 0 0 --- 0.06 1 
risk 2.8 3.6 2.5 0.9 0.4 0 0 --- 0.7 11 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
model) 
 
num 13.4 16.9 12.1 4.2 2.1 0.2 0 --- 3.1 52 
 (10.8-16.6) (14.1-19.4) (7.8-16.5) (1.8-6.6) (1.0-4.3) (0.1-0.4) (0.0-0.3) --- (1.5-4.8)  
Late 
 
prop 0.12 0.16 0.12 0.46 0.06 0.01 0.01 --- 0.05 1 
risk 0.5 0.6 0.5 1.8 0.2 0.1 0 --- 0.2 3.8 
num 2.2 2.9 2.3 8.5 1 0.3 0.1 --- 1 18.3 
 (1.3-3.4) (1.9-3.9) (0.9-4.1) (5.4-11.2) (0.6-1.5) (0.1-0.7) (0.1-0.3) --- (0.5-2.2)  
Overall 
 
prop 0.22 0.28 0.21 0.18 0.04 0.01 0 0 0.06 1 
risk 3.3 4.2 3.1 2.8 0.7 0.1 0 0 0.9 15.2 
num 15.5 19.8 14.6 13.1 3.1 0.4 0.2 0 4.1 70.8 
 (11.8-20.6) (16.2-23.5) (9.0-19.9) (7.3-18.2) (1.6-6.0) (0.1-1.1) (0.1-0.6) (0.0-0.0) (2.0-7.1)  
Guinea 
(high mort 
model) 
 
Early 
 
prop 0.31 0.41 0.07 0.08 0.08 0.01 0 --- 0.04 1 
risk 7.5 10 1.6 1.8 1.9 0.3 0.1 --- 1.1 24.3 
num 31.6 41.9 6.7 7.7 8 1.1 0.4 --- 4.5 101.8 
 (24.7-39.0) (31.1-47.2) (5.0-11.6) (3.0-11.9) (4.0-14.0) (0.4-2.2) (0.0-4.1) --- (2.4-9.9)  
Late 
 
prop 0.15 0.16 0.04 0.46 0.05 0.04 0.02 --- 0.06 1 
risk 1.3 1.4 0.4 3.9 0.5 0.4 0.2 --- 0.6 8.5 
num 5.4 5.7 1.6 16.4 1.9 1.6 0.9 --- 2.3 35.8 
 (3.1-8.0) (3.7-7.4) (0.6-3.9) (10.2-21.5) (1.2-2.8) (0.5-3.8) (0.4-1.5) --- (1.1-5.5)  
Overall 
 
prop 0.27 0.35 0.06 0.17 0.07 0.02 0.01 0 0.05 1 
risk 9 11.6 2 5.9 2.5 0.7 0.3 0 1.7 33.6 
num 37.4 48 8.1 24.3 10.2 2.8 1.4 0 6.9 139.1 
 (28.1-47.5) (36.1-55.3) (5.4-15.8) (13.3-34.0) (5.3-17.1) (0.9-6.6) (0.4-6.0) (0.0-0.0) (3.5-15.4)  
Guinea-
Bissau  
(high mort 
model) 
 
Early 
 
prop 0.31 0.38 0.07 0.1 0.08 0.01 0.01 --- 0.04 1 
risk 10 12.4 2.2 3.3 2.7 0.5 0.2 --- 1.3 32.6 
num 6.1 7.6 1.3 2 1.6 0.3 0.1 --- 0.8 19.9 
 (4.5-7.9) (5.6-9.7) (0.8-2.3) (0.7-3.3) (0.8-3.1) (0.1-0.8) (0.0-0.9) --- (0.4-2.0)  
Late 
 
prop 0.15 0.16 0.04 0.45 0.05 0.08 0.01 --- 0.06 1 
risk 1.7 1.8 0.4 5.1 0.6 0.9 0.1 --- 0.7 11.4 
num 1 1.1 0.3 3.1 0.4 0.5 0.1 --- 0.5 7 
 (0.6-1.7) (0.7-1.6) (0.1-0.7) (1.9-4.6) (0.2-0.6) (0.2-1.3) (0.0-0.2) --- (0.2-1.1)  
Overall 
 
prop 0.26 0.32 0.06 0.19 0.08 0.03 0.01 0 0.05 1 
risk 11.9 14.5 2.7 8.6 3.4 1.4 0.3 0 2.1 44.9 
num 7.1 8.7 1.6 5.2 2.1 0.9 0.2 0 1.3 27 
 (5.1-9.6) (6.3-11.3) (0.9-2.8) (2.6-8.1) (1.1-3.9) (0.3-2.3) (0.0-1.0) (0.0-0.0) (0.6-3.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
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Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Guyana 
(high-
quality VR) 
 
Early 
 
prop 0.4 0.24 0.09 0.1 0.02 --- --- 0 0.15 1 
risk 6.2 3.7 1.4 1.6 0.3 --- --- 0 2.4 15.6 
num 0.9 0.6 0.2 0.2 0 --- --- 0 0.4 2.3 
 (0.7-1.1) (0.4-0.7) (0.1-0.3) (0.1-0.3) (0.0-0.1) --- --- (0.0-0.0) (0.2-0.5)  
Late 
 
prop 0.19 0.16 0.13 0.19 0.06 --- --- 0 0.26 1 
risk 0.9 0.7 0.6 0.9 0.3 --- --- 0 1.1 4.4 
num 0.1 0.1 0.1 0.1 0 --- --- 0 0.2 0.7 
 (0.1-0.2) (0.0-0.2) (0.0-0.1) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.3)  
Overall 
 
prop 0.35 0.22 0.1 0.12 0.03 0 0 0 0.18 1 
risk 7.2 4.5 2 2.5 0.6 0 0 0 3.6 20.4 
num 1.2 0.7 0.3 0.4 0.1 0 0 0 0.6 3.3 
 (0.9-1.4) (0.5-0.9) (0.2-0.5) (0.2-0.6) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.4-0.8)  
Haiti  
(high mort 
model) 
 
Early 
 
prop 0.38 0.3 0.09 0.08 0.05 0.01 0 --- 0.07 1 
risk 7.1 5.6 1.7 1.5 1 0.1 0.1 --- 1.4 18.4 
num 18.7 14.8 4.4 4.1 2.6 0.3 0.2 --- 3.6 48.8 
 (16.1-21.3) (12.6-17.3) (3.3-6.3) (1.7-7.1) (1.4-5.0) (0.1-0.7) (0.0-1.1) --- (2.0-4.8)  
Late 
 
prop 0.2 0.13 0.06 0.45 0.05 0.02 0.03 --- 0.07 1 
risk 1.3 0.9 0.4 2.9 0.3 0.2 0.2 --- 0.4 6.5 
num 3.4 2.3 0.9 7.7 0.8 0.4 0.5 --- 1.2 17.1 
 (2.4-4.5) (1.5-3.1) (0.5-1.7) (5.4-10.1) (0.5-1.1) (0.1-1.0) (0.2-0.9) --- (0.7-1.9)  
Overall 
 
prop 0.34 0.26 0.08 0.18 0.05 0.01 0.01 0 0.07 1 
risk 8.5 6.6 2 4.5 1.3 0.3 0.2 0 1.9 25.4 
num 22.7 17.5 5.3 12.1 3.5 0.8 0.6 0 4.9 67.4 
 (19.1-26.5) (14.4-20.8) (3.7-8.0) (7.2-17.6) (2.0-6.3) (0.3-1.8) (0.2-2.2) (0.0-0.0) (2.8-6.9)  
Honduras 
(low mort 
model) 
 
Early 
 
prop 0.47 0.18 0.16 0.1 0.05 --- --- 0.01 0.03 1 
risk 4.1 1.6 1.3 0.9 0.4 --- --- 0.1 0.2 8.6 
num 8.5 3.3 2.8 1.9 0.8 --- --- 0.2 0.4 17.9 
 (7.5-9.3) (2.4-3.9) (2.4-3.7) (1.5-2.4) (0.5-1.4) --- --- (0.1-0.6) (0.2-1.0)  
Late 
 
prop 0.25 0.08 0.21 0.25 0.13 --- --- 0.01 0.06 1 
risk 0.8 0.2 0.6 0.7 0.4 --- --- 0 0.2 3 
num 1.6 0.5 1.3 1.6 0.8 --- --- 0.1 0.4 6.3 
 (1.3-1.9) (0.3-0.6) (1.1-1.6) (1.2-2.0) (0.6-1.2) --- --- (0.1-0.1) (0.3-0.5)  
Overall 
 
prop 0.42 0.16 0.17 0.14 0.07 0 0 0.01 0.04 1 
risk 5 1.9 2 1.7 0.8 0 0 0.1 0.4 11.9 
num 10.2 3.9 4.2 3.4 1.7 0 0 0.3 0.9 24.6 
 (9.0-11.4) (2.7-4.7) (3.6-5.3) (2.8-4.5) (1.1-2.7) (0.0-0.0) (0.0-0.0) (0.2-0.7) (0.5-1.6)  
* prop = proportion; num = number of deaths (in 100s) 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Hungary 
(high-
quality VR) 
 
Early 
 
prop 0.56 0.11 0.24 0.03 0.01 --- --- 0.02 0.03 1 
risk 1.4 0.3 0.6 0.1 0 --- --- 0 0.1 2.5 
num 1.4 0.3 0.6 0.1 0 --- --- 0 0.1 2.5 
 (1.2-1.6) (0.2-0.4) (0.4-0.8) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.1) (0.0-0.1)  
Late 
 
prop 0.44 0.05 0.3 0.09 0.04 --- --- 0.01 0.07 1 
risk 0.5 0.1 0.3 0.1 0 --- --- 0 0.1 1.1 
num 0.5 0.1 0.3 0.1 0 --- --- 0 0.1 1.1 
 (0.3-0.6) (0.0-0.1) (0.2-0.4) (0.0-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.53 0.09 0.26 0.04 0.02 0 0 0.01 0.04 1 
risk 2 0.3 1 0.2 0.1 0 0 0.1 0.2 3.7 
num 1.9 0.3 0.9 0.2 0.1 0 0 0.1 0.1 3.6 
 (1.5-2.3) (0.2-0.5) (0.7-1.2) (0.1-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.3)  
Iceland 
(high-
quality VR) 
 
Early 
 
prop 0.67 0 0 0 0 --- --- 0 0.33 1 
risk 0.6 0 0 0 0 --- --- 0 0.3 0.9 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop --- --- --- --- --- --- --- --- --- 1 
risk 0 0 0 0 0 --- --- 0 0 0 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.67 0 0 0 0 0 0 0 0.33 1 
risk 0.7 0 0 0 0 0 0 0 0.3 1 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
India  
(high mort 
model) 
 
Early 
 
prop 0.5 0.22 0.08 0.08 0.04 0.01 0 --- 0.08 1 
risk 10.7 4.7 1.7 1.7 0.8 0.2 0.1 --- 1.7 21.6 
num 
2742.2 1210.3 447.5 435.2 198.1 43.9 15.8 --- 438.5 
5531.
5 
 
(1586.8-
4064.8) (676.5-1959.1) 
(202.1-
806.2) 
(107.6-
849.0) (66.6-510.3) (9.0-137.1) (0.0-120.7) --- 
(120.1-
800.5)  
Late 
 
prop 0.27 0.11 0.08 0.35 0.04 0.04 0.02 --- 0.09 1 
risk 2 0.9 0.6 2.6 0.3 0.3 0.1 --- 0.7 7.6 
num 
522.6 222.5 159.1 674.5 77.9 71.9 38.3 --- 176.8 
1943.
5 
 
(236.5-891.3) (100.4-384.6) (65.1-321.5) 
(305.5-
1204.9) (33.3-145.4) 
(19.3-
200.0) (9.4-122.4) --- (57.8-366.3)  
Overall prop 0.44 0.19 0.08 0.15 0.04 0.02 0.01 0 0.08 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 13.2 5.8 2.4 4.5 1.1 0.5 0.2 0 2.5 30.1 
num 3323.7 1452.4 593.8 1127.2 283.1 121.7 55.2 0 623.8 7580.9 
 
(1833.8-5081.7) (777.7-2381.7) 
(263.6-
1106.8) 
(414.8-
2094.7) (100.9-673.8) (28.7-354.6) (9.3-251.4) (0.0-0.0) 
(178.3-
1194.0)  
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Indonesia 
(high mort 
model) 
 
Early 
 
prop 0.41 0.22 0.18 0.06 0.03 0 0 --- 0.1 1 
risk 4.4 2.3 1.9 0.7 0.3 0 0 --- 1 10.7 
num 200.4 106.9 88.4 30 13 1.1 0.1 --- 47.2 487.1 
 
(169.9-
255.2) (87.0-143.2) (59.0-118.0) (12.5-47.9) (6.0-28.8) (0.4-2.8) (0.0-1.0) --- (16.1-75.1)  
Late 
 
prop 0.23 0.11 0.16 0.33 0.04 0.01 0 --- 0.11 1 
risk 0.9 0.4 0.6 1.2 0.1 0 0 --- 0.4 3.7 
num 38.9 19.5 27.7 56.6 6.9 1.7 0.7 --- 19.3 171.2 
 (28.6-56.6) (13.7-27.2) (14.4-43.0) (34.3-85.3) (4.4-10.4) (0.5-4.8) (0.3-1.4) --- (7.8-34.4)  
Overall 
 
prop 0.37 0.19 0.17 0.13 0.03 0 0 0 0.1 1 
risk 5.5 2.9 2.5 2 0.5 0.1 0 0 1.5 14.9 
num 264.7 138 123 95.2 21.8 3.1 0.9 0 72.7 719.4 
 
(220.1-
349.7) (110.4-185.6) (77.7-171.3) (52.2-146.8) (11.5-43.3) (1.0-8.6) (0.3-2.7) (0.0-0.0) 
(26.3-
118.8)  
Iran  
(high mort 
model) 
 
Early 
 
prop 0.38 0.2 0.24 0.05 0.02 0 0 --- 0.11 1 
risk 2.9 1.5 1.9 0.4 0.2 0 0 --- 0.8 7.6 
num 42.5 22.3 27.4 6 2.4 0.2 0 --- 11.9 112.7 
 (30.9-57.3) (16.1-30.3) (14.6-36.1) (2.1-9.5) (1.0-5.5) (0.1-0.4) (0.0-0.1) --- (3.1-20.1)  
Late 
 
prop 0.18 0.1 0.27 0.28 0.04 0.01 0 --- 0.12 1 
risk 0.5 0.3 0.7 0.7 0.1 0 0 --- 0.3 2.7 
num 7.3 3.9 10.9 10.9 1.5 0.2 0.1 --- 4.8 39.6 
 (4.2-12.4) (2.3-5.8) (4.4-16.1) (5.5-18.4) (0.8-2.6) (0.1-0.7) (0.0-0.2) --- (1.6-8.3)  
Overall 
 
prop 0.33 0.17 0.25 0.11 0.03 0 0 0 0.11 1 
risk 3.5 1.8 2.6 1.2 0.3 0 0 0 1.2 10.6 
num 51.8 27.5 39.5 17.7 4.1 0.4 0.1 0 17.4 158.4 
 (36.4-71.8) (19.2-38.0) (19.1-53.4) (8.2-28.8) (1.8-8.4) (0.1-1.2) (0.0-0.3) (0.0-0.0) (4.9-29.4)  
Iraq  
(high mort 
model) 
 
Early 
 
prop 0.41 0.27 0.16 0.07 0.03 0 0 --- 0.05 1 
risk 5.6 3.7 2.2 1 0.5 0.1 0 --- 0.7 13.8 
num 58.5 38.5 23.3 10.3 5 0.6 0.2 --- 7.1 143.5 
 (46.1-67.8) (30.1-43.4) (14.2-30.8) (4.2-15.5) (2.3-9.8) (0.2-1.5) (0.0-1.5) --- (3.4-10.4)  
Late prop 0.13 0.14 0.22 0.39 0.05 0.02 0.01 --- 0.04 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.6 0.7 1.1 1.9 0.2 0.1 0 --- 0.2 4.9 
num 6.5 6.9 11.3 19.8 2.3 0.9 0.5 --- 2.2 50.4 
 (4.0-9.5) (4.4-8.8) (5.8-16.7) (12.2-26.6) (1.4-3.2) (0.3-2.2) (0.2-0.8) --- (1.0-5.1)  
Overall 
 
prop 0.32 0.24 0.18 0.16 0.04 0.01 0 0 0.05 1 
risk 6 4.6 3.4 3.1 0.7 0.1 0.1 0 0.9 19.1 
num 61.4 47.2 34.7 32 7.6 1.3 0.8 0 9.6 194.6 
 (46.3-74.4) (36.2-54.2) (19.9-47.1) (17.4-44.8) (3.7-13.5) (0.4-3.0) (0.2-2.5) (0.0-0.0) (4.6-16.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Ireland 
(high-
quality VR) 
 
Early 
 
prop 0.33 0.13 0.46 0.01 0.02 --- --- 0 0.06 1 
risk 0.6 0.2 0.9 0 0 --- --- 0 0.1 1.9 
num 0.5 0.2 0.6 0 0 --- --- 0 0.1 1.4 
 (0.3-0.6) (0.1-0.3) (0.5-0.8) (0.0-0.0) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.38 0.09 0.38 0.06 0.03 --- --- 0 0.06 1 
risk 0.2 0 0.2 0 0 --- --- 0 0 0.4 
num 0.1 0 0.1 0 0 --- --- 0 0 0.3 
 (0.0-0.2) (0.0-0.1) (0.0-0.2) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.34 0.12 0.45 0.02 0.02 0 0 0 0.06 1 
risk 0.8 0.3 1 0 0.1 0 0 0 0.1 2.3 
num 0.6 0.2 0.8 0 0 0 0 0 0.1 1.7 
 (0.4-0.8) (0.1-0.3) (0.5-1.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.2)  
Israel  
(high-
quality VR) 
 
Early 
 
prop 0.45 0.07 0.33 0.03 0 --- --- 0.01 0.12 1 
risk 0.7 0.1 0.5 0 0 --- --- 0 0.2 1.6 
num 1.1 0.2 0.8 0.1 0 --- --- 0 0.3 2.5 
 (0.9-1.3) (0.1-0.3) (0.6-1.0) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.2-0.4)  
Late 
 
prop 0.49 0.05 0.34 0.1 0 --- --- 0 0.01 1 
risk 0.2 0 0.2 0 0 --- --- 0 0 0.4 
num 0.4 0 0.2 0.1 0 --- --- 0 0 0.7 
 (0.2-0.5) (0.0-0.1) (0.1-0.3) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.46 0.07 0.33 0.05 0 0 0 0.01 0.09 1 
risk 1 0.1 0.7 0.1 0 0 0 0 0.2 2.1 
num 1.5 0.2 1.1 0.2 0 0 0 0 0.3 3.3 
 (1.2-1.9) (0.1-0.3) (0.8-1.4) (0.0-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.4)  
Italy  
(high-
Early 
 
prop 0.41 0.14 0.22 0.04 0 --- --- 0 0.19 1 
risk 0.6 0.2 0.3 0.1 0 --- --- 0 0.3 1.6 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
quality VR) 
 
num 3.6 1.2 2 0.4 0 --- --- 0 1.7 8.8 
 (3.2-4.0) (1.0-1.4) (1.7-2.2) (0.2-0.5) (0.0-0.0) --- --- (0.0-0.0) (1.4-2.0)  
Late 
 
prop 0.4 0.07 0.24 0.11 0.01 --- --- 0.01 0.15 1 
risk 0.3 0 0.2 0.1 0 --- --- 0 0.1 0.6 
num 1.5 0.3 0.9 0.4 0 --- --- 0 0.6 3.7 
 (1.2-1.7) (0.2-0.4) (0.7-1.1) (0.3-0.5) (0.0-0.1) --- --- (0.0-0.1) (0.4-0.7)  
Overall 
 
prop 0.41 0.12 0.23 0.06 0 0 0 0 0.18 1 
risk 0.9 0.3 0.5 0.1 0 0 0 0 0.4 2.2 
num 5.1 1.5 2.8 0.7 0 0 0 0 2.3 12.5 
 (4.4-5.7) (1.1-1.8) (2.4-3.3) (0.5-1.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (1.9-2.7)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Jamaica 
(low mort 
model) 
 
Early 
 
prop 0.42 0.15 0.21 0.08 0.03 --- --- 0 0.11 1 
risk 3.3 1.1 1.6 0.6 0.2 --- --- 0 0.8 7.7 
num 1.7 0.6 0.8 0.3 0.1 --- --- 0 0.4 4 
 (1.4-2.5) (0.5-0.9) (0.6-1.3) (0.3-0.5) (0.1-0.2) --- --- (0.0-0.0) (0.3-0.7)  
Late 
 
prop 0.3 0.08 0.27 0.19 0.05 --- --- 0.02 0.09 1 
risk 0.8 0.2 0.7 0.5 0.1 --- --- 0 0.2 2.7 
num 0.4 0.1 0.4 0.3 0.1 --- --- 0 0.1 1.4 
 (0.3-0.6) (0.1-0.2) (0.3-0.6) (0.2-0.4) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.2)  
Overall 
 
prop 0.38 0.13 0.22 0.12 0.03 0 0 0.01 0.1 1 
risk 4.1 1.4 2.4 1.3 0.4 0 0 0.1 1.1 10.7 
num 2.2 0.7 1.3 0.7 0.2 0 0 0 0.6 5.8 
 (1.8-3.3) (0.6-1.1) (1.0-2.0) (0.5-1.1) (0.1-0.4) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.4-0.9)  
Japan 
(high-
quality VR) 
 
Early 
 
prop 0.24 0.14 0.43 0.03 0.01 --- --- 0.01 0.13 1 
risk 0.2 0.1 0.3 0 0 --- --- 0 0.1 0.7 
num 1.9 1.1 3.4 0.3 0.1 --- --- 0.1 1 7.9 
 (1.7-2.2) (0.9-1.3) (3.0-3.7) (0.2-0.3) (0.0-0.2) --- --- (0.0-0.1) (0.8-1.2)  
Late 
 
prop 0.1 0.03 0.52 0.14 0.04 --- --- 0.05 0.12 1 
risk 0 0 0.1 0 0 --- --- 0 0 0.3 
num 0.3 0.1 1.5 0.4 0.1 --- --- 0.2 0.4 3 
 (0.2-0.4) (0.0-0.1) (1.3-1.8) (0.3-0.5) (0.1-0.2) --- --- (0.1-0.2) (0.2-0.5)  
Overall 
 
prop 0.21 0.11 0.45 0.06 0.02 0 0 0.02 0.13 1 
risk 0.2 0.1 0.5 0.1 0 0 0 0 0.1 1.1 
num 2.5 1.3 5.4 0.7 0.3 0 0 0.2 1.5 11.9 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (2.1-2.8) (1.0-1.6) (4.8-6.0) (0.5-1.0) (0.1-0.4) (0.0-0.0) (0.0-0.0) (0.1-0.4) (1.2-1.9)  
Jordan  
(low mort 
model) 
 
Early 
 
prop 0.45 0.16 0.24 0.08 0.04 --- --- 0.01 0.02 1 
risk 3.7 1.3 2 0.7 0.3 --- --- 0.1 0.2 8.3 
num 7.4 2.7 4 1.3 0.6 --- --- 0.2 0.3 16.5 
 (6.6-8.2) (2.2-3.1) (3.0-4.9) (0.9-1.8) (0.4-1.0) --- --- (0.1-0.6) (0.1-0.9)  
Late 
 
prop 0.3 0.09 0.27 0.17 0.06 --- --- 0.02 0.09 1 
risk 0.9 0.3 0.8 0.5 0.2 --- --- 0 0.3 2.9 
num 1.7 0.5 1.6 1 0.3 --- --- 0.1 0.5 5.8 
 (1.5-2.0) (0.4-0.7) (1.4-1.8) (0.7-1.2) (0.2-0.6) --- --- (0.1-0.1) (0.4-0.8)  
Overall 
 
prop 0.41 0.14 0.24 0.11 0.04 0 0 0.01 0.04 1 
risk 4.7 1.7 2.8 1.2 0.5 0 0 0.1 0.5 11.5 
num 9.5 3.3 5.6 2.4 1 0 0 0.3 0.9 23 
 (8.4-10.7) (2.6-3.9) (4.5-6.8) (1.6-3.2) (0.6-1.6) (0.0-0.0) (0.0-0.0) (0.2-0.7) (0.5-1.7)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Kazakhsta
n (high 
mort model) 
 
Early 
 
prop 0.36 0.22 0.26 0.06 0.02 0 0 --- 0.09 1 
risk 2.3 1.4 1.7 0.4 0.2 0 0 --- 0.6 6.5 
num 7.7 4.7 5.5 1.2 0.5 0 0 --- 1.9 21.4 
 (6.7-11.5) (4.0-7.1) (3.5-8.4) (0.5-2.1) (0.2-1.3) (0.0-0.1) (0.0-0.0) --- (0.8-3.1)  
Late 
 
prop 0.15 0.11 0.32 0.28 0.04 0.01 0 --- 0.09 1 
risk 0.3 0.2 0.7 0.6 0.1 0 0 --- 0.2 2.3 
num 1.1 0.8 2.4 2.1 0.3 0.1 0 --- 0.7 7.5 
 (0.8-2.1) (0.6-1.4) (1.2-4.0) (1.2-3.9) (0.2-0.6) (0.0-0.2) (0.0-0.0) --- (0.4-1.4)  
Overall 
 
prop 0.31 0.19 0.27 0.11 0.03 0 0 0 0.09 1 
risk 2.9 1.8 2.6 1.1 0.3 0 0 0 0.9 9.6 
num 10.1 6.3 8.9 3.8 0.9 0.1 0 0 2.9 33.1 
 (8.2-14.6) (4.9-9.2) (5.2-13.2) (1.9-6.3) (0.5-2.0) (0.0-0.3) (0.0-0.1) (0.0-0.0) (1.3-4.8)  
Kenya  
(high mort 
model) 
 
Early 
 
prop 0.32 0.4 0.1 0.08 0.06 0.01 0 --- 0.04 1 
risk 6.1 7.7 1.9 1.6 1.2 0.2 0 --- 0.7 19.5 
num 92.5 116.3 28.6 24.4 17.7 2.3 0.5 --- 10.8 293 
 (73.7-120.9) (91.9-140.8) (21.9-47.9) (10.5-39.5) (8.6-35.9) (0.8-5.5) (0.0-4.9) --- (5.4-30.2)  
Late 
 
prop 0.16 0.17 0.07 0.43 0.06 0.04 0 --- 0.07 1 
risk 1.1 1.2 0.5 3 0.4 0.3 0 --- 0.5 6.8 
num 16.1 17.8 7.1 44.5 6 3.8 0.4 --- 7.2 102.9 
 (9.2-26.4) (12.2-25.1) (2.5-19.2) (26.7-62.3) (3.8-9.1) (1.3-9.4) (0.1-0.9) --- (3.0-18.9)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.27 0.34 0.09 0.18 0.06 0.02 0 0 0.05 1 
risk 7.3 9 2.4 4.8 1.6 0.4 0.1 0 1.2 26.8 
num 109.4 134.4 35.7 71.2 24 6.3 0.9 0 18.1 400.1 
 (82.7-148.8) (105.2-166.2) (24.6-68.5) (38.5-105.7) (12.8-46.2) (2.3-15.1) (0.1-6.1) (0.0-0.0) (8.3-50.7)  
Kiribati 
(high mort 
model) 
 
Early 
 
prop 0.35 0.32 0.11 0.07 0.04 0 0 --- 0.1 1 
risk 5.6 5.1 1.7 1.1 0.7 0.1 0 --- 1.6 16 
num 0.1 0.1 0 0 0 0 0 --- 0 0.4 
 (0.1-0.2) (0.1-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.1)  
Late 
 
prop 0.16 0.15 0.13 0.39 0.05 0.02 0 --- 0.1 1 
risk 0.9 0.8 0.7 2.2 0.3 0.1 0 --- 0.6 5.6 
num 0 0 0 0.1 0 0 0 --- 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)  
Overall 
 
prop 0.31 0.27 0.11 0.16 0.05 0.01 0 0 0.1 1 
risk 6.8 5.8 2.5 3.4 1 0.2 0 0 2.1 21.9 
num 0.2 0.1 0.1 0.1 0 0 0 0 0.1 0.5 
 (0.1-0.2) (0.1-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Kuwait 
(high-
quality VR) 
 
Early 
 
prop 0.45 0.01 0.51 0.01 0.02 --- --- 0 0.01 1 
risk 1.4 0 1.5 0 0 --- --- 0 0 3 
num 1 0 1.1 0 0 --- --- 0 0 2.1 
 (0.8-1.1) (0.0-0.0) (0.9-1.3) (0.0-0.0) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.39 0.07 0.42 0.05 0.01 --- --- 0.02 0.04 1 
risk 0.7 0.1 0.7 0.1 0 --- --- 0 0.1 1.7 
num 0.5 0.1 0.5 0.1 0 --- --- 0 0 1.2 
 (0.3-0.6) (0.0-0.1) (0.4-0.6) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.43 0.03 0.48 0.02 0.01 0 0 0.01 0.02 1 
risk 2.2 0.2 2.4 0.1 0.1 0 0 0 0.1 5 
num 1.5 0.1 1.6 0.1 0 0 0 0 0.1 3.4 
 (1.1-1.8) (0.0-0.2) (1.3-2.0) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.1)  
Kyrgyzsta
n (high 
mort model) 
 
Early 
 
prop 0.34 0.26 0.24 0.07 0.03 0 0 --- 0.07 1 
risk 3.3 2.6 2.3 0.7 0.3 0 0 --- 0.7 9.8 
num 5 3.9 3.6 1 0.4 0 0 --- 1 15 
 (3.9-6.7) (3.0-5.1) (2.2-4.9) (0.4-1.6) (0.2-1.0) (0.0-0.1) (0.0-0.0) --- (0.5-1.4)  
Late prop 0.11 0.13 0.31 0.32 0.05 0.01 0 --- 0.07 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.4 0.4 1.1 1.1 0.2 0 0 --- 0.2 3.5 
num 0.6 0.7 1.7 1.7 0.2 0 0 --- 0.4 5.3 
 (0.3-1.0) (0.4-1.0) (0.8-2.4) (0.9-2.6) (0.1-0.4) (0.0-0.1) (0.0-0.0) --- (0.2-0.6)  
Overall 
 
prop 0.29 0.23 0.24 0.14 0.03 0 0 0 0.07 1 
risk 4.1 3.2 3.5 1.9 0.5 0.1 0 0 1 14.2 
num 6.1 4.9 5.2 2.9 0.7 0.1 0 0 1.4 21.4 
 (4.6-8.3) (3.7-6.4) (3.1-7.4) (1.4-4.5) (0.3-1.5) (0.0-0.3) (0.0-0.1) (0.0-0.0) (0.8-2.1)  
Lao 
People's 
Democrati
c Republic 
(high mort 
model) 
 
Early 
 
prop 0.27 0.38 0.09 0.09 0.06 0.01 0.01 --- 0.09 1 
risk 5.9 8.2 2 1.9 1.3 0.2 0.1 --- 1.9 21.5 
num 10.8 15.2 3.7 3.4 2.4 0.4 0.2 --- 3.5 39.6 
 (7.7-15.4) (11.3-20.5) (2.5-6.5) (1.4-6.0) (1.2-4.9) (0.1-1.0) (0.0-2.2) --- (1.9-5.2)  
Late 
 
prop 0.15 0.16 0.07 0.46 0.06 0.03 0.01 --- 0.07 1 
risk 1.2 1.2 0.5 3.5 0.4 0.2 0.1 --- 0.6 7.6 
num 2.1 2.2 0.9 6.4 0.8 0.3 0.1 --- 1 13.9 
 (1.2-3.7) (1.3-3.2) (0.5-1.8) (4.0-10.0) (0.4-1.3) (0.1-1.0) (0.1-0.3) --- (0.6-2.1)  
Overall 
 
prop 0.26 0.32 0.08 0.18 0.06 0.02 0.01 0 0.08 1 
risk 7.8 9.4 2.4 5.2 1.7 0.5 0.2 0 2.5 29.8 
num 15.1 18.3 4.6 10.2 3.3 1 0.4 0 4.8 57.8 
 (10.7-21.7) (13.3-25.0) (3.1-8.8) (5.7-16.2) (1.7-6.6) (0.3-2.4) (0.1-2.8) (0.0-0.0) (2.6-7.7)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Latvia 
(high-
quality VR) 
 
Early 
 
prop 0.13 0.65 0.13 0.06 0.02 --- --- 0.02 0 1 
risk 0.5 2.4 0.5 0.2 0.1 --- --- 0.1 0 3.7 
num 0.1 0.5 0.1 0 0 --- --- 0 0 0.8 
 (0.0-0.2) (0.4-0.7) (0.0-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.15 0.2 0.4 0.25 0 --- --- 0 0 1 
risk 0.2 0.3 0.6 0.4 0 --- --- 0 0 1.5 
num 0 0.1 0.1 0.1 0 --- --- 0 0 0.3 
 (0.0-0.1) (0.0-0.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.13 0.51 0.21 0.12 0.01 0 0 0.01 0 1 
risk 0.7 2.8 1.1 0.6 0.1 0 0 0.1 0 5.4 
num 0.2 0.6 0.2 0.1 0 0 0 0 0 1.2 
 (0.0-0.3) (0.4-0.8) (0.1-0.4) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Lebanon 
(low mort 
Early 
 
prop 0.46 0.17 0.18 0.04 0.02 --- --- 0.01 0.12 1 
risk 1.8 0.7 0.7 0.2 0.1 --- --- 0 0.5 3.8 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
model) 
 
num 1.2 0.5 0.5 0.1 0.1 --- --- 0 0.3 2.6 
 (1.0-1.5) (0.3-0.6) (0.4-0.7) (0.1-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.2-0.4)  
Late 
 
prop 0.3 0.09 0.3 0.15 0.08 --- --- 0.02 0.06 1 
risk 0.4 0.1 0.4 0.2 0.1 --- --- 0 0.1 1.4 
num 0.3 0.1 0.3 0.1 0.1 --- --- 0 0.1 0.9 
 (0.2-0.3) (0.1-0.1) (0.2-0.4) (0.1-0.2) (0.1-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.41 0.15 0.21 0.07 0.04 0 0 0.01 0.1 1 
risk 2.2 0.8 1.1 0.4 0.2 0 0 0.1 0.6 5.4 
num 1.3 0.5 0.7 0.2 0.1 0 0 0 0.3 3.2 
 (1.2-1.7) (0.4-0.6) (0.6-1.0) (0.1-0.3) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.3-0.5)  
Lesotho 
(high mort 
model) 
 
Early 
 
prop 0.34 0.37 0.07 0.09 0.07 0.01 0 --- 0.04 1 
risk 11.1 12.2 2.3 3 2.2 0.5 0.1 --- 1.2 32.5 
num 6.4 7.1 1.3 1.7 1.3 0.3 0 --- 0.7 18.9 
 (4.3-7.5) (4.7-7.8) (0.8-2.1) (0.6-2.5) (0.6-2.3) (0.1-0.7) (0.0-0.6) --- (0.3-2.1)  
Late 
 
prop 0.19 0.15 0.05 0.42 0.05 0.05 0 --- 0.09 1 
risk 2.2 1.7 0.6 4.8 0.6 0.6 0 --- 1 11.4 
num 1.3 1 0.3 2.8 0.3 0.4 0 --- 0.6 6.6 
 (0.6-2.1) (0.5-1.2) (0.1-0.8) (1.4-3.7) (0.2-0.5) (0.1-0.8) (0.0-0.1) --- (0.1-1.3)  
Overall 
 
prop 0.3 0.32 0.06 0.18 0.06 0.02 0 0 0.05 1 
risk 13.4 14 2.8 7.8 2.9 1.1 0.1 0 2.2 44.3 
num 7.7 8.1 1.6 4.5 1.7 0.6 0.1 0 1.3 25.6 
 (4.9-9.7) (5.2-9.1) (0.9-2.8) (2.1-6.2) (0.8-2.8) (0.2-1.5) (0.0-0.7) (0.0-0.0) (0.5-3.4)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Liberia 
(high mort 
model) 
 
Early 
 
prop 0.29 0.39 0.11 0.1 0.06 0.01 0 --- 0.04 1 
risk 5.5 7.4 2.1 1.9 1.2 0.1 0 --- 0.7 18.9 
num 8.2 10.9 3.1 2.8 1.8 0.2 0 --- 1.1 28.1 
 (6.1-9.8) (8.2-11.9) (2.2-4.1) (1.1-4.1) (0.8-3.2) (0.1-0.5) (0.0-0.4) --- (0.5-2.6)  
Late 
 
prop 0.14 0.16 0.06 0.49 0.06 0.02 0.01 --- 0.06 1 
risk 0.9 1 0.4 3.3 0.4 0.1 0.1 --- 0.4 6.7 
num 1.4 1.6 0.6 4.9 0.6 0.2 0.1 --- 0.6 9.9 
 (0.6-2.2) (0.9-2.0) (0.2-1.4) (2.9-6.4) (0.3-0.9) (0.1-0.5) (0.0-0.2) --- (0.3-1.5)  
Overall 
 
prop 0.25 0.33 0.09 0.2 0.06 0.01 0 0 0.05 1 
risk 6.6 8.8 2.4 5.3 1.7 0.3 0.1 0 1.2 26.3 
num 9.6 12.9 3.5 7.7 2.4 0.5 0.2 0 1.8 38.6 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (6.6-12.6) (9.4-14.5) (2.3-5.4) (4.1-10.7) (1.2-4.3) (0.1-1.1) (0.0-0.7) (0.0-0.0) (0.8-4.3)  
Libya  
(low mort 
model) 
 
Early 
 
prop 0.42 0.17 0.27 0.04 0.01 --- --- 0 0.09 1 
risk 2.7 1.1 1.7 0.3 0.1 --- --- 0 0.6 6.4 
num 3.4 1.4 2.2 0.4 0.1 --- --- 0 0.7 8.1 
 (2.8-3.8) (0.9-1.7) (1.6-2.8) (0.2-0.5) (0.1-0.1) --- --- (0.0-0.1) (0.5-0.9)  
Late 
 
prop 0.28 0.11 0.28 0.18 0.07 --- --- 0.01 0.07 1 
risk 0.6 0.2 0.6 0.4 0.2 --- --- 0 0.2 2.3 
num 0.8 0.3 0.8 0.5 0.2 --- --- 0 0.2 2.9 
 (0.7-1.0) (0.1-0.4) (0.7-0.9) (0.3-0.7) (0.1-0.3) --- --- (0.0-0.1) (0.1-0.3)  
Overall 
 
prop 0.38 0.15 0.27 0.08 0.03 0 0 0.01 0.08 1 
risk 3.5 1.4 2.4 0.7 0.2 0 0 0.1 0.8 9.1 
num 4.5 1.8 3.2 0.9 0.3 0 0 0.1 1 11.7 
 (3.7-5.1) (1.1-2.2) (2.4-4.0) (0.6-1.2) (0.2-0.5) (0.0-0.0) (0.0-0.0) (0.1-0.1) (0.7-1.2)  
Lithuania 
(high-
quality VR) 
 
Early 
 
prop 0.28 0.21 0.3 0.19 0.02 --- --- 0 0 1 
risk 0.5 0.4 0.5 0.3 0 --- --- 0 0 1.7 
num 0.2 0.1 0.2 0.1 0 --- --- 0 0 0.6 
 (0.1-0.2) (0.1-0.2) (0.1-0.3) (0.0-0.2) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.17 0.07 0.45 0.21 0 --- --- 0.1 0 1 
risk 0.2 0.1 0.4 0.2 0 --- --- 0.1 0 1 
num 0.1 0 0.1 0.1 0 --- --- 0 0 0.3 
 (0.0-0.1) (0.0-0.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.1) (0.0-0.0)  
Overall 
 
prop 0.24 0.16 0.35 0.2 0.01 0 0 0.04 0 1 
risk 0.7 0.5 1 0.6 0 0 0 0.1 0 2.9 
num 0.2 0.2 0.4 0.2 0 0 0 0 0 1 
 (0.1-0.4) (0.1-0.3) (0.2-0.5) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Luxembour
g (high-
quality VR) 
 
Early 
 
prop 0.5 0.13 0 0.13 0 --- --- 0 0.25 1 
risk 0.4 0.1 0 0.1 0 --- --- 0 0.2 0.7 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0 0 1 0 0 --- --- 0 0 1 
risk 0 0 0.2 0 0 --- --- 0 0 0.2 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.4 0.1 0.2 0.1 0 0 0 0 0.2 1 
risk 0.4 0.1 0.2 0.1 0 0 0 0 0.2 1 
num 0 0 0 0 0 0 0 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Madagascar 
(high mort 
model) 
 
Early 
 
prop 0.31 0.37 0.13 0.08 0.06 0.01 0 --- 0.03 1 
risk 4.9 5.9 2.1 1.3 0.9 0.1 0 --- 0.6 15.8 
num 38.5 46.7 16.7 10.5 6.9 0.8 0.1 --- 4.3 124.6 
 (31.3-46.0) (36.6-52.3) (12.3-23.6) (4.4-16.6) (3.5-13.2) (0.3-1.7) (0.0-0.9) --- (2.2-11.8)  
Late 
 
prop 0.17 0.15 0.06 0.46 0.05 0.02 0.01 --- 0.06 1 
risk 0.9 0.8 0.4 2.6 0.3 0.1 0.1 --- 0.3 5.6 
num 7.3 6.7 2.8 20.3 2.3 1 0.7 --- 2.7 43.8 
 (4.3-12.0) (4.4-8.9) (0.8-7.6) (12.6-26.9) (1.4-3.2) (0.3-2.4) (0.3-1.2) --- (1.1-7.0)  
Overall 
 
prop 0.28 0.32 0.11 0.18 0.06 0.01 0 0 0.04 1 
risk 6.1 6.9 2.4 4 1.2 0.2 0.1 0 0.9 22 
num 46.8 53.4 18.8 31.1 9.3 1.8 0.8 0 7.1 169.2 
 (36.9-58.0) (41.8-61.2) (12.8-30.0) (17.3-44.3) (4.8-16.6) (0.6-4.3) (0.3-2.1) (0.0-0.0) (3.3-18.9)  
Malawi  
(high mort 
model) 
 
Early 
 
prop 0.37 0.33 0.11 0.09 0.05 0 0 --- 0.05 1 
risk 6.3 5.6 1.9 1.6 0.9 0.1 0 --- 0.8 17.2 
num 38.1 34 11.5 9.5 5.3 0.5 0.2 --- 4.8 103.8 
 (31.0-47.3) (28.1-40.3) (7.7-16.7) (3.6-15.0) (2.7-10.6) (0.2-1.1) (0.0-1.3) --- (3.0-8.9)  
Late 
 
prop 0.14 0.16 0.08 0.48 0.06 0.02 0.01 --- 0.07 1 
risk 0.8 0.9 0.5 2.9 0.3 0.1 0 --- 0.4 6 
num 4.9 5.7 2.9 17.3 2.1 0.8 0.2 --- 2.5 36.5 
 (2.7-7.8) (3.7-7.7) (1.0-7.2) (10.9-24.1) (1.1-3.2) (0.2-2.1) (0.1-0.6) --- (1.3-5.4)  
Overall 
 
prop 0.3 0.28 0.1 0.19 0.05 0.01 0 0 0.05 1 
risk 7.2 6.7 2.4 4.6 1.2 0.2 0.1 0 1.2 23.5 
num 44.1 41 14.7 28.1 7.7 1.3 0.4 0 7.5 144.9 
 (33.9-58.5) (32.9-50.1) (8.0-24.9) (15.1-41.4) (4.0-14.4) (0.4-3.4) (0.1-2.0) (0.0-0.0) (4.4-14.9)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Malaysia 
(low mort 
model) 
 
Early 
 
prop 0.44 0.15 0.21 0.04 0.02 --- --- 0.01 0.12 1 
risk 1.4 0.5 0.7 0.1 0.1 --- --- 0 0.4 3.3 
num 7.7 2.7 3.7 0.8 0.3 --- --- 0.1 2.2 17.5 
 (6.8-8.5) (2.3-3.0) (3.0-5.0) (0.5-1.0) (0.2-0.4) --- --- (0.1-0.1) (1.5-2.6)  
Late prop 0.27 0.08 0.32 0.18 0.07 --- --- 0.01 0.07 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.3 0.1 0.4 0.2 0.1 --- --- 0 0.1 1.1 
num 1.7 0.5 1.9 1.1 0.5 --- --- 0.1 0.4 6.1 
 (1.5-1.9) (0.3-0.7) (1.8-2.2) (0.9-1.2) (0.3-0.7) --- --- (0.1-0.1) (0.3-0.6)  
Overall 
 
prop 0.4 0.14 0.23 0.08 0.03 0 0 0.01 0.11 1 
risk 1.8 0.6 1 0.4 0.1 0 0 0 0.5 4.4 
num 8.9 3 5.2 1.8 0.7 0 0 0.2 2.4 22.1 
 (7.9-9.7) (2.5-3.5) (4.4-6.4) (1.3-2.1) (0.5-1.0) (0.0-0.0) (0.0-0.0) (0.1-0.2) (1.6-3.1)  
Maldives 
(low mort 
model) 
 
Early 
 
prop 0.41 0.12 0.29 0.05 0.03 --- --- 0 0.08 1 
risk 1.8 0.6 1.3 0.2 0.1 --- --- 0 0.4 4.4 
num 0.1 0 0.1 0 0 --- --- 0 0 0.4 
 (0.1-0.2) (0.0-0.1) (0.0-0.2) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.29 0.07 0.33 0.13 0.05 --- --- 0.02 0.11 1 
risk 0.5 0.1 0.5 0.2 0.1 --- --- 0 0.2 1.6 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.38 0.11 0.3 0.08 0.04 0 0 0.01 0.09 1 
risk 2.5 0.7 1.9 0.5 0.2 0 0 0 0.6 6.5 
num 0.2 0.1 0.2 0 0 0 0 0 0 0.5 
 (0.1-0.3) (0.1-0.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
Mali  
(high mort 
model) 
 
Early 
 
prop 0.4 0.3 0.05 0.08 0.07 0.01 0.01 --- 0.08 1 
risk 11.8 9 1.5 2.4 2.1 0.4 0.3 --- 2.3 29.7 
num 81.4 61.9 10.6 16.7 14.2 2.8 1.7 --- 15.8 205.2 
 (59.7-102.2) (47.3-71.4) (6.7-15.5) (6.3-26.9) (7.6-25.6) (1.0-6.3) (0.0-16.5) --- (6.8-29.1)  
Late 
 
prop 0.15 0.14 0.04 0.47 0.05 0.05 0.03 --- 0.07 1 
risk 1.6 1.5 0.4 4.9 0.5 0.6 0.3 --- 0.8 10.5 
num 10.8 10.2 2.6 33.8 3.6 3.8 2 --- 5.3 72.1 
 (5.8-16.0) (6.3-13.6) (1.0-5.5) (20.9-45.9) (1.9-5.5) (1.0-9.7) (0.6-5.0) --- (1.9-15.8)  
Overall 
 
prop 0.33 0.26 0.05 0.18 0.07 0.02 0.01 0 0.08 1 
risk 13.4 10.8 1.9 7.6 2.7 1 0.6 0 3.1 41.1 
num 89.7 72.2 13 50.8 18.4 6.5 3.7 0 21.1 275.4 
 (62.6-115.6) (53.3-85.6) (7.7-20.5) (26.6-73.0) (9.7-32.5) (1.8-16.5) (0.6-20.4) (0.0-0.0) (8.8-45.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Malta  
(high-
Early 
 
prop 0.32 0.11 0.47 0.05 0 --- --- 0 0.05 1 
risk 1 0.3 1.5 0.2 0 --- --- 0 0.2 3.2 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
quality VR) 
 
num 0 0 0.1 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.8 0 0.2 0 0 --- --- 0 0 1 
risk 0.7 0 0.2 0 0 --- --- 0 0 0.8 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.08 0.42 0.04 0 0 0 0 0.04 1 
risk 1.7 0.3 1.7 0.2 0 0 0 0 0.2 4.1 
num 0.1 0 0.1 0 0 0 0 0 0 0.2 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Marshall 
Islands 
(high mort 
model) 
 
Early 
 
prop 0.51 0.2 0.14 0.06 0.03 0 0 --- 0.06 1 
risk 5.9 2.4 1.6 0.7 0.3 0 0 --- 0.7 11.8 
num 0.1 0 0 0 0 0 0 --- 0 0.2 
 (0.1-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)  
Late 
 
prop 0.17 0.11 0.22 0.37 0.04 0.01 0.01 --- 0.07 1 
risk 0.7 0.5 0.9 1.5 0.2 0 0 --- 0.3 4.1 
num 0 0 0 0 0 0 0 --- 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)  
Overall 
 
prop 0.39 0.19 0.17 0.15 0.03 0 0 0 0.07 1 
risk 6.3 3.1 2.8 2.4 0.5 0.1 0 0 1.1 16.2 
num 0.1 0 0 0 0 0 0 0 0 0.2 
 (0.1-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Mauritania 
(high mort 
model) 
 
Early 
 
prop 0.45 0.28 0.07 0.1 0.06 0.01 0 --- 0.03 1 
risk 11.7 7.2 1.8 2.6 1.5 0.2 0.1 --- 0.6 25.8 
num 15.1 9.3 2.4 3.4 2 0.3 0.1 --- 0.8 33.3 
 (10.0-17.8) (6.4-11.7) (1.2-3.5) (1.2-7.3) (1.0-4.0) (0.1-0.7) (0.0-0.8) --- (0.4-2.5)  
Late 
 
prop 0.14 0.14 0.05 0.51 0.05 0.04 0.01 --- 0.06 1 
risk 1.3 1.3 0.4 4.6 0.4 0.3 0.1 --- 0.5 9 
num 1.7 1.6 0.6 6 0.6 0.4 0.1 --- 0.7 11.7 
 (0.7-2.7) (0.9-2.2) (0.2-1.4) (3.9-7.8) (0.3-0.8) (0.2-0.9) (0.0-0.3) --- (0.3-1.7)  
Overall 
 
prop 0.37 0.24 0.06 0.21 0.06 0.02 0 0 0.03 1 
risk 13.2 8.6 2.3 7.4 2 0.6 0.2 0 1.2 35.5 
num 16.8 11 2.9 9.4 2.6 0.8 0.2 0 1.5 45.2 
 (10.8-20.4) (7.3-14.0) (1.3-4.8) (5.0-14.8) (1.4-4.8) (0.3-1.8) (0.0-1.1) (0.0-0.0) (0.6-4.3)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
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Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Mauritius 
(high-
quality VR) 
 
Early 
 
prop 0.48 0.12 0.29 0.05 0.01 --- --- 0.02 0.02 1 
risk 2.7 0.7 1.7 0.3 0.1 --- --- 0.1 0.1 5.7 
num 0.4 0.1 0.2 0 0 --- --- 0 0 0.8 
 (0.3-0.5) (0.0-0.2) (0.1-0.3) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.32 0.02 0.19 0.23 0.13 --- --- 0.04 0.06 1 
risk 1 0.1 0.6 0.7 0.4 --- --- 0.1 0.2 3.1 
num 0.1 0 0.1 0.1 0.1 --- --- 0 0 0.4 
 (0.1-0.2) (0.0-0.0) (0.0-0.1) (0.0-0.2) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.42 0.08 0.26 0.11 0.05 0 0 0.03 0.04 1 
risk 3.8 0.7 2.3 1 0.5 0 0 0.3 0.3 9 
num 0.5 0.1 0.3 0.1 0.1 0 0 0 0 1.2 
 (0.3-0.7) (0.0-0.2) (0.2-0.5) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.1)  
Mexico 
(high-
quality VR) 
 
Early 
 
prop 0.43 0.15 0.23 0.09 0.03 --- --- 0 0.06 1 
risk 2 0.7 1.1 0.4 0.1 --- --- 0 0.3 4.6 
num 44.5 15.4 24.2 9.6 3.3 --- --- 0.4 6.1 103.6 
 (43.1-45.8) (14.7-16.2) (23.2-25.2) (9.0-10.3) (3.0-3.7) --- --- (0.3-0.6) (5.6-6.6)  
Late 
 
prop 0.22 0.09 0.26 0.27 0.09 --- --- 0.01 0.06 1 
risk 0.4 0.2 0.5 0.5 0.2 --- --- 0 0.1 1.9 
num 9.5 3.6 11.2 11.2 3.9 --- --- 0.2 2.6 42.3 
 (8.9-10.1) (3.2-4.0) (10.5-11.8) (10.6-11.9) (3.5-4.3) --- --- (0.1-0.3) (2.3-2.9)  
Overall 
 
prop 0.37 0.13 0.24 0.14 0.05 0 0 0 0.06 1 
risk 2.6 0.9 1.7 1 0.3 0 0 0 0.4 6.9 
num 58.1 20.5 38.1 22.5 7.8 0 0 0.7 9.4 157 
 (56.1-60.0) (19.3-21.7) (36.4-39.7) (21.2-23.8) (7.0-8.6) (0.0-0.0) (0.0-0.0) (0.5-0.9) (8.6-10.2)  
Micronesia 
(Federated 
States of) 
(high mort 
model) 
 
Early 
 
prop 0.42 0.26 0.15 0.06 0.04 0 0 --- 0.07 1 
risk 5 3.1 1.8 0.7 0.4 0 0 --- 0.8 11.8 
num 0.1 0.1 0 0 0 0 0 --- 0 0.3 
 (0.1-0.2) (0.1-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)   
Late 
 
prop 0.14 0.11 0.24 0.38 0.04 0.01 0.01 --- 0.06 1 
risk 0.6 0.5 1 1.6 0.2 0 0 --- 0.2 4.1 
num 0 0 0 0 0 0 0 --- 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)   
Overall 
 
prop 0.36 0.22 0.17 0.14 0.04 0.01 0 0 0.06 1 
risk 5.9 3.6 2.8 2.3 0.6 0.1 0 0 1 16.3 
num 0.1 0.1 0.1 0.1 0 0 0 0 0 0.4 
 (0.1-0.2) (0.1-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)   
* prop = proportion; num = number of deaths (in 100s) 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Monaco  
(low mort 
model) 
 
Early 
 
prop 0.42 0.14 0.31 0.02 0 --- --- 0.01 0.11 1 
risk 0.6 0.2 0.5 0 0 --- --- 0 0.2 1.5 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.3 0.08 0.39 0.1 0 --- --- 0.02 0.11 1 
risk 0.2 0 0.2 0 0 --- --- 0 0.1 0.5 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.39 0.13 0.32 0.04 0 0 0 0.01 0.11 1 
risk 0.8 0.3 0.7 0.1 0 0 0 0 0.2 2.1 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Mongolia 
(high mort 
model) 
 
Early 
 
prop 0.38 0.24 0.19 0.06 0.03 0 0 --- 0.09 1 
risk 3.7 2.3 1.9 0.6 0.3 0 0 --- 0.9 9.8 
num 2.4 1.5 1.2 0.4 0.2 0 0 --- 0.6 6.4 
 (1.9-3.5) (1.1-2.2) (0.8-1.8) (0.1-0.7) (0.1-0.4) (0.0-0.0) (0.0-0.0) --- (0.2-0.9)  
Late 
 
prop 0.15 0.12 0.27 0.3 0.04 0.01 0 --- 0.1 1 
risk 0.5 0.4 0.9 1 0.1 0 0 --- 0.3 3.4 
num 0.3 0.3 0.6 0.7 0.1 0 0 --- 0.2 2.2 
 (0.2-0.6) (0.2-0.4) (0.3-1.0) (0.4-1.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- (0.1-0.4)  
Overall 
 
prop 0.33 0.21 0.21 0.13 0.03 0 0 0 0.1 1 
risk 4.4 2.8 2.8 1.7 0.4 0.1 0 0 1.3 13.6 
num 3 1.9 1.9 1.1 0.3 0 0 0 0.9 9.1 
 (2.1-4.3) (1.4-2.7) (1.2-2.9) (0.5-1.9) (0.1-0.6) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.4-1.4)  
Montenegr
o (high-
quality VR) 
 
Early 
 
prop 0.35 0.46 0.12 0.04 0.04 --- --- 0 0 1 
risk 1 1.3 0.3 0.1 0.1 --- --- 0 0 2.8 
num 0.1 0.1 0 0 0 --- --- 0 0 0.2 
 (0.0-0.1) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.33 0.5 0 0 0.17 --- --- 0 0 1 
risk 0.2 0.3 0 0 0.1 --- --- 0 0 0.7 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.34 0.47 0.09 0.03 0.06 0 0 0 0 1 
risk 1.3 1.8 0.4 0.1 0.2 0 0 0 0 3.8 
num 0.1 0.1 0 0 0 0 0 0 0 0.3 
 (0.0-0.2) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
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* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Morocco 
(high mort 
model) 
 
Early 
 
prop 0.39 0.24 0.18 0.07 0.03 0 0 --- 0.09 1 
risk 5.1 3.2 2.3 1 0.4 0 0 --- 1.2 13.2 
num 41.3 25.8 18.9 7.7 3.3 0.4 0.1 --- 9.4 106.8 
 (32.4-50.7) (20.0-31.3) (10.9-24.4) (2.8-12.1) (1.5-6.7) (0.1-1.0) (0.0-0.4) --- (3.6-12.9)  
Late 
 
prop 0.21 0.12 0.13 0.38 0.04 0.01 0.02 --- 0.09 1 
risk 1 0.5 0.6 1.8 0.2 0 0.1 --- 0.4 4.7 
num 7.9 4.4 4.9 14.2 1.6 0.4 0.6 --- 3.5 37.5 
 (5.1-11.4) (2.7-5.5) (2.1-7.4) (8.2-20.2) (0.9-2.2) (0.1-1.0) (0.2-1.5) --- (1.5-5.7)  
Overall 
 
prop 0.34 0.21 0.16 0.15 0.03 0.01 0 0 0.09 1 
risk 6.3 3.9 2.9 2.8 0.6 0.1 0.1 0 1.7 18.4 
num 47.2 28.9 22 21 4.7 0.8 0.6 0 12.4 137.5 
 (35.9-59.9) (21.6-35.4) (12.0-29.5) (10.6-31.0) (2.3-8.7) (0.3-1.9) (0.2-1.9) (0.0-0.0) (4.9-17.9)  
Mozambiqu
e (high mort 
model) 
 
Early 
 
prop 0.37 0.34 0.08 0.1 0.06 0.01 0 --- 0.04 1 
risk 8.3 7.7 1.8 2.2 1.4 0.2 0.1 --- 1 22.5 
num 79 73.5 17.2 20.7 13.3 1.5 0.7 --- 9.1 215 
 (66.0-91.0) (61.1-84.7) (11.4-24.8) (8.4-31.9) (7.2-25.1) (0.5-3.5) (0.0-6.6) --- (5.3-18.4)  
Late 
 
prop 0.15 0.15 0.05 0.48 0.05 0.03 0.02 --- 0.06 1 
risk 1.2 1.2 0.4 3.8 0.4 0.3 0.1 --- 0.5 7.9 
num 11.5 11.5 3.8 36.2 4 2.5 1.3 --- 4.8 75.5 
 (6.8-17.3) (7.6-15.1) (1.3-9.7) (23.3-48.1) (2.4-5.8) (0.7-5.9) (0.6-2.5) --- (2.5-10.7)  
Overall 
 
prop 0.31 0.29 0.07 0.19 0.06 0.01 0.01 0 0.05 1 
risk 9.6 9.1 2.1 6 1.9 0.4 0.2 0 1.5 30.9 
num 90.3 85.2 20 56.3 17.6 4.1 2.1 0 13.9 289.5 
 (73.0-107.7) (69.0-98.5) (12.5-33.3) (31.3-79.9) (9.6-31.2) (1.3-9.7) (0.6-9.7) (0.0-0.0) (7.8-29.1)  
Myanmar 
(high mort 
model) 
 
Early 
 
prop 0.42 0.25 0.09 0.06 0.03 0 0 --- 0.14 1 
risk 7.9 4.7 1.6 1.1 0.6 0.1 0 --- 2.7 18.9 
num 72.9 43.2 14.9 10.1 5.8 0.8 0.3 --- 25.1 173.1 
 (55.1-93.0) (31.6-55.1) (9.8-23.7) (3.9-15.4) (2.5-11.9) (0.3-1.9) (0.0-2.6) --- (5.7-43.8)  
Late 
 
prop 0.27 0.11 0.09 0.32 0.04 0.02 0 --- 0.15 1 
risk 1.8 0.8 0.6 2.1 0.3 0.1 0 --- 1 6.6 
num 16.2 7 5.4 19.3 2.5 1 0.2 --- 9.3 60.8 
 (10.4-22.7) (4.4-9.4) (2.9-8.7) (10.7-28.4) (1.4-3.6) (0.3-2.4) (0.1-0.5) --- (2.5-16.7)  
Overall 
 
prop 0.36 0.22 0.09 0.13 0.04 0.01 0 0 0.15 1 
risk 9.5 5.8 2.3 3.4 1 0.2 0.1 0 3.9 26.1 
num 88.6 53.6 21 31.7 9.1 1.7 0.5 0 36.7 243 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (65.3-116.7) (38.7-68.0) (13.1-34.0) (15.8-48.1) (4.3-17.1) (0.6-4.4) (0.1-3.3) (0.0-0.0) (8.8-63.8)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Namibia 
(high mort 
model) 
 
Early 
 
prop 0.43 0.29 0.13 0.08 0.04 0 0 --- 0.03 1 
risk 6.9 4.6 2.1 1.3 0.7 0.1 0 --- 0.5 16.1 
num 4.1 2.7 1.2 0.8 0.4 0 0 --- 0.3 9.6 
 (3.5-4.6) (2.2-3.1) (0.8-1.6) (0.3-1.2) (0.2-0.8) (0.0-0.1) (0.0-0.0) --- (0.2-1.1)  
Late 
 
prop 0.23 0.12 0.1 0.39 0.04 0.02 0.01 --- 0.09 1 
risk 1.3 0.7 0.6 2.2 0.2 0.1 0 --- 0.5 5.7 
num 0.8 0.4 0.3 1.3 0.1 0.1 0 --- 0.3 3.4 
 (0.4-1.3) (0.3-0.6) (0.1-0.8) (0.8-1.9) (0.1-0.2) (0.0-0.1) (0.0-0.1) --- (0.1-0.8)  
Overall 
 
prop 0.38 0.25 0.12 0.16 0.04 0.01 0 0 0.05 1 
risk 8.2 5.4 2.5 3.5 0.9 0.2 0 0 1.1 21.8 
num 4.9 3.2 1.5 2.1 0.5 0.1 0 0 0.6 12.9 
 (3.9-5.9) (2.5-3.7) (0.9-2.3) (1.0-3.1) (0.3-1.0) (0.0-0.2) (0.0-0.1) (0.0-0.0) (0.3-1.8)  
Nauru  
(high mort 
model) 
 
Early 
 
prop 0.42 0.25 0.15 0.07 0.03 0 0 --- 0.08 1 
risk 6.2 3.8 2.2 1 0.5 0 0 --- 1.2 14.9 
num 0 0 0 0 0 0 0 --- 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)  
Late 
 
prop 0.15 0.12 0.24 0.34 0.05 0.01 0 --- 0.08 1 
risk 0.8 0.6 1.3 1.8 0.2 0.1 0 --- 0.4 5.2 
num 0 0 0 0 0 0 0 --- 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.0)  
Overall 
 
prop 0.35 0.22 0.17 0.14 0.04 0.01 0 0 0.08 1 
risk 7.1 4.5 3.4 2.9 0.7 0.1 0 0 1.6 20.4 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Nepal  
(high mort 
model) 
 
Early 
 
prop 0.34 0.27 0.14 0.11 0.04 0.01 0 --- 0.1 1 
risk 5.7 4.6 2.4 1.8 0.6 0.1 0 --- 1.6 17 
num 32.2 26.2 13.8 10.2 3.6 0.7 0.1 --- 9.3 96 
 (26.5-40.3) (21.4-32.5) (8.9-18.2) (3.2-15.8) (1.7-7.5) (0.3-2.0) (0.0-0.8) --- (3.9-12.9)  
Late 
 
prop 0.24 0.12 0.08 0.39 0.04 0.02 0.02 --- 0.09 1 
risk 1.4 0.7 0.5 2.3 0.3 0.1 0.1 --- 0.6 6 
num 8.1 4.1 2.6 13.2 1.4 0.5 0.6 --- 3.2 33.7 
 (5.6-11.0) (2.6-5.3) (1.1-4.7) (8.3-18.2) (0.9-2.0) (0.2-1.3) (0.2-1.4) --- (1.4-5.2)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.31 0.23 0.12 0.18 0.04 0.01 0.01 0 0.1 1 
risk 7.4 5.6 2.9 4.3 0.9 0.2 0.1 0 2.3 23.7 
num 42.6 32 16.4 24.6 5.3 1.4 0.8 0 13.2 136.2 
 (33.8-54.5) (25.4-40.4) (10.5-23.1) (12.0-35.8) (2.7-9.9) (0.5-3.6) (0.2-2.4) (0.0-0.0) (5.6-19.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Netherland
s (high-
quality VR) 
 
Early 
 
prop 0.26 0.19 0.35 0.05 0 --- --- 0.01 0.14 1 
risk 0.5 0.4 0.7 0.1 0 --- --- 0 0.3 2 
num 0.9 0.7 1.2 0.2 0 --- --- 0 0.5 3.5 
 (0.7-1.1) (0.5-0.8) (1.0-1.5) (0.1-0.3) (0.0-0.0) --- --- (0.0-0.0) (0.3-0.6)  
Late 
 
prop 0.23 0.08 0.39 0.19 0.01 --- --- 0.02 0.08 1 
risk 0.1 0.1 0.2 0.1 0 --- --- 0 0.1 0.6 
num 0.2 0.1 0.4 0.2 0 --- --- 0 0.1 1.1 
 (0.2-0.3) (0.0-0.2) (0.3-0.6) (0.1-0.3) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.2)  
Overall 
 
prop 0.25 0.16 0.36 0.09 0 0 0 0.01 0.13 1 
risk 0.7 0.4 1 0.2 0 0 0 0 0.3 2.7 
num 1.2 0.7 1.7 0.4 0 0 0 0 0.6 4.6 
 (0.9-1.5) (0.5-1.0) (1.3-2.0) (0.2-0.6) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.4-0.8)  
New 
Zealand 
(high-quality 
VR) 
 
Early 
 
prop 0.4 0.18 0.27 0.04 0.05 --- --- 0 0.06 1 
risk 0.9 0.4 0.6 0.1 0.1 --- --- 0 0.1 2.3 
num 0.6 0.3 0.4 0.1 0.1 --- --- 0 0.1 1.4 
 (0.4-0.7) (0.2-0.4) (0.3-0.5) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.23 0.12 0.28 0.09 0.02 --- --- 0.14 0.12 1 
risk 0.2 0.1 0.2 0.1 0 --- --- 0.1 0.1 0.7 
num 0.1 0 0.1 0 0 --- --- 0.1 0 0.4 
 (0.0-0.2) (0.0-0.1) (0.0-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.1) (0.0-0.1)  
Overall 
 
prop 0.36 0.17 0.27 0.05 0.05 0 0 0.03 0.07 1 
risk 1.1 0.5 0.8 0.2 0.1 0 0 0.1 0.2 3.1 
num 0.7 0.3 0.5 0.1 0.1 0 0 0.1 0.1 2 
 (0.5-0.9) (0.2-0.5) (0.3-0.7) (0.0-0.2) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.3)  
Nicaragua 
(low mort 
model) 
 
Early 
 
prop 0.44 0.19 0.19 0.07 0.04 --- --- 0.01 0.06 1 
risk 3.7 1.6 1.6 0.6 0.4 --- --- 0.1 0.5 8.5 
num 5.2 2.3 2.2 0.8 0.5 --- --- 0.1 0.7 11.8 
 (4.5-6.1) (1.4-3.1) (1.6-3.3) (0.6-1.2) (0.3-0.9) --- --- (0.1-0.1) (0.5-1.0)  
Late prop 0.25 0.11 0.23 0.2 0.12 --- --- 0.01 0.07 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.8 0.3 0.7 0.6 0.4 --- --- 0 0.2 3 
num 1 0.5 0.9 0.8 0.5 --- --- 0.1 0.3 4.2 
 (0.9-1.4) (0.1-0.6) (0.8-1.2) (0.5-1.3) (0.4-0.8) --- --- (0.0-0.1) (0.2-0.4)  
Overall 
 
prop 0.39 0.17 0.2 0.1 0.06 0 0 0.01 0.06 1 
risk 4.6 2 2.3 1.2 0.7 0 0 0.1 0.8 11.8 
num 6.5 2.9 3.3 1.8 1.1 0 0 0.1 1.1 16.7 
 (5.7-7.9) (1.5-4.0) (2.5-4.7) (1.1-2.6) (0.7-1.8) (0.0-0.0) (0.0-0.0) (0.1-0.2) (0.8-1.5)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Niger  
(high mort 
model) 
 
Early 
 
prop 0.37 0.32 0.06 0.05 0.07 0.01 0.01 --- 0.11 1 
risk 7.5 6.5 1.2 1.1 1.4 0.3 0.1 --- 2.3 20.4 
num 64.8 55.8 10 9.4 12.3 2.4 1 --- 19.4 174.9 
 (43.5-109.7) (41.0-82.3) (6.3-17.9) (3.4-18.9) (7.2-26.4) (0.8-7.5) (0.0-12.3) --- (6.3-48.2)  
Late 
 
prop 0.15 0.14 0.04 0.48 0.05 0.03 0.04 --- 0.08 1 
risk 1.1 1 0.3 3.4 0.3 0.2 0.3 --- 0.5 7.1 
num 9.3 8.3 2.2 29.4 2.9 2 2.6 --- 4.7 61.5 
 (4.5-16.4) (5.4-13.0) (0.9-5.7) (19.2-45.4) (1.7-4.9) (0.5-5.5) (0.5-9.4) --- (1.5-19.9)  
Overall 
 
prop 0.34 0.23 0.06 0.19 0.06 0.02 0.01 0 0.09 1 
risk 9.8 6.6 1.6 5.5 1.6 0.5 0.3 0 2.5 28.3 
num 80.6 54.3 13.1 45.6 13.4 4 2.3 0 20.7 233.9 
 (54.8-128.0) (41.2-80.8) (6.3-23.8) (26.0-80.1) (8.0-28.3) (1.2-12.1) (0.4-15.9) (0.0-0.0) (6.8-60.8)  
Nigeria 
(high mort 
model) 
 
Early 
 
prop 0.38 0.34 0.05 0.08 0.07 0.02 0.01 --- 0.05 1 
risk 10.5 9.4 1.5 2.1 2 0.6 0.2 --- 1.4 27.7 
num 731.1 660.5 102.1 147.7 138.5 44.1 12.3 --- 99.2 1935.5 
 
(601.4-854.5) 
(544.9-
750.3) (75.6-182.0) (60.3-232.3) (72.7-256.9) (19.6-90.2) (0.0-112.8) --- 
(61.9-
175.3)  
Late 
 
prop 0.19 0.16 0.04 0.39 0.05 0.09 0.01 --- 0.07 1 
risk 1.8 1.5 0.4 3.8 0.5 0.8 0.1 --- 0.7 9.7 
num 126 107.8 28 266.9 36.9 58.8 8 --- 47.6 680 
 
(80.0-173.9) (74.3-147.5) (11.9-66.5) (164.2-369.6) (22.2-57.0) 
(18.9-
136.4) (3.0-14.7) --- 
(26.0-
104.8)  
Overall 
 
prop 0.34 0.29 0.05 0.15 0.07 0.04 0.01 0 0.06 1 
risk 13.1 11 1.8 5.8 2.6 1.5 0.4 0 2.1 38.2 
num 893.8 746.2 119.7 393.1 174.1 105.4 23.9 0 143.1 2599.3 
 
(644.4-
1199.0) 
(534.4-
904.7) (76.0-237.0) (210.7-569.8) (90.5-310.7) 
(38.2-
232.1) (2.0-177.3) (0.0-0.0) 
(83.5-
273.5)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Niue  
(low mort 
model) 
 
Early 
 
prop 0.45 0.17 0.21 0.07 0.04 --- --- 0.01 0.05 1 
risk 3.9 1.5 1.8 0.6 0.3 --- --- 0.1 0.5 8.6 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.26 0.09 0.24 0.19 0.13 --- --- 0.01 0.08 1 
risk 0.8 0.3 0.7 0.6 0.4 --- --- 0 0.2 3 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.41 0.15 0.21 0.1 0.06 0 0 0.01 0.06 1 
risk 4.8 1.8 2.5 1.2 0.7 0 0 0.1 0.7 11.9 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Norway 
(high-
quality VR) 
 
Early 
 
prop 0.28 0.15 0.3 0 0 --- --- 0 0.27 1 
risk 0.3 0.2 0.4 0 0 --- --- 0 0.3 1.2 
num 0.2 0.1 0.2 0 0 --- --- 0 0.2 0.8 
 (0.1-0.3) (0.1-0.2) (0.1-0.3) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.17 0.04 0.52 0.09 0 --- --- 0 0.17 1 
risk 0.1 0 0.2 0 0 --- --- 0 0.1 0.4 
num 0 0 0.1 0 0 --- --- 0 0 0.3 
 (0.0-0.1) (0.0-0.0) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.26 0.13 0.35 0.02 0 0 0 0 0.24 1 
risk 0.4 0.2 0.6 0 0 0 0 0 0.4 1.7 
num 0.3 0.1 0.4 0 0 0 0 0 0.3 1.1 
 (0.1-0.4) (0.1-0.2) (0.2-0.6) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.4)  
Oman  
(low mort 
model) 
 
Early 
 
prop 0.47 0.19 0.25 0.03 0.01 --- --- 0.01 0.03 1 
risk 2.3 1 1.2 0.2 0 --- --- 0 0.2 4.9 
num 1.8 0.7 1 0.1 0 --- --- 0 0.1 3.8 
 (1.6-2.5) (0.6-1.1) (0.7-1.5) (0.1-0.2) (0.0-0.1) --- --- (0.0-0.1) (0.1-0.3)  
Late 
 
prop 0.3 0.12 0.32 0.14 0.02 --- --- 0.02 0.08 1 
risk 0.5 0.2 0.6 0.2 0 --- --- 0 0.1 1.7 
num 0.4 0.2 0.4 0.2 0 --- --- 0 0.1 1.3 
 (0.4-0.6) (0.1-0.2) (0.4-0.6) (0.1-0.3) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.2)  
Overall prop 0.42 0.18 0.27 0.06 0.01 0 0 0.01 0.04 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 2.8 1.2 1.8 0.4 0.1 0 0 0.1 0.3 6.6 
num 2.1 0.9 1.3 0.3 0.1 0 0 0.1 0.2 5 
 (1.9-2.9) (0.6-1.3) (1.1-2.0) (0.2-0.5) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.1-0.4)  
Pakistan 
(high mort 
model) 
 
Early 
 
prop 0.42 0.27 0.06 0.11 0.05 0.02 0.01 --- 0.07 1 
risk 13 8.3 2 3.3 1.7 0.5 0.2 --- 2 31.1 
num 600.8 383.2 90.8 152.8 78.4 25 8.9 --- 93.7 1433.5 
 
(496.0-
677.6) (320.0-468.0) (61.5-136.2) (55.5-241.4) (45.2-160.3) (9.7-61.6) (0.0-65.6) --- 
(52.0-
125.4)  
Late 
 
prop 0.18 0.13 0.05 0.46 0.04 0.05 0.02 --- 0.07 1 
risk 1.9 1.4 0.5 5 0.5 0.5 0.2 --- 0.7 10.9 
num 89.8 66.4 24.6 232.6 22.4 23.8 10.4 --- 33.7 503.7 
 (60.3-114.1) (39.9-91.2) (14.2-45.4) (167.6-296.2) (13.8-32.3) (9.3-48.6) (4.9-19.1) --- (19.9-53.8)  
Overall 
 
prop 0.36 0.23 0.06 0.2 0.05 0.03 0.01 0 0.07 1 
risk 15.2 9.9 2.5 8.5 2.2 1.1 0.4 0 2.8 42.7 
num 730.6 475.7 120 407.6 107.8 53.3 20.4 0 134.8 2050.3 
 
(590.8-
839.9) (380.3-588.8) (76.8-187.1) (237.6-571.9) (62.8-207.2) 
(20.7-
120.2) (5.2-90.3) (0.0-0.0) 
(75.0-
189.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Palau  
(low mort 
model) 
 
Early 
 
prop 0.46 0.16 0.24 0.05 0.02 --- --- 0.01 0.06 1 
risk 3 1 1.6 0.3 0.1 --- --- 0 0.4 6.4 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.28 0.09 0.29 0.18 0.07 --- --- 0.02 0.07 1 
risk 0.6 0.2 0.6 0.4 0.2 --- --- 0 0.2 2.3 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.44 0.15 0.24 0.08 0.04 0 0 0.01 0.06 1 
risk 3.9 1.3 2.1 0.7 0.3 0 0 0.1 0.5 9 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Panama 
(high-
quality VR) 
 
Early 
 
prop 0.4 0.13 0.25 0.12 0.02 --- --- 0.01 0.06 1 
risk 2.4 0.8 1.5 0.7 0.1 --- --- 0.1 0.4 6 
num 1.8 0.6 1.1 0.5 0.1 --- --- 0.1 0.3 4.5 
 (1.6-2.1) (0.5-0.8) (0.9-1.4) (0.4-0.7) (0.0-0.1) --- --- (0.0-0.1) (0.2-0.4)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Late 
 
prop 0.16 0.05 0.32 0.27 0.09 --- --- 0.03 0.08 1 
risk 0.4 0.1 0.8 0.6 0.2 --- --- 0.1 0.2 2.4 
num 0.3 0.1 0.6 0.5 0.2 --- --- 0.1 0.1 1.8 
 (0.2-0.4) (0.0-0.1) (0.4-0.7) (0.3-0.6) (0.1-0.2) --- --- (0.0-0.1) (0.1-0.2)  
Overall 
 
prop 0.33 0.11 0.27 0.16 0.04 0 0 0.02 0.07 1 
risk 2.9 1 2.4 1.4 0.3 0 0 0.2 0.6 8.7 
num 2.2 0.7 1.8 1.1 0.2 0 0 0.1 0.4 6.5 
 (1.8-2.6) (0.5-0.9) (1.4-2.1) (0.8-1.3) (0.1-0.4) (0.0-0.0) (0.0-0.0) (0.0-0.2) (0.2-0.6)  
Papua New 
Guinea 
(high mort 
model) 
 
Early 
 
prop 0.34 0.34 0.11 0.08 0.05 0.01 0 --- 0.07 1 
risk 6 6.1 2 1.5 0.9 0.1 0.1 --- 1.2 17.8 
num 12.5 12.7 4.1 3.1 1.9 0.3 0.1 --- 2.4 37 
 (9.3-14.2) (9.8-14.1) (2.9-5.7) (1.2-4.5) (0.9-3.6) (0.1-0.7) (0.0-1.1) --- (1.2-3.3)  
Late 
 
prop 0.17 0.17 0.09 0.42 0.06 0.04 0.01 --- 0.06 1 
risk 1 1 0.5 2.6 0.4 0.2 0.1 --- 0.4 6.2 
num 2.2 2.2 1.1 5.4 0.7 0.5 0.1 --- 0.8 13 
 (1.4-2.9) (1.4-2.8) (0.6-1.9) (3.2-7.0) (0.4-1.1) (0.1-1.1) (0.1-0.2) --- (0.4-1.6)  
Overall 
 
prop 0.29 0.3 0.1 0.17 0.05 0.01 0.01 0 0.07 1 
risk 7 7.4 2.4 4.2 1.3 0.4 0.1 0 1.6 24.4 
num 14.6 15.4 5.1 8.8 2.7 0.7 0.3 0 3.4 50.9 
 (10.7-17.1) (11.5-17.3) (3.5-7.7) (4.5-11.8) (1.3-4.8) (0.2-1.7) (0.1-1.5) (0.0-0.0) (1.6-5.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Paraguay 
(low mort 
model) 
 
Early 
 
prop 0.45 0.15 0.21 0.1 0.04 --- --- 0.01 0.04 1 
risk 4.1 1.4 1.9 0.9 0.4 --- --- 0.1 0.4 9.1 
num 6.6 2.2 3.1 1.4 0.6 --- --- 0.1 0.6 14.6 
 (5.8-7.0) (1.8-2.5) (2.6-3.8) (1.1-1.8) (0.4-0.9) --- --- (0.1-0.2) (0.3-1.0)  
Late 
 
prop 0.28 0.07 0.23 0.23 0.11 --- --- 0.01 0.07 1 
risk 0.9 0.2 0.7 0.7 0.3 --- --- 0 0.2 3.2 
num 1.5 0.4 1.2 1.2 0.6 --- --- 0.1 0.3 5.1 
 (1.3-1.6) (0.3-0.4) (1.0-1.4) (1.0-1.4) (0.4-0.8) --- --- (0.1-0.1) (0.2-0.5)  
Overall 
 
prop 0.41 0.13 0.22 0.13 0.06 0 0 0.01 0.05 1 
risk 5.2 1.7 2.8 1.7 0.7 0 0 0.1 0.6 12.7 
num 8.1 2.6 4.3 2.6 1.1 0 0 0.2 0.9 19.9 
 (7.2-8.8) (2.1-3.0) (3.6-5.2) (2.1-3.3) (0.7-1.7) (0.0-0.0) (0.0-0.0) (0.1-0.3) (0.6-1.5)  
Peru  Early prop 0.43 0.17 0.2 0.07 0.03 --- --- 0.01 0.09 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
(low mort 
model) 
 
 risk 2.6 1 1.2 0.4 0.2 --- --- 0 0.5 5.9 
num 15.3 6 7.1 2.4 1 --- --- 0.2 3.2 35.2 
 (11.7-17.4) (4.0-7.3) (4.7-13.7) (1.7-3.1) (0.6-1.4) --- --- (0.1-0.2) (2.4-4.0)  
Late 
 
prop 0.28 0.09 0.27 0.19 0.1 --- --- 0.01 0.06 1 
risk 0.6 0.2 0.6 0.4 0.2 --- --- 0 0.1 2.1 
num 3.5 1.1 3.3 2.3 1.2 --- --- 0.2 0.7 12.4 
 (3.0-4.1) (0.6-1.4) (3.0-3.9) (1.7-3.1) (0.9-1.7) --- --- (0.1-0.2) (0.5-0.9)  
Overall 
 
prop 0.38 0.15 0.23 0.11 0.04 0 0 0.01 0.08 1 
risk 3.2 1.2 1.9 0.9 0.4 0 0 0.1 0.7 8.3 
num 18.8 7.2 11.2 5.6 2.2 0 0 0.4 4 49.3 
 (15.1-21.4) (4.7-8.7) (8.5-17.9) (4.2-6.7) (1.5-3.0) (0.0-0.0) (0.0-0.0) (0.3-0.5) (3.0-4.9)  
Philippine
s (high mort 
model) 
 
Early 
 
prop 0.36 0.26 0.21 0.07 0.03 0 0 --- 0.07 1 
risk 3.6 2.6 2.1 0.7 0.3 0 0 --- 0.7 10.1 
num 86 62.4 51.1 17.1 7.9 0.8 0.1 --- 16.3 241.7 
 (71.9-105.9) (51.0-73.7) (30.0-68.5) (7.5-26.8) (3.8-16.4) (0.3-2.1) (0.0-0.6) --- (8.8-21.7)  
Late 
 
prop 0.19 0.13 0.14 0.41 0.04 0.01 0.01 --- 0.07 1 
risk 0.7 0.5 0.5 1.4 0.2 0 0 --- 0.3 3.6 
num 16 11.1 12 34.4 3.8 1 0.5 --- 6.1 84.9 
 (11.3-22.4) (7.3-14.5) (5.6-19.4) (21.3-47.7) (2.4-5.4) (0.3-2.7) (0.1-1.3) --- (3.6-10.2)  
Overall 
 
prop 0.32 0.22 0.18 0.15 0.04 0.01 0 0 0.07 1 
risk 4.5 3.1 2.6 2.1 0.5 0.1 0 0 1 13.9 
num 104 72 59.2 49.1 11.5 2 0.7 0 21.9 320.4 
 (86.3-127.3) (57.2-85.8) (34.1-84.9) (27.7-70.3) (6.0-21.0) (0.6-5.2) (0.2-1.8) (0.0-0.0) (12.0-30.8)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Poland 
(high-
quality VR) 
 
Early 
 
prop 0.51 0.09 0.3 0.05 0.01 --- --- 0.01 0.05 1 
risk 1.2 0.2 0.7 0.1 0 --- --- 0 0.1 2.3 
num 4.9 0.9 2.9 0.5 0.1 --- --- 0.1 0.4 9.6 
 (4.5-5.3) (0.7-1.0) (2.5-3.2) (0.3-0.6) (0.0-0.1) --- --- (0.0-0.1) (0.3-0.6)  
Late 
 
prop 0.44 0.04 0.38 0.08 0.02 --- --- 0.01 0.03 1 
risk 0.3 0 0.3 0.1 0 --- --- 0 0 0.8 
num 1.4 0.1 1.2 0.2 0.1 --- --- 0 0.1 3.2 
 (1.2-1.6) (0.1-0.2) (1.0-1.4) (0.2-0.3) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.2)  
Overall 
 
prop 0.49 0.08 0.32 0.06 0.01 0 0 0.01 0.04 1 
risk 1.6 0.2 1 0.2 0 0 0 0 0.1 3.2 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
num 6.7 1.1 4.3 0.8 0.1 0 0 0.1 0.6 13.7 
 (6.0-7.4) (0.8-1.3) (3.8-4.9) (0.5-1.0) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.2) (0.4-0.8)  
Portugal 
(low mort 
model) 
 
Early 
 
prop 0.42 0.14 0.26 0.07 0.01 --- --- 0.01 0.08 1 
risk 0.6 0.2 0.4 0.1 0 --- --- 0 0.1 1.5 
num 0.6 0.2 0.4 0.1 0 --- --- 0 0.1 1.3 
 (0.5-0.7) (0.2-0.2) (0.3-0.4) (0.1-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.1)  
Late 
 
prop 0.29 0.08 0.38 0.12 0.02 --- --- 0.02 0.1 1 
risk 0.2 0 0.2 0.1 0 --- --- 0 0.1 0.5 
num 0.1 0 0.2 0.1 0 --- --- 0 0 0.5 
 (0.1-0.2) (0.0-0.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.39 0.12 0.29 0.08 0.01 0 0 0.01 0.09 1 
risk 0.8 0.2 0.6 0.2 0 0 0 0 0.2 2 
num 0.7 0.2 0.5 0.2 0 0 0 0 0.2 1.8 
 (0.6-0.8) (0.2-0.3) (0.4-0.6) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.2)  
Qatar  
(low mort 
model) 
 
Early 
 
prop 0.47 0.15 0.24 0.01 0 --- --- 0.01 0.11 1 
risk 1.5 0.5 0.8 0 0 --- --- 0 0.4 3.2 
num 0.4 0.1 0.2 0 0 --- --- 0 0.1 0.8 
 (0.3-0.4) (0.1-0.1) (0.1-0.3) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.1)  
Late 
 
prop 0.31 0.08 0.36 0.15 0 --- --- 0.02 0.08 1 
risk 0.3 0.1 0.4 0.2 0 --- --- 0 0.1 1.1 
num 0.1 0 0.1 0 0 --- --- 0 0 0.3 
 (0.1-0.1) (0.0-0.0) (0.1-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.45 0.14 0.26 0.05 0 0 0 0.01 0.1 1 
risk 2 0.6 1.1 0.2 0 0 0 0 0.5 4.4 
num 0.4 0.1 0.2 0 0 0 0 0 0.1 0.9 
 (0.4-0.5) (0.1-0.1) (0.2-0.3) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Republic 
of Korea  
(high-
quality VR) 
 
Early 
 
prop 0.57 0.1 0.15 0.04 0 --- --- 0.03 0.11 1 
risk 0.6 0.1 0.2 0 0 --- --- 0 0.1 1 
num 3 0.6 0.8 0.2 0 --- --- 0.1 0.6 5.3 
 (2.7-3.4) (0.4-0.7) (0.6-0.9) (0.1-0.3) (0.0-0.0) --- --- (0.1-0.2) (0.4-0.7)   
Late 
 
prop 0.46 0.04 0.3 0.09 0.01 --- --- 0.01 0.08 1 
risk 0.3 0 0.2 0.1 0 --- --- 0 0 0.6 
num 1.3 0.1 0.9 0.3 0 --- --- 0 0.2 2.8 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (1.1-1.5) (0.0-0.2) (0.7-1.0) (0.2-0.4) (0.0-0.1) --- --- (0.0-0.1) (0.1-0.3)   
Overall 
 
prop 0.53 0.08 0.2 0.06 0 0 0 0.02 0.1 1 
risk 0.9 0.1 0.3 0.1 0 0 0 0 0.2 1.7 
num 4.6 0.7 1.7 0.5 0 0 0 0.2 0.9 8.7 
 (4.0-5.2) (0.5-0.9) (1.4-2.1) (0.3-0.7) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.1-0.3) (0.6-1.1)   
Republic 
of Moldova 
(high-
quality VR) 
 
Early 
 
prop 0.3 0.08 0.35 0.07 0.16 --- --- 0.02 0.02 1 
risk 1.7 0.5 2 0.4 0.9 --- --- 0.1 0.1 5.8 
num 0.7 0.2 0.8 0.2 0.4 --- --- 0 0 2.3 
 (0.5-0.9) (0.1-0.3) (0.6-1.0) (0.1-0.3) (0.2-0.5) --- --- (0.0-0.1) (0.0-0.1)   
Late 
 
prop 0.05 0.07 0.57 0.1 0.1 --- --- 0 0.1 1 
risk 0.1 0.1 1 0.2 0.2 --- --- 0 0.2 1.8 
num 0 0 0.4 0.1 0.1 --- --- 0 0.1 0.7 
 (0.0-0.1) (0.0-0.1) (0.3-0.5) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)   
Overall 
 
prop 0.24 0.08 0.4 0.08 0.14 0 0 0.02 0.04 1 
risk 1.9 0.6 3.1 0.6 1.1 0 0 0.1 0.3 7.8 
num 0.8 0.3 1.4 0.3 0.5 0 0 0.1 0.1 3.5 
 (0.6-1.0) (0.1-0.4) (1.1-1.7) (0.1-0.4) (0.3-0.7) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.2)   
Romania 
(high-
quality VR) 
 
Early 
 
prop 0.48 0.1 0.27 0.01 0.07 --- --- 0.01 0.06 1 
risk 2.3 0.5 1.3 0.1 0.3 --- --- 0 0.3 4.8 
num 5.2 1.1 2.9 0.2 0.7 --- --- 0.1 0.6 10.7 
 (4.7-5.6) (0.9-1.3) (2.5-3.2) (0.1-0.2) (0.5-0.9) --- --- (0.0-0.2) (0.5-0.8)  
Late 
 
prop 0.3 0.04 0.33 0.03 0.25 --- --- 0.01 0.04 1 
risk 0.7 0.1 0.8 0.1 0.6 --- --- 0 0.1 2.3 
num 1.6 0.2 1.7 0.2 1.3 --- --- 0.1 0.2 5.3 
 (1.3-1.8) (0.1-0.3) (1.5-2.0) (0.1-0.3) (1.1-1.5) --- --- (0.0-0.1) (0.1-0.3)  
Overall 
 
prop 0.42 0.08 0.29 0.02 0.13 0 0 0.01 0.05 1 
risk 3.1 0.6 2.1 0.1 0.9 0 0 0.1 0.4 7.3 
num 7 1.3 4.8 0.3 2.1 0 0 0.2 0.9 16.6 
 (6.3-7.7) (1.0-1.6) (4.2-5.4) (0.2-0.5) (1.7-2.5) (0.0-0.0) (0.0-0.0) (0.1-0.3) (0.6-1.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Russian 
Federation 
(low mort 
model) 
Early 
 
prop 0.42 0.12 0.3 0.04 0.01 --- --- 0.01 0.11 1 
risk 1.6 0.5 1.2 0.1 0 --- --- 0 0.4 3.9 
num 27.2 8.1 19.4 2.4 0.7 --- --- 0.5 6.9 65.2 
 (25.4-32.0) (6.8-10.8) (16.4-24.1) (1.7-3.1) (0.5-1.0) --- --- (0.4-0.6) (5.5-8.7)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 
Late 
 
prop 0.3 0.07 0.34 0.16 0.06 --- --- 0.02 0.06 1 
risk 0.4 0.1 0.5 0.2 0.1 --- --- 0 0.1 1.4 
num 6.8 1.6 7.7 3.6 1.4 --- --- 0.4 1.5 22.9 
 (6.3-8.1) (1.2-2.2) (7.2-9.0) (2.9-4.6) (0.8-2.3) --- --- (0.3-0.5) (1.1-2.0)  
Overall 
 
prop 0.39 0.11 0.31 0.07 0.02 0 0 0.01 0.09 1 
risk 2.2 0.6 1.7 0.4 0.1 0 0 0.1 0.5 5.6 
num 35.9 10.3 28.5 6.4 2.3 0 0 0.9 8.8 93.1 
 (33.3-42.5) (8.5-13.7) (24.8-34.5) (4.9-8.3) (1.4-3.6) (0.0-0.0) (0.0-0.0) (0.7-1.1) (7.0-11.3)  
Rwanda 
(high mort 
model) 
 
Early 
 
prop 0.3 0.36 0.16 0.1 0.05 0 0 --- 0.03 1 
risk 4.5 5.3 2.4 1.4 0.7 0.1 0 --- 0.5 14.9 
num 19 22.5 10.1 6.1 3 0.3 0 --- 2.1 63.2 
 (14.3-24.6) (18.2-25.7) (6.7-14.5) (2.1-9.6) (1.4-6.5) (0.1-0.7) (0.0-0.3) --- (1.0-6.1)  
Late 
 
prop 0.13 0.17 0.1 0.45 0.06 0.02 0 --- 0.07 1 
risk 0.7 0.9 0.5 2.3 0.3 0.1 0 --- 0.4 5.2 
num 2.9 3.7 2.2 9.9 1.3 0.4 0.1 --- 1.5 22.2 
 (1.4-5.0) (2.5-4.9) (0.8-5.5) (5.6-13.5) (0.8-1.9) (0.1-1.1) (0.0-0.2) --- (0.6-3.9)  
Overall 
 
prop 0.26 0.31 0.14 0.19 0.05 0.01 0 0 0.04 1 
risk 5.4 6.4 2.9 3.9 1.1 0.2 0 0 0.9 20.7 
num 23.7 28.5 12.7 17.3 4.8 0.8 0.1 0 3.9 91.7 
 (17.1-32.0) (22.6-33.1) (7.6-20.6) (8.3-24.9) (2.4-9.2) (0.3-2.0) (0.0-0.6) (0.0-0.0) (1.7-10.7)  
Saint Kitts 
and Nevis 
(high-
quality VR) 
 
Early 
 
prop 0.4 0.6 0 0 0 --- --- 0 0 1 
risk 1.8 2.6 0 0 0 --- --- 0 0 4.4 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0 0 0.33 0.33 0 --- --- 0 0.33 1 
risk 0 0 0.9 0.9 0 --- --- 0 0.9 2.6 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.25 0.38 0.13 0.13 0 0 0 0 0.13 1 
risk 1.8 2.7 0.9 0.9 0 0 0 0 0.9 7.3 
num 0 0 0 0 0 0 0 0 0 0.1 
 (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Saint Lucia Early prop 0 0 0.45 0 0.14 --- --- 0.09 0.32 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
(high-
quality VR) 
 
 risk 0 0 3.3 0 1 --- --- 0.7 2.3 7.2 
num 0 0 0.1 0 0 --- --- 0 0.1 0.2 
 (0.0-0.0) (0.0-0.0) (0.0-0.2) (0.0-0.0) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0 0 0.8 0 0.2 --- --- 0 0 1 
risk 0 0 1.3 0 0.3 --- --- 0 0 1.6 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0 0 0.52 0 0.15 0 0 0.07 0.26 1 
risk 0 0 4.7 0 1.3 0 0 0.7 2.3 9 
num 0 0 0.1 0 0 0 0 0 0.1 0.3 
 (0.0-0.0) (0.0-0.0) (0.0-0.2) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
Saint 
Vincent 
and the 
Grenadine
s (high-
quality VR) 
 
Early 
 
prop 0.58 0.21 0.13 0.04 0 --- --- 0 0.04 1 
risk 5.6 2 1.2 0.4 0 --- --- 0 0.4 9.7 
num 0.1 0 0 0 0 --- --- 0 0 0.2 
 (0.0-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.67 0.17 0.17 0 0 --- --- 0 0 1 
risk 1.6 0.4 0.4 0 0 --- --- 0 0 2.4 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.6 0.2 0.13 0.03 0 0 0 0 0.03 1 
risk 7.4 2.5 1.7 0.4 0 0 0 0 0.4 12.4 
num 0.1 0 0 0 0 0 0 0 0 0.2 
 (0.0-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Samoa  
(low mort 
model) 
 
Early 
 
prop 0.46 0.14 0.23 0.08 0.04 --- --- 0.04 0 1 
risk 2.6 0.8 1.3 0.4 0.2 --- --- 0.2 0 5.5 
num 0.1 0 0.1 0 0 --- --- 0 0 0.3 
 (0.1-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.1) (0.0-0.0)  
Late 
 
prop 0.27 0.06 0.28 0.16 0.15 --- --- 0.01 0.06 1 
risk 0.5 0.1 0.5 0.3 0.3 --- --- 0 0.1 2 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.12 0.24 0.09 0.07 0 0 0.03 0.02 1 
risk 3.2 0.9 1.8 0.7 0.6 0 0 0.2 0.1 7.6 
num 0.2 0 0.1 0 0 0 0 0 0 0.4 
 (0.1-0.2) (0.0-0.1) (0.1-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
San 
Marino 
(low mort 
model) 
 
Early 
 
prop 0.52 0.17 0.14 0.03 0 --- --- 0.01 0.13 1 
risk 0.4 0.1 0.1 0 0 --- --- 0 0.1 0.8 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.32 0.07 0.35 0.13 0 --- --- 0.02 0.11 1 
risk 0.1 0 0.1 0 0 --- --- 0 0 0.3 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.44 0.14 0.25 0.04 0 0 0 0.01 0.12 1 
risk 0.5 0.2 0.3 0 0 0 0 0 0.1 1.1 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Sao Tome 
and 
Principe 
(high mort 
model) 
 
Early 
 
prop 0.32 0.35 0.16 0.09 0.05 0 0 --- 0.03 1 
risk 4.6 5 2.3 1.3 0.7 0.1 0 --- 0.4 14.4 
num 0.3 0.3 0.1 0.1 0 0 0 --- 0 0.9 
 (0.2-0.4) (0.2-0.4) (0.1-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- (0.0-0.1)  
Late 
 
prop 0.12 0.16 0.13 0.44 0.06 0.02 0 --- 0.07 1 
risk 0.6 0.8 0.7 2.2 0.3 0.1 0 --- 0.3 5 
num 0 0.1 0 0.1 0 0 0 --- 0 0.3 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- (0.0-0.1)  
Overall 
 
prop 0.28 0.3 0.15 0.18 0.05 0.01 0 0 0.04 1 
risk 5.5 5.9 2.9 3.7 1 0.1 0 0 0.8 19.9 
num 0.4 0.4 0.2 0.2 0.1 0 0 0 0.1 1.3 
 (0.2-0.5) (0.3-0.5) (0.1-0.3) (0.1-0.4) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
Saudi 
Arabia  
(low mort 
model) 
 
Early 
 
prop 0.45 0.19 0.24 0.04 0.01 --- --- 0.01 0.06 1 
risk 2.9 1.2 1.6 0.2 0.1 --- --- 0 0.4 6.5 
num 16 6.6 8.6 1.3 0.3 --- --- 0.2 2.3 35.3 
 (12.8-20.4) (4.3-9.3) (5.9-12.4) (0.8-2.0) (0.2-0.5) --- --- (0.1-0.4) (1.7-3.4)  
Late 
 
prop 0.3 0.12 0.3 0.16 0.03 --- --- 0.02 0.08 1 
risk 0.7 0.3 0.7 0.4 0.1 --- --- 0 0.2 2.3 
num 3.7 1.5 3.7 2 0.4 --- --- 0.2 1 12.4 
 (3.1-5.0) (0.5-2.0) (3.1-4.8) (1.2-3.0) (0.2-0.6) --- --- (0.1-0.3) (0.7-1.5)  
Overall 
 
prop 0.41 0.17 0.26 0.07 0.01 0 0 0.01 0.07 1 
risk 3.8 1.6 2.4 0.6 0.1 0 0 0.1 0.6 9.2 
num 21.4 8.8 13.2 3.6 0.7 0 0 0.5 3.6 51.7 
 (17.1-27.3) (5.3-12.1) (9.4-18.5) (2.1-5.5) (0.4-1.1) (0.0-0.0) (0.0-0.0) (0.3-0.7) (2.6-5.1)  
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* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Senegal 
(high mort 
model) 
 
Early 
 
prop 0.35 0.32 0.14 0.1 0.05 0 0 --- 0.03 1 
risk 6 5.5 2.3 1.7 0.8 0.1 0 --- 0.6 17 
num 31.8 28.9 12.2 8.8 4.4 0.4 0.1 --- 2.9 89.5 
 (25.8-39.2) (23.8-34.5) (7.6-17.0) (3.5-14.8) (2.3-8.8) (0.1-1.0) (0.0-0.8) --- (1.6-7.6)  
Late 
 
prop 0.14 0.14 0.08 0.49 0.05 0.02 0.02 --- 0.06 1 
risk 0.8 0.9 0.5 2.9 0.3 0.1 0.1 --- 0.4 6 
num 4.4 4.5 2.4 15.4 1.7 0.5 0.6 --- 1.8 31.5 
 (2.2-7.5) (2.8-6.2) (0.8-6.0) (9.9-21.5) (0.9-2.7) (0.1-1.3) (0.2-1.5) --- (0.8-4.6)  
Overall 
 
prop 0.3 0.28 0.11 0.2 0.05 0.01 0.01 0 0.04 1 
risk 7.2 6.6 2.7 4.8 1.2 0.2 0.1 0 1 23.9 
num 36.8 34 14 24.6 6.2 1 0.8 0 4.9 122.2 
 (28.1-47.7) (27.4-41.1) (7.9-22.4) (13.5-36.7) (3.4-11.8) (0.3-2.4) (0.2-2.4) (0.0-0.0) (2.4-12.2)  
Serbia 
(high-
quality VR) 
 
Early 
 
prop 0.62 0.13 0.14 0.03 0.02 --- --- 0.01 0.05 1 
risk 2.1 0.5 0.5 0.1 0.1 --- --- 0 0.2 3.4 
num 1.9 0.4 0.4 0.1 0.1 --- --- 0 0.2 3.1 
 (1.6-2.2) (0.3-0.5) (0.3-0.6) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.1) (0.1-0.2)  
Late 
 
prop 0.42 0.12 0.32 0.07 0.04 --- --- 0 0.04 1 
risk 0.3 0.1 0.3 0.1 0 --- --- 0 0 0.8 
num 0.3 0.1 0.2 0.1 0 --- --- 0 0 0.7 
 (0.2-0.4) (0.0-0.1) (0.1-0.3) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.58 0.13 0.18 0.03 0.02 0 0 0.01 0.05 1 
risk 2.6 0.6 0.8 0.1 0.1 0 0 0 0.2 4.4 
num 2.4 0.5 0.7 0.1 0.1 0 0 0 0.2 4.1 
 (2.0-2.8) (0.3-0.7) (0.5-0.9) (0.0-0.2) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.1-0.3)  
Seychelles 
(low mort 
model) 
 
Early 
 
prop 0.48 0.16 0.22 0.08 0.01 --- --- 0.04 0 1 
risk 3.2 1.1 1.5 0.5 0.1 --- --- 0.3 0 6.6 
num 0.1 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.24 0.07 0.24 0.33 0.04 --- --- 0.01 0.07 1 
risk 0.6 0.2 0.6 0.8 0.1 --- --- 0 0.2 2.3 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.14 0.23 0.14 0.02 0 0 0.03 0.02 1 
risk 3.7 1.2 2 1.3 0.2 0 0 0.3 0.2 8.9 
num 0.1 0 0 0 0 0 0 0 0 0.1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Sierra 
Leone  
(high mort 
model) 
 
Early 
 
prop 0.32 0.36 0.07 0.1 0.1 0.01 0 --- 0.04 1 
risk 10.5 11.9 2.1 3.3 3.2 0.4 0.1 --- 1.1 32.8 
num 22.4 25.2 4.6 7.1 6.8 0.9 0.3 --- 2.4 69.8 
 (15.8-26.4) (18.2-28.6) (2.0-7.4) (2.3-11.0) (3.3-12.7) (0.3-2.4) (0.0-2.6) --- (1.1-6.2)  
Late 
 
prop 0.13 0.16 0.05 0.46 0.06 0.07 0.01 --- 0.06 1 
risk 1.5 1.8 0.5 5.2 0.6 0.9 0.1 --- 0.7 11.5 
num 3.3 3.9 1.1 11.2 1.4 1.8 0.3 --- 1.6 24.5 
 (1.5-5.3) (2.3-5.1) (0.4-2.4) (6.3-15.0) (0.7-2.0) (0.3-5.6) (0.1-0.7) --- (0.6-4.0)  
Overall 
 
prop 0.27 0.31 0.06 0.19 0.09 0.03 0.01 0 0.04 1 
risk 12.2 13.9 2.7 8.7 4 1.4 0.3 0 1.9 45.1 
num 25.7 29.2 5.8 18.2 8.5 2.9 0.6 0 4 94.9 
 (17.6-31.9) (20.6-33.9) (2.3-9.9) (8.4-26.3) (4.2-15.2) (0.6-8.4) (0.1-3.2) (0.0-0.0) (1.8-10.0)  
Singapore 
(high-
quality VR) 
 
Early 
 
prop 0.39 0.12 0.3 0.03 0.03 --- --- 0 0.12 1 
risk 0.3 0.1 0.3 0 0 --- --- 0 0.1 0.8 
num 0.2 0.1 0.1 0 0 --- --- 0 0.1 0.5 
 (0.1-0.3) (0.0-0.1) (0.1-0.2) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.4 0.2 0.2 0 0.1 --- --- 0 0.1 1 
risk 0.1 0.1 0.1 0 0 --- --- 0 0 0.3 
num 0.1 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.4 0.14 0.28 0.02 0.05 0 0 0 0.12 1 
risk 0.4 0.2 0.3 0 0.1 0 0 0 0.1 1.1 
num 0.2 0.1 0.2 0 0 0 0 0 0.1 0.6 
 (0.1-0.4) (0.0-0.2) (0.1-0.3) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
Slovakia 
(high-
quality VR) 
 
Early 
 
prop 0.51 0.11 0.3 0.01 0.01 --- --- 0.01 0.03 1 
risk 1.4 0.3 0.8 0 0 --- --- 0 0.1 2.8 
num 0.8 0.2 0.5 0 0 --- --- 0 0 1.6 
 (0.6-1.0) (0.1-0.3) (0.3-0.6) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.1) (0.0-0.1)  
Late 
 
prop 0.5 0.03 0.38 0.04 0.01 --- --- 0.03 0.01 1 
risk 0.7 0 0.5 0.1 0 --- --- 0 0 1.4 
num 0.4 0 0.3 0 0 --- --- 0 0 0.8 
 (0.3-0.5) (0.0-0.1) (0.2-0.4) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.1) (0.0-0.0)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.51 0.08 0.33 0.02 0.01 0 0 0.02 0.02 1 
risk 2.2 0.3 1.4 0.1 0.1 0 0 0.1 0.1 4.3 
num 1.3 0.2 0.8 0.1 0 0 0 0 0.1 2.6 
 (1.0-1.6) (0.1-0.3) (0.6-1.1) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Slovenia 
(high-
quality VR) 
 
Early 
 
prop 0.67 0.07 0.07 0.13 0 --- --- 0 0.07 1 
risk 0.8 0.1 0.1 0.2 0 --- --- 0 0.1 1.2 
num 0.2 0 0 0 0 --- --- 0 0 0.3 
 (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.8 0 0.2 0 0 --- --- 0 0 1 
risk 0.3 0 0.1 0 0 --- --- 0 0 0.4 
num 0.1 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.7 0.05 0.1 0.1 0 0 0 0 0.05 1 
risk 1.2 0.1 0.2 0.2 0 0 0 0 0.1 1.7 
num 0.3 0 0 0 0 0 0 0 0 0.4 
 (0.1-0.4) (0.0-0.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Solomon 
Islands 
(high mort 
model) 
 
Early 
 
prop 0.32 0.29 0.22 0.07 0.04 0 0 --- 0.05 1 
risk 3.2 2.9 2.1 0.7 0.4 0 0 --- 0.5 9.8 
num 0.5 0.5 0.4 0.1 0.1 0 0 --- 0.1 1.7 
 (0.4-0.8) (0.4-0.7) (0.2-0.6) (0.1-0.2) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- (0.0-0.2)  
Late 
 
prop 0.11 0.14 0.21 0.42 0.05 0.01 0.01 --- 0.05 1 
risk 0.4 0.5 0.7 1.4 0.2 0 0 --- 0.2 3.4 
num 0.1 0.1 0.1 0.2 0 0 0 --- 0 0.6 
 (0.0-0.1) (0.1-0.1) (0.1-0.2) (0.1-0.4) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- (0.0-0.1)  
Overall 
 
prop 0.27 0.26 0.21 0.16 0.04 0.01 0 0 0.05 1 
risk 3.6 3.5 2.9 2.2 0.5 0.1 0 0 0.7 13.5 
num 0.6 0.6 0.5 0.4 0.1 0 0 0 0.1 2.3 
 (0.4-0.9) (0.4-0.8) (0.3-0.8) (0.2-0.6) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.2)  
Somalia 
(high mort 
model) 
 
Early 
 
prop 0.3 0.37 0.05 0.04 0.09 0.06 0.01 --- 0.08 1 
risk 10.3 12.8 1.5 1.3 3.2 2.1 0.4 --- 2.6 34.2 
num 46.1 57.3 6.9 6.1 14.4 9.4 1.6 --- 11.7 153.6 
 (30.3-66.2) (38.5-68.3) (3.6-11.7) (1.2-10.8) (7.2-24.8) (3.1-24.0) (0.0-11.4) --- (5.9-19.8)  
Late prop 0.17 0.15 0.04 0.39 0.05 0.12 0.02 --- 0.07 1 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 2.1 1.8 0.4 4.6 0.6 1.5 0.2 --- 0.9 12 
num 9.4 8 1.9 20.8 2.7 6.5 0.9 --- 3.9 54 
 (5.2-13.1) (4.8-10.9) (0.8-3.7) (11.8-29.1) (1.5-4.1) (1.7-14.4) (0.2-2.2) --- (1.7-9.6)  
Overall 
 
prop 0.27 0.31 0.04 0.13 0.08 0.08 0.01 0 0.07 1 
risk 12.7 14.5 2 6.1 3.9 3.7 0.5 0 3.5 47 
num 56.6 64.7 9 27.3 17.4 16.5 2.4 0 15.5 209.3 
 (38.1-78.1) (42.9-79.9) (4.7-15.6) (13.2-40.5) (8.7-29.2) (5.0-39.7) (0.2-13.4) (0.0-0.0) (7.5-29.4)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
South 
Africa 
(high-
quality VR) 
 
Early 
 
prop 0.37 0.29 0.07 0.08 0.05 --- --- 0.01 0.13 1 
risk 4.2 3.3 0.7 0.9 0.5 --- --- 0.1 1.5 11.3 
num 44.9 35.2 7.8 10 5.5 --- --- 0.9 16 120.3 
 (43.6-46.2) (34.1-36.4) (7.3-8.4) (9.4-10.6) (5.0-5.9) --- --- (0.7-1.1) (15.2-16.8)  
Late 
 
prop 0.22 0.06 0.06 0.27 0.17 --- --- 0.02 0.19 1 
risk 0.8 0.2 0.2 0.9 0.6 --- --- 0.1 0.7 3.5 
num 8.1 2.3 2.3 9.9 6.2 --- --- 0.9 6.9 36.6 
 (7.5-8.6) (2.0-2.6) (2.0-2.6) (9.3-10.5) (5.7-6.7) --- --- (0.7-1.1) (6.4-7.4)  
Overall 
 
prop 0.34 0.24 0.06 0.13 0.07 0 0 0.01 0.15 1 
risk 5 3.6 1 1.9 1.1 0 0 0.2 2.2 14.9 
num 55.5 39.3 10.7 20.8 12.2 0 0 1.9 24 164.4 
 (53.6-57.5) (37.8-40.8) (9.8-11.5) (19.5-22.1) (11.2-13.2) (0.0-0.0) (0.0-0.0) (1.5-2.3) (22.7-25.3)  
South 
Sudan  
(high mort 
model) 
 
Early 
 
prop 0.38 0.34 0.06 0.06 0.08 0.04 0 --- 0.03 1 
risk 11.1 9.8 1.7 1.8 2.2 1.1 0.1 --- 1 28.9 
num 44.1 39.3 6.7 7.3 8.7 4.6 0.6 --- 3.9 115.1 
 (33.6-53.9) (31.5-48.3) (4.4-9.9) (2.6-14.4) (5.1-16.3) (2.3-10.8) (0.0-5.3) --- (2.0-10.3)  
Late 
 
prop 0.21 0.14 0.04 0.37 0.05 0.1 0.02 --- 0.06 1 
risk 2.2 1.4 0.4 3.8 0.6 1 0.2 --- 0.6 10.1 
num 8.6 5.7 1.7 15 2.2 4.2 0.7 --- 2.3 40.4 
 (4.5-13.5) (3.7-8.1) (0.6-4.0) (9.8-22.2) (1.3-3.7) (1.7-8.6) (0.2-1.6) --- (1.1-5.9)  
Overall 
 
prop 0.34 0.28 0.05 0.15 0.07 0.06 0.01 0 0.04 1 
risk 13.4 11.3 2.2 6 2.8 2.3 0.3 0 1.6 39.9 
num 51.9 43.7 8.3 23.2 10.8 8.9 1.1 0 6.1 154 
 (36.3-65.9) (34.4-55.1) (5.3-13.9) (12.9-38.8) (6.6-20.1) (4.1-19.8) (0.2-6.2) (0.0-0.0) (3.0-15.6)  
Spain  
(high-
Early 
 
prop 0.31 0.2 0.24 0.08 0 --- --- 0 0.17 1 
risk 0.5 0.3 0.4 0.1 0 --- --- 0 0.3 1.6 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
quality VR) 
 
num 2.4 1.6 1.9 0.6 0 --- --- 0 1.4 8 
 (2.1-2.7) (1.3-1.8) (1.7-2.2) (0.5-0.8) (0.0-0.1) --- --- (0.0-0.0) (1.1-1.6)  
Late 
 
prop 0.28 0.08 0.36 0.17 0.01 --- --- 0 0.1 1 
risk 0.3 0.1 0.3 0.2 0 --- --- 0 0.1 1 
num 1.3 0.4 1.7 0.8 0.1 --- --- 0 0.5 4.7 
 (1.1-1.5) (0.3-0.5) (1.4-2.0) (0.6-1.0) (0.0-0.1) --- --- (0.0-0.0) (0.3-0.6)  
Overall 
 
prop 0.3 0.15 0.29 0.11 0.01 0 0 0 0.14 1 
risk 0.8 0.4 0.8 0.3 0 0 0 0 0.4 2.7 
num 4 2.1 3.9 1.5 0.1 0 0 0 2 13.5 
 (3.4-4.5) (1.7-2.4) (3.3-4.4) (1.2-1.8) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (1.6-2.3)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Sri Lanka 
(low mort 
model) 
 
Early 
 
prop 0.41 0.15 0.25 0.05 0.03 --- --- 0 0.1 1 
risk 1.8 0.6 1.1 0.2 0.1 --- --- 0 0.4 4.4 
num 6.9 2.4 4.1 0.9 0.6 --- --- 0.1 1.7 16.7 
 (5.8-8.1) (2.0-2.9) (2.3-5.6) (0.5-1.3) (0.3-1.0) --- --- (0.1-0.1) (1.2-2.2)  
Late 
 
prop 0.29 0.09 0.33 0.14 0.05 --- --- 0.02 0.09 1 
risk 0.4 0.1 0.5 0.2 0.1 --- --- 0 0.1 1.5 
num 1.7 0.5 1.9 0.8 0.3 --- --- 0.1 0.5 5.9 
 (1.5-2.0) (0.4-0.7) (1.7-2.2) (0.6-0.9) (0.1-0.5) --- --- (0.1-0.1) (0.3-0.9)  
Overall 
 
prop 0.38 0.13 0.27 0.08 0.04 0 0 0.01 0.1 1 
risk 2.3 0.8 1.6 0.5 0.2 0 0 0 0.6 6.1 
num 8.8 3.1 6.3 1.8 0.9 0 0 0.2 2.3 23.3 
 (7.5-10.4) (2.4-3.7) (4.1-8.0) (1.2-2.3) (0.5-1.5) (0.0-0.0) (0.0-0.0) (0.1-0.2) (1.5-3.2)  
Sudan  
(high mort 
model) 
 
Early 
 
prop 0.34 0.34 0.1 0.11 0.06 0.01 0 --- 0.03 1 
risk 7.5 7.4 2.2 2.5 1.4 0.3 0 --- 0.7 22.1 
num 93.3 91.9 27.2 31.2 17.7 3.9 0.5 --- 8.2 274 
 (65.8-115.5) (73.3-117.7) (16.1-39.3) (12.9-61.8) (10.1-37.3) (1.6-10.6) (0.0-6.1) --- (4.0-25.5)  
Late 
 
prop 0.16 0.14 0.05 0.49 0.05 0.04 0.01 --- 0.06 1 
risk 1.3 1.1 0.4 3.8 0.4 0.3 0.1 --- 0.5 7.8 
num 15.7 13.7 4.8 47.4 4.6 3.4 1 --- 5.7 96.3 
 (8.2-25.7) (8.6-19.1) (1.5-13.0) (33.5-63.5) (2.9-6.8) (1.3-7.4) (0.3-2.3) --- (2.3-15.0)  
Overall 
 
prop 0.29 0.29 0.08 0.21 0.06 0.02 0 0 0.04 1 
risk 9 8.7 2.5 6.5 1.9 0.6 0.1 0 1.1 30.5 
num 110.1 107 31.2 79.1 22.8 7.6 1.6 0 14.1 373.5 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (74.4-142.3) (83.0-138.3) (17.4-51.2) (47.3-128.1) (13.2-44.9) (3.0-18.6) (0.3-8.8) (0.0-0.0) (6.4-41.1)  
Suriname 
(high-
quality VR) 
 
Early 
 
prop 0.48 0.2 0.12 0.12 0 --- --- 0 0.09 1 
risk 4.3 1.7 1 1 0 --- --- 0 0.8 8.9 
num 0.4 0.2 0.1 0.1 0 --- --- 0 0.1 0.9 
 (0.3-0.5) (0.1-0.3) (0.0-0.2) (0.0-0.2) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Late 
 
prop 0.26 0.08 0.28 0.33 0 --- --- 0.03 0.03 1 
risk 0.9 0.3 1 1.1 0 --- --- 0.1 0.1 3.4 
num 0.1 0 0.1 0.1 0 --- --- 0 0 0.3 
 (0.0-0.1) (0.0-0.1) (0.0-0.2) (0.0-0.2) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.16 0.16 0.18 0 0 0 0.01 0.07 1 
risk 5.3 2.1 2.1 2.2 0 0 0 0.1 0.9 12.6 
num 0.5 0.2 0.2 0.2 0 0 0 0 0.1 1.2 
 (0.3-0.7) (0.1-0.3) (0.1-0.3) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Swaziland 
(high mort 
model) 
 
Early 
 
prop 0.37 0.35 0.09 0.1 0.06 0.01 0 --- 0.03 1 
risk 8.1 7.7 1.9 2.1 1.3 0.1 0 --- 0.7 22.1 
num 3 2.8 0.7 0.8 0.5 0.1 0 --- 0.3 8.1 
 (2.4-4.7) (2.3-4.4) (0.5-1.5) (0.3-1.4) (0.3-1.1) (0.0-0.1) (0.0-0.2) --- (0.1-1.0)  
Late 
 
prop 0.16 0.15 0.09 0.43 0.05 0.03 0 --- 0.08 1 
risk 1.3 1.2 0.7 3.3 0.4 0.2 0 --- 0.6 7.7 
num 0.5 0.4 0.3 1.2 0.2 0.1 0 --- 0.2 2.8 
 (0.2-1.0) (0.3-0.7) (0.1-0.7) (0.7-2.2) (0.1-0.3) (0.0-0.3) (0.0-0.0) --- (0.1-0.7)  
Overall 
 
prop 0.32 0.3 0.09 0.18 0.06 0.01 0 0 0.04 1 
risk 9.4 8.9 2.6 5.4 1.7 0.4 0.1 0 1.3 29.8 
num 3.5 3.3 1 2 0.6 0.1 0 0 0.5 11 
 (2.7-5.6) (2.6-5.2) (0.5-2.2) (1.0-3.7) (0.3-1.3) (0.1-0.4) (0.0-0.2) (0.0-0.0) (0.2-1.7)  
Sweden 
(high-
quality VR) 
 
Early 
 
prop 0.2 0.19 0.31 0.07 0 --- --- 0 0.23 1 
risk 0.2 0.2 0.4 0.1 0 --- --- 0 0.3 1.2 
num 0.3 0.3 0.4 0.1 0 --- --- 0 0.3 1.3 
 (0.2-0.4) (0.2-0.4) (0.3-0.5) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.2-0.4)  
Late 
 
prop 0.26 0.1 0.36 0.14 0 --- --- 0 0.14 1 
risk 0.1 0 0.1 0.1 0 --- --- 0 0.1 0.4 
num 0.1 0 0.2 0.1 0 --- --- 0 0.1 0.5 
 (0.1-0.2) (0.0-0.1) (0.1-0.2) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.22 0.17 0.32 0.09 0 0 0 0 0.21 1 
risk 0.3 0.3 0.5 0.1 0 0 0 0 0.3 1.6 
num 0.4 0.3 0.6 0.2 0 0 0 0 0.4 1.8 
 (0.2-0.6) (0.2-0.4) (0.4-0.8) (0.0-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.5)  
Switzerlan
d (low mort 
model) 
 
Early 
 
prop 0.45 0.15 0.26 0.02 0 --- --- 0.01 0.11 1 
risk 1 0.3 0.6 0.1 0 --- --- 0 0.2 2.2 
num 0.8 0.3 0.5 0 0 --- --- 0 0.2 1.9 
 (0.8-0.9) (0.2-0.3) (0.4-0.6) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.2)  
Late 
 
prop 0.31 0.08 0.39 0.12 0.01 --- --- 0.02 0.08 1 
risk 0.2 0.1 0.3 0.1 0 --- --- 0 0.1 0.8 
num 0.2 0.1 0.3 0.1 0 --- --- 0 0.1 0.7 
 (0.2-0.2) (0.0-0.1) (0.2-0.3) (0.1-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.1)  
Overall 
 
prop 0.42 0.13 0.29 0.05 0 0 0 0.01 0.1 1 
risk 1.2 0.4 0.9 0.1 0 0 0 0 0.3 3 
num 1 0.3 0.7 0.1 0 0 0 0 0.3 2.5 
 (0.9-1.1) (0.3-0.4) (0.6-0.9) (0.1-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.3)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Syrian 
Arab 
Republic 
(low mort 
model) 
 
Early 
 
prop 0.48 0.22 0.15 0.07 0.04 --- --- 0.01 0.04 1 
risk 2.8 1.3 0.9 0.4 0.2 --- --- 0.1 0.2 5.8 
num 14.8 6.6 4.5 2.1 1.3 --- --- 0.3 1.2 30.8 
 (12.5-20.2) (4.1-10.1) (3.1-10.6) (0.7-3.1) (0.8-2.6) --- --- (0.2-0.7) (0.7-2.4)  
Late 
 
prop 0.27 0.1 0.22 0.24 0.1 --- --- 0.01 0.06 1 
risk 0.5 0.2 0.4 0.5 0.2 --- --- 0 0.1 2.1 
num 2.9 1.1 2.3 2.6 1.1 --- --- 0.2 0.7 10.8 
 (2.4-4.6) (0.2-2.0) (1.6-4.8) (0.9-4.3) (0.8-1.8) --- --- (0.1-0.3) (0.1-3.1)  
Overall 
 
prop 0.42 0.19 0.16 0.11 0.06 0 0 0.01 0.04 1 
risk 3.4 1.5 1.3 0.9 0.5 0 0 0.1 0.4 8.1 
num 18.4 8 7.1 4.9 2.5 0 0 0.5 1.9 43.4 
 (15.6-25.6) (4.6-13.0) (4.9-15.5) (1.7-7.9) (1.6-4.5) (0.0-0.0) (0.0-0.0) (0.3-0.9) (0.8-6.0)  
Tajikistan 
(high mort 
model) 
 
Early 
 
prop 0.34 0.32 0.14 0.09 0.04 0.01 0 --- 0.06 1 
risk 5.5 5.1 2.3 1.4 0.7 0.1 0 --- 1 16.2 
num 15.3 14.1 6.4 3.9 1.9 0.2 0.1 --- 2.6 44.6 
 (11.2-21.0) (10.8-18.8) (4.0-10.1) (1.4-6.7) (0.9-4.2) (0.1-0.6) (0.0-0.9) --- (1.3-4.3)  
Late prop 0.11 0.15 0.18 0.43 0.05 0.02 0 --- 0.05 1 
 90 
 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.6 0.9 1 2.5 0.3 0.1 0 --- 0.3 5.7 
num 1.7 2.4 2.9 6.8 0.9 0.3 0 --- 0.8 15.7 
 (0.9-2.9) (1.5-3.5) (1.6-4.7) (4.1-10.5) (0.5-1.4) (0.1-0.7) (0.0-0.1) --- (0.4-1.9)  
Overall 
 
prop 0.28 0.28 0.15 0.18 0.05 0.01 0 0 0.06 1 
risk 6.4 6.2 3.3 4 1 0.2 0.1 0 1.3 22.4 
num 17.2 16.6 8.9 10.7 2.8 0.5 0.2 0 3.4 60.2 
 (12.6-24.5) (12.3-22.0) (5.5-14.2) (5.5-16.7) (1.4-5.6) (0.2-1.4) (0.0-1.1) (0.0-0.0) (1.7-6.3)  
Thailand 
(low mort 
model) 
 
Early 
 
prop 0.4 0.14 0.28 0.06 0.03 --- --- 0.01 0.08 1 
risk 2.3 0.8 1.7 0.4 0.2 --- --- 0.1 0.5 5.8 
num 16 5.5 11.4 2.5 1.1 --- --- 0.4 3.3 40.3 
 (13.8-19.4) (4.5-6.8) (9.1-14.0) (1.7-3.4) (0.7-1.6) --- --- (0.3-0.5) (2.4-4.3)  
Late 
 
prop 0.3 0.09 0.31 0.17 0.05 --- --- 0.02 0.07 1 
risk 0.6 0.2 0.6 0.3 0.1 --- --- 0 0.1 2.1 
num 4.3 1.3 4.4 2.3 0.6 --- --- 0.2 1 14.1 
 (3.6-5.2) (0.9-1.8) (3.8-5.3) (1.7-2.9) (0.4-1.1) --- --- (0.2-0.3) (0.7-1.4)  
Overall 
 
prop 0.37 0.12 0.29 0.09 0.03 0 0 0.01 0.08 1 
risk 3 1 2.4 0.7 0.3 0 0 0.1 0.6 8.1 
num 21.1 7.1 16.5 5.1 1.8 0 0 0.6 4.5 56.6 
 (18.0-25.7) (5.6-9.0) (13.4-20.1) (3.6-6.6) (1.1-2.8) (0.0-0.0) (0.0-0.0) (0.5-0.8) (3.2-6.1)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
The 
former 
Yugoslav 
Republic 
of 
Macedonia 
(high-
quality VR) 
 
Early 
 
prop 0.79 0.12 0.06 0.01 0.01 --- --- 0 0.01 1 
risk 2.6 0.4 0.2 0 0 --- --- 0 0 3.3 
num 0.6 0.1 0 0 0 --- --- 0 0 0.7 
 (0.4-0.7) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)   
Late 
 
prop 0.69 0.03 0.14 0.1 0.03 --- --- 0 0 1 
risk 0.7 0 0.1 0.1 0 --- --- 0 0 1.1 
num 0.2 0 0 0 0 --- --- 0 0 0.2 
 (0.1-0.2) (0.0-0.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)   
Overall 
 
prop 0.76 0.1 0.08 0.03 0.02 0 0 0 0.01 1 
risk 3.7 0.5 0.4 0.2 0.1 0 0 0 0 4.9 
num 0.8 0.1 0.1 0 0 0 0 0 0 1.1 
 (0.6-1.1) (0.0-0.2) (0.0-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)   
Timor-
Leste  
Early 
 
prop 0.25 0.37 0.13 0.09 0.05 0.01 0.01 --- 0.1 1 
risk 4.5 6.5 2.2 1.5 0.9 0.1 0.1 --- 1.7 17.6 
 91 
 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
(high mort 
model) 
 
num 1.8 2.7 0.9 0.6 0.4 0 0.1 --- 0.7 7.2 
 (1.4-2.4) (2.3-3.2) (0.7-1.4) (0.3-1.0) (0.2-0.8) (0.0-0.1) (0.0-0.6) --- (0.3-1.0)  
Late 
 
prop 0.11 0.17 0.09 0.49 0.06 0.02 0.01 --- 0.05 1 
risk 0.7 1 0.5 3 0.4 0.1 0.1 --- 0.3 6.2 
num 0.3 0.4 0.2 1.2 0.1 0.1 0 --- 0.1 2.5 
 (0.2-0.5) (0.3-0.6) (0.1-0.4) (0.8-1.7) (0.1-0.2) (0.0-0.2) (0.0-0.1) --- (0.1-0.4)  
Overall 
 
prop 0.21 0.33 0.11 0.18 0.06 0.01 0.01 0 0.09 1 
risk 5.2 8.1 2.6 4.5 1.4 0.3 0.2 0 2.1 24.4 
num 2.2 3.4 1.1 1.9 0.6 0.1 0.1 0 0.9 10.3 
 (1.6-3.2) (2.7-4.1) (0.8-1.9) (1.1-2.8) (0.3-1.1) (0.0-0.3) (0.0-0.8) (0.0-0.0) (0.4-1.6)  
Togo  
(high mort 
model) 
 
Early 
 
prop 0.34 0.36 0.09 0.1 0.06 0.01 0 --- 0.03 1 
risk 7.7 8.1 1.9 2.3 1.4 0.3 0.1 --- 0.8 22.5 
num 18.7 19.7 4.7 5.5 3.4 0.6 0.1 --- 1.9 54.6 
 (14.3-22.8) (15.1-23.9) (2.7-7.9) (1.9-8.5) (1.7-6.8) (0.3-1.4) (0.0-1.3) --- (0.9-5.1)  
Late 
 
prop 0.16 0.16 0.06 0.45 0.05 0.04 0.01 --- 0.07 1 
risk 1.2 1.3 0.5 3.6 0.4 0.3 0.1 --- 0.5 7.9 
num 3 3.1 1.1 8.6 1.1 0.8 0.2 --- 1.3 19.2 
 (1.7-5.0) (2.0-4.2) (0.4-2.8) (5.1-11.9) (0.6-1.5) (0.3-1.9) (0.1-0.4) --- (0.5-3.1)  
Overall 
 
prop 0.29 0.31 0.08 0.19 0.06 0.02 0 0 0.04 1 
risk 8.9 9.7 2.4 6 1.9 0.6 0.2 0 1.3 31 
num 21.3 23 5.7 14.3 4.5 1.4 0.4 0 3.1 73.7 
 (15.4-27.2) (17.1-28.3) (3.0-10.7) (7.1-21.1) (2.4-8.4) (0.5-3.2) (0.1-1.7) (0.0-0.0) (1.4-8.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Tonga  
(low mort 
model) 
 
Early 
 
prop 0.46 0.14 0.25 0.08 0.04 --- --- 0.02 0.01 1 
risk 2.2 0.6 1.2 0.4 0.2 --- --- 0.1 0.1 4.7 
num 0.1 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.29 0.07 0.33 0.15 0.08 --- --- 0.02 0.06 1 
risk 0.5 0.1 0.5 0.3 0.1 --- --- 0 0.1 1.6 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.42 0.12 0.26 0.1 0.05 0 0 0.02 0.02 1 
risk 2.8 0.8 1.7 0.6 0.3 0 0 0.1 0.2 6.5 
num 0.1 0 0 0 0 0 0 0 0 0.2 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 (0.1-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
Trinidad 
and 
Tobago 
(high-
quality VR) 
 
Early 
 
prop 0.45 0.19 0.18 0.03 0.04 --- --- 0 0.11 1 
risk 4.2 1.8 1.6 0.3 0.4 --- --- 0 1.1 9.2 
num 0.8 0.3 0.3 0.1 0.1 --- --- 0 0.2 1.8 
 (0.6-1.0) (0.2-0.5) (0.2-0.4) (0.0-0.1) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.28 0.02 0.34 0.11 0.12 --- --- 0.01 0.12 1 
risk 1.6 0.1 2 0.6 0.7 --- --- 0.1 0.7 5.9 
num 0.3 0 0.4 0.1 0.1 --- --- 0 0.1 1.1 
 (0.2-0.4) (0.0-0.1) (0.3-0.5) (0.1-0.2) (0.1-0.2) --- --- (0.0-0.0) (0.1-0.2)  
Overall 
 
prop 0.38 0.13 0.24 0.06 0.07 0 0 0 0.12 1 
risk 5.9 2 3.7 0.9 1.1 0 0 0.1 1.8 15.5 
num 1.2 0.4 0.7 0.2 0.2 0 0 0 0.4 3 
 (0.9-1.5) (0.2-0.5) (0.5-1.0) (0.1-0.3) (0.1-0.3) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.2-0.5)  
Tunisia 
(low mort 
model) 
 
Early 
 
prop 0.38 0.19 0.24 0.06 0.03 --- --- 0 0.11 1 
risk 2.5 1.3 1.6 0.4 0.2 --- --- 0 0.7 6.7 
num 4.8 2.4 3 0.7 0.3 --- --- 0.1 1.3 12.6 
 (3.7-5.8) (1.2-3.7) (1.7-4.9) (0.5-1.0) (0.2-0.5) --- --- (0.0-0.1) (0.9-1.7)  
Late 
 
prop 0.26 0.14 0.26 0.17 0.09 --- --- 0.01 0.06 1 
risk 0.6 0.3 0.6 0.4 0.2 --- --- 0 0.1 2.3 
num 1.2 0.6 1.1 0.8 0.4 --- --- 0.1 0.3 4.4 
 (1.0-1.5) (0.1-0.9) (1.0-1.5) (0.4-1.3) (0.3-0.6) --- --- (0.1-0.1) (0.2-0.4)  
Overall 
 
prop 0.35 0.18 0.24 0.09 0.04 0 0 0.01 0.09 1 
risk 3.3 1.7 2.3 0.8 0.4 0 0 0.1 0.9 9.4 
num 6.3 3.2 4.3 1.6 0.7 0 0 0.1 1.7 17.9 
 (4.9-7.8) (1.3-4.9) (2.8-6.5) (0.9-2.5) (0.5-1.1) (0.0-0.0) (0.0-0.0) (0.1-0.2) (1.1-2.2)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Turkey  
(low mort 
model) 
 
Early 
 
prop 0.43 0.17 0.21 0.06 0.02 --- --- 0.01 0.12 1 
risk 3.6 1.4 1.7 0.5 0.1 --- --- 0 1 8.3 
num 45.9 17.7 22.2 6.2 1.8 --- --- 0.5 12.6 106.9 
 (40.1-51.8) (13.1-21.6) (17.4-28.5) (4.5-8.1) (1.3-2.3) --- --- (0.4-0.7) (8.9-15.3)  
Late 
 
prop 0.28 0.1 0.25 0.2 0.07 --- --- 0.01 0.09 1 
risk 0.8 0.3 0.7 0.6 0.2 --- --- 0 0.2 2.9 
num 10.5 3.7 9.5 7.4 2.7 --- --- 0.6 3.2 37.6 
 (9.2-12.8) (2.2-4.5) (8.3-11.3) (5.0-9.2) (1.7-4.1) --- --- (0.4-0.7) (2.2-4.3)  
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Overall 
 
prop 0.39 0.15 0.21 0.1 0.03 0 0 0.01 0.11 1 
risk 4.6 1.7 2.5 1.1 0.4 0 0 0.1 1.3 11.8 
num 60 22.6 32.5 14.7 4.8 0 0 1.2 16.8 152.6 
 (52.4-68.4) (15.9-27.8) (26.5-41.0) (10.3-19.4) (3.2-6.7) (0.0-0.0) (0.0-0.0) (0.9-1.5) (11.9-20.8)  
Turkmenista
n (high mort 
model) 
 
Early 
 
prop 0.42 0.26 0.1 0.07 0.04 0 0 --- 0.11 1 
risk 7.3 4.5 1.7 1.2 0.6 0.1 0 --- 1.8 17.2 
num 7.9 4.9 1.8 1.3 0.7 0.1 0 --- 2 18.6 
 (6.0-10.8) (3.7-6.7) (1.2-3.2) (0.5-2.1) (0.3-1.6) (0.0-0.2) (0.0-0.2) --- (0.7-3.1)  
Late 
 
prop 0.17 0.13 0.21 0.32 0.05 0.01 0 --- 0.11 1 
risk 1 0.8 1.2 1.9 0.3 0.1 0 --- 0.7 6 
num 1.1 0.8 1.3 2.1 0.3 0.1 0 --- 0.7 6.5 
 (0.7-1.9) (0.5-1.2) (0.8-2.4) (1.1-3.5) (0.2-0.5) (0.0-0.3) (0.0-0.0) --- (0.3-1.3)  
Overall 
 
prop 0.36 0.23 0.12 0.13 0.04 0.01 0 0 0.11 1 
risk 8.6 5.4 2.9 3.2 0.9 0.2 0 0 2.6 23.7 
num 8.9 5.6 3 3.3 0.9 0.2 0 0 2.7 24.7 
 (6.8-12.5) (4.2-7.7) (1.8-5.4) (1.5-5.3) (0.5-2.0) (0.1-0.5) (0.0-0.2) (0.0-0.0) (1.0-4.4)  
Tuvalu  
(low mort 
model) 
 
Early 
 
prop 0.46 0.18 0.2 0.07 0.04 --- --- 0.01 0.06 1 
risk 4.5 1.7 2 0.7 0.4 --- --- 0.1 0.5 9.9 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.3 0.09 0.24 0.18 0.09 --- --- 0.02 0.08 1 
risk 1.1 0.3 0.8 0.6 0.3 --- --- 0.1 0.3 3.5 
num 0 0 0 0 0 --- --- 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.4 0.15 0.21 0.11 0.05 0 0 0.01 0.06 1 
risk 5.5 2.1 2.9 1.5 0.7 0 0 0.1 0.8 13.7 
num 0 0 0 0 0 0 0 0 0 0 
 (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.0)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Uganda 
(high mort 
model) 
 
Early 
 
prop 0.37 0.31 0.11 0.09 0.05 0 0 --- 0.06 1 
risk 6.1 5.1 1.8 1.4 0.8 0.1 0 --- 1 16.4 
num 95.6 80.6 28.1 22.1 12.6 1.1 0.4 --- 15.6 256.1 
 (79.0-128.1) (68.7-100.2) (20.6-40.8) (8.9-35.8) (6.6-27.0) (0.4-2.8) (0.0-3.8) --- (9.0-28.1)  
Late prop 0.15 0.15 0.06 0.47 0.05 0.02 0.01 --- 0.07 1 
 94 
 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
 risk 0.9 0.9 0.4 2.7 0.3 0.1 0 --- 0.4 5.7 
num 13.4 13.9 5.8 42.7 4.9 2 0.8 --- 6.6 90 
 (8.0-20.3) (9.3-19.3) (2.0-15.2) (28.8-62.6) (2.9-7.8) (0.6-5.5) (0.2-1.8) --- (3.2-17.0)  
Overall 
 
prop 0.32 0.27 0.09 0.19 0.05 0.01 0 0 0.06 1 
risk 7.1 6.2 2.1 4.2 1.2 0.2 0.1 0 1.5 22.5 
num 108.7 94.3 32.4 64.6 17.6 3.2 1.2 0 22.2 344.2 
 (87.8-147.9) (77.9-121.9) (21.3-54.9) (37.1-97.8) (9.7-33.8) (1.1-8.7) (0.2-6.0) (0.0-0.0) (12.4-45.4)  
Ukraine 
(low mort 
model) 
 
Early 
 
prop 0.46 0.14 0.21 0.04 0.04 --- --- 0.01 0.11 1 
risk 1.6 0.5 0.7 0.2 0.1 --- --- 0 0.4 3.5 
num 7.7 2.3 3.5 0.7 0.6 --- --- 0.1 1.8 16.8 
 (6.6-8.9) (1.9-2.9) (2.5-5.1) (0.4-1.1) (0.4-0.9) --- --- (0.1-0.2) (1.4-2.2)  
Late 
 
prop 0.34 0.07 0.34 0.11 0.07 --- --- 0.02 0.06 1 
risk 0.4 0.1 0.4 0.1 0.1 --- --- 0 0.1 1.2 
num 2 0.4 2 0.7 0.4 --- --- 0.1 0.3 5.9 
 (1.6-2.4) (0.2-0.6) (1.6-2.6) (0.4-1.0) (0.2-0.7) --- --- (0.1-0.1) (0.2-0.6)  
Overall 
 
prop 0.43 0.12 0.24 0.06 0.04 0 0 0.01 0.09 1 
risk 2.1 0.6 1.2 0.3 0.2 0 0 0.1 0.5 5 
num 11.3 3.2 6.4 1.7 1.2 0 0 0.3 2.5 26.5 
 (9.6-13.1) (2.5-4.1) (4.8-9.0) (0.9-2.4) (0.7-1.9) (0.0-0.0) (0.0-0.0) (0.2-0.4) (1.9-3.2)  
United 
Arab 
Emirates 
(low mort 
model) 
 
Early 
 
prop 0.43 0.15 0.29 0.01 0 --- --- 0 0.11 1 
risk 1.5 0.5 1 0 0 --- --- 0 0.4 3.6 
num 2.2 0.7 1.4 0 0 --- --- 0 0.6 5 
 (1.8-2.6) (0.6-0.9) (1.2-1.8) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.4-0.7)  
Late 
 
prop 0.33 0.09 0.37 0.12 0 --- --- 0.02 0.07 1 
risk 0.4 0.1 0.5 0.1 0 --- --- 0 0.1 1.2 
num 0.6 0.2 0.7 0.2 0 --- --- 0 0.1 1.8 
 (0.5-0.7) (0.1-0.2) (0.6-0.8) (0.2-0.3) (0.0-0.0) --- --- (0.0-0.0) (0.1-0.2)  
Overall 
 
prop 0.4 0.13 0.32 0.04 0 0 0 0.01 0.1 1 
risk 2 0.7 1.6 0.2 0 0 0 0 0.5 5 
num 2.9 1 2.3 0.3 0 0 0 0.1 0.7 7.2 
 (2.5-3.5) (0.8-1.2) (1.9-2.8) (0.2-0.4) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.1-0.1) (0.5-0.9)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
United 
Kingdom 
Early 
 
prop 0.57 0.11 0.26 0.01 0.02 --- --- 0 0.03 1 
risk 1.3 0.2 0.6 0 0 --- --- 0 0.1 2.2 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
(high-
quality VR) 
 
num 9.7 1.9 4.5 0.2 0.3 --- --- 0 0.4 17 
 (9.1-10.3) (1.6-2.2) (4.0-4.9) (0.1-0.3) (0.2-0.4) --- --- (0.0-0.1) (0.3-0.6)  
Late 
 
prop 0.44 0.06 0.39 0.07 0.02 --- --- 0.01 0.03 1 
risk 0.3 0 0.2 0 0 --- --- 0 0 0.6 
num 1.9 0.2 1.7 0.3 0.1 --- --- 0 0.1 4.5 
 (1.7-2.2) (0.1-0.3) (1.5-2.0) (0.2-0.4) (0.0-0.2) --- --- (0.0-0.1) (0.1-0.2)  
Overall 
 
prop 0.54 0.1 0.29 0.02 0.02 0 0 0 0.03 1 
risk 1.6 0.3 0.8 0.1 0 0 0 0 0.1 2.9 
num 12.7 2.3 6.8 0.6 0.4 0 0 0.1 0.6 23.5 
 (11.8-13.7) (2.0-2.7) (6.1-7.5) (0.4-0.8) (0.2-0.6) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.4-0.8)  
United 
Republic 
of 
Tanzania 
(high mort 
model) 
 
Early 
 
prop 0.28 0.36 0.16 0.1 0.05 0 0 --- 0.05 1 
risk 4.3 5.5 2.4 1.5 0.7 0.1 0 --- 0.7 15.3 
num 81.1 102.1 45.6 28.1 13.9 1.4 0.3 --- 13.3 285.7 
 (62.1-104.5) (83.8-115.6) (29.6-63.5) (10.0-42.7) (6.6-29.4) (0.5-3.4) (0.0-2.5) --- (7.7-26.2)  
Late 
 
prop 0.13 0.17 0.08 0.47 0.06 0.02 0 --- 0.07 1 
risk 0.7 0.9 0.4 2.5 0.3 0.1 0 --- 0.4 5.4 
num 12.8 17 7.9 47 6.1 2 0.4 --- 7.2 100.4 
 (6.6-20.4) (10.9-22.4) (2.4-20.1) (28.0-62.4) (3.5-9.0) (0.6-5.0) (0.1-1.0) --- (3.6-16.4)  
Overall 
 
prop 0.24 0.31 0.13 0.2 0.05 0.01 0 0 0.05 1 
risk 5.1 6.5 2.8 4.1 1.1 0.2 0 0 1.1 21.1 
num 94.9 120.8 52 75.9 20.4 3.5 0.8 0 20.8 389.2 
 (69.3-124.6) (95.6-139.4) (30.8-82.3) (38.2-106.8) (10.2-39.4) (1.1-8.7) (0.1-3.7) (0.0-0.0) (11.3-42.4)  
United 
States of 
America 
(high-
quality VR) 
 
Early 
 
prop 0.5 0.08 0.23 0.02 0 --- --- 0 0.16 1 
risk 1.6 0.2 0.8 0.1 0 --- --- 0 0.5 3.2 
num 67.2 10.4 31.8 3 0.4 --- --- 0.5 22.2 135.6 
 (65.6-68.8) (9.8-11.1) (30.7-32.9) (2.7-3.4) (0.2-0.5) --- --- (0.4-0.7) (21.3-23.1)  
Late 
 
prop 0.29 0.06 0.35 0.13 0.02 --- --- 0.04 0.11 1 
risk 0.2 0 0.3 0.1 0 --- --- 0 0.1 0.8 
num 9.4 1.9 11.2 4.4 0.5 --- --- 1.4 3.6 32.5 
 (8.8-10.0) (1.6-2.2) (10.6-11.9) (4.0-4.8) (0.4-0.7) --- --- (1.2-1.6) (3.3-4.0)  
Overall 
 
prop 0.46 0.07 0.26 0.04 0.01 0 0 0.01 0.15 1 
risk 1.9 0.3 1 0.2 0 0 0 0 0.6 4.1 
num 77.5 12.5 43.5 7.5 0.9 0 0 2 26.1 170 
 (75.3-79.7) (11.6-13.4) (41.7-45.3) (6.7-8.3) (0.7-1.2) (0.0-0.0) (0.0-0.0) (1.6-2.4) (24.8-27.5)  
* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
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Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Uruguay 
(high-
quality VR) 
 
Early 
 
prop 0.42 0.09 0.24 0.13 0.02 --- --- 0 0.09 1 
risk 1.7 0.4 1 0.5 0.1 --- --- 0 0.4 4.1 
num 0.8 0.2 0.5 0.3 0 --- --- 0 0.2 2 
 (0.7-1.0) (0.1-0.3) (0.4-0.6) (0.2-0.4) (0.0-0.1) --- --- (0.0-0.0) (0.1-0.3)  
Late 
 
prop 0.09 0.03 0.43 0.36 0.03 --- --- 0.03 0.02 1 
risk 0.1 0.1 0.7 0.6 0.1 --- --- 0.1 0 1.7 
num 0.1 0 0.4 0.3 0 --- --- 0 0 0.8 
 (0.0-0.1) (0.0-0.1) (0.2-0.5) (0.2-0.4) (0.0-0.1) --- --- (0.0-0.1) (0.0-0.0)  
Overall 
 
prop 0.32 0.08 0.3 0.2 0.03 0 0 0.01 0.07 1 
risk 2 0.5 1.8 1.2 0.2 0 0 0.1 0.4 6.1 
num 1 0.2 0.9 0.6 0.1 0 0 0 0.2 3 
 (0.7-1.2) (0.1-0.4) (0.6-1.2) (0.4-0.8) (0.0-0.2) (0.0-0.0) (0.0-0.0) (0.0-0.1) (0.1-0.3)  
Uzbekistan 
(high mort 
model) 
 
Early 
 
prop 0.4 0.25 0.16 0.07 0.03 0 0 --- 0.1 1 
risk 4.1 2.6 1.7 0.7 0.3 0 0 --- 1 10.4 
num 25.4 15.9 10.3 4.2 2 0.1 0 --- 6.1 63.9 
 (18.9-31.3) (11.7-19.4) (6.7-14.0) (1.5-6.3) (0.8-4.3) (0.0-0.3) (0.0-0.1) --- (2.2-9.0)  
Late 
 
prop 0.16 0.12 0.24 0.31 0.04 0.01 0 --- 0.1 1 
risk 0.6 0.4 0.9 1.1 0.2 0 0 --- 0.4 3.7 
num 3.7 2.8 5.4 7 1 0.2 0 --- 2.4 22.5 
 (2.1-5.5) (1.7-3.8) (3.1-8.3) (3.5-10.4) (0.6-1.5) (0.1-0.6) (0.0-0.1) --- (1.1-3.7)  
Overall 
 
prop 0.34 0.22 0.18 0.13 0.03 0 0 0 0.1 1 
risk 4.9 3.1 2.5 1.9 0.5 0.1 0 0 1.4 14.4 
num 31 19.7 16.1 11.8 3.1 0.4 0.1 0 9 91.1 
 (22.6-38.7) (14.0-24.5) (10.1-23.1) (5.0-17.8) (1.5-6.1) (0.1-1.0) (0.0-0.2) (0.0-0.0) (3.5-13.3)  
Vanuatu 
(low mort 
model) 
 
Early 
 
prop 0.49 0.21 0.15 0.07 0.05 --- --- 0.02 0.01 1 
risk 3.1 1.3 1 0.5 0.3 --- --- 0.1 0.1 6.3 
num 0.2 0.1 0.1 0 0 --- --- 0 0 0.4 
 (0.2-0.3) (0.1-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Late 
 
prop 0.27 0.09 0.23 0.25 0.09 --- --- 0.01 0.06 1 
risk 0.6 0.2 0.5 0.6 0.2 --- --- 0 0.1 2.2 
num 0 0 0 0 0 --- --- 0 0 0.1 
 (0.0-0.1) (0.0-0.0) (0.0-0.1) (0.0-0.1) (0.0-0.0) --- --- (0.0-0.0) (0.0-0.0)  
Overall 
 
prop 0.44 0.18 0.17 0.12 0.06 0 0 0.02 0.03 1 
risk 3.8 1.5 1.5 1 0.5 0 0 0.1 0.2 8.7 
num 0.3 0.1 0.1 0.1 0 0 0 0 0 0.6 
 (0.2-0.4) (0.1-0.2) (0.1-0.2) (0.0-0.1) (0.0-0.1) (0.0-0.0) (0.0-0.0) (0.0-0.0) (0.0-0.1)  
* prop = proportion; num = number of deaths (in 100s) 
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Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Venezuela 
(high-
quality VR) 
 
Early 
 
prop 0.46 0.18 0.14 0.12 0.05 --- --- 0 0.05 1 
risk 3 1.2 0.9 0.8 0.3 --- --- 0 0.4 6.5 
num 17.9 6.9 5.4 4.5 1.8 --- --- 0.2 2.1 38.8 
 (17.1-18.7) (6.4-7.4) (4.9-5.8) (4.1-5.0) (1.6-2.1) --- --- (0.1-0.3) (1.8-2.4)  
Late 
 
prop 0.25 0.07 0.23 0.32 0.09 --- --- 0.01 0.03 1 
risk 0.5 0.1 0.4 0.6 0.2 --- --- 0 0 1.8 
num 2.7 0.8 2.5 3.4 1 --- --- 0.1 0.3 10.8 
 (2.4-3.0) (0.6-1.0) (2.2-2.8) (3.1-3.8) (0.8-1.2) --- --- (0.1-0.2) (0.2-0.4)  
Overall 
 
prop 0.41 0.15 0.16 0.16 0.06 0 0 0.01 0.05 1 
risk 3.5 1.3 1.4 1.4 0.5 0 0 0.1 0.4 8.5 
num 21.1 7.9 8.1 8.2 2.9 0 0 0.3 2.5 50.9 
 (19.9-22.3) (7.2-8.6) (7.3-8.9) (7.4-8.9) (2.4-3.3) (0.0-0.0) (0.0-0.0) (0.2-0.5) (2.1-2.8)  
Viet Nam 
(low mort 
model) 
 
Early 
 
prop 0.44 0.15 0.15 0.08 0.04 --- --- 0.01 0.12 1 
risk 4.2 1.4 1.4 0.8 0.4 --- --- 0.1 1.2 9.5 
num 57.5 20 19.9 10.8 5.7 --- --- 0.7 16.2 131 
 (43.4-63.0) (14.3-22.8) (11.7-34.0) (3.4-14.0) (3.2-9.6) --- --- (0.5-0.9) (10.4-19.3)  
Late 
 
prop 0.27 0.07 0.18 0.24 0.15 --- --- 0.01 0.07 1 
risk 0.9 0.2 0.6 0.8 0.5 --- --- 0 0.2 3.3 
num 12.5 3.1 8.4 11.2 6.9 --- --- 0.7 3.3 46 
 (9.2-15.4) (1.3-4.4) (4.4-14.8) (3.2-14.3) (4.0-10.9) --- --- (0.4-0.9) (0.3-13.1)  
Overall 
 
prop 0.37 0.12 0.23 0.09 0.07 0 0 0.01 0.1 1 
risk 4.8 1.6 3 1.2 0.9 0 0 0.1 1.4 13.1 
num 68.2 22.9 43 17.2 12.8 0 0 1.4 19.3 184.7 
 (52.5-76.0) (15.9-26.4) (29.5-55.0) (10.2-23.4) (7.5-19.1) (0.0-0.0) (0.0-0.0) (1.0-1.8) (12.4-23.1)  
Yemen 
(high mort 
model) 
 
Early 
 
prop 0.34 0.32 0.12 0.08 0.05 0.01 0 --- 0.06 1 
risk 6.2 5.8 2.2 1.5 1 0.2 0.1 --- 1.1 18 
num 45.6 42.8 16.5 10.9 7.1 1.8 0.5 --- 7.9 133.1 
 (30.8-59.0) (33.7-53.9) (9.3-26.0) (4.6-22.3) (3.7-15.3) (0.7-5.0) (0.0-4.6) --- (4.0-12.3)  
Late 
 
prop 0.14 0.15 0.08 0.49 0.05 0.03 0.02 --- 0.05 1 
risk 0.9 0.9 0.5 3.1 0.3 0.2 0.1 --- 0.3 6.3 
num 6.5 6.8 3.7 23.1 2.3 1.3 0.9 --- 2.2 46.8 
 (4.3-8.9) (4.2-9.6) (1.8-6.7) (17.0-30.3) (1.4-3.4) (0.5-2.9) (0.3-2.2) --- (1.2-4.9)  
Overall 
 
prop 0.3 0.28 0.1 0.18 0.05 0.02 0.01 0 0.06 1 
risk 7.4 7 2.6 4.5 1.3 0.5 0.2 0 1.4 25.1 
num 53.9 50.9 19 32.9 9.7 3.4 1.6 0 10.4 181.8 
 (36.5-69.1) (39.0-65.4) (10.7-30.9) (20.8-50.1) (5.4-19.0) (1.3-8.6) (0.4-7.7) (0.0-0.0) (5.3-17.5)  
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* prop = proportion; num = number of deaths (in 100s) 
Table S14: Cause-specific proportions, risks, and numbers of deaths (with uncertainty) for 194 countries by neonatal period 
Country Period Stat* Preterm Intrapartum Congenital Sepsis Pneumonia Tetanus Diarrhoea Injuries Other Total 
Zambia 
(high mort 
model) 
 
Early 
 
prop 0.33 0.37 0.08 0.09 0.06 0.01 0 --- 0.06 1 
risk 7.1 8.1 1.7 1.8 1.4 0.2 0.1 --- 1.3 21.7 
num 43.1 49.1 10.1 11.2 8.5 1 0.5 --- 8 131.6 
 (34.3-55.6) (39.5-57.5) (7.6-17.1) (4.5-17.8) (4.4-16.1) (0.3-2.3) (0.0-4.9) --- (4.9-13.9)  
Late 
 
prop 0.15 0.16 0.05 0.46 0.06 0.04 0.01 --- 0.07 1 
risk 1.1 1.2 0.4 3.5 0.4 0.3 0.1 --- 0.6 7.6 
num 6.9 7.6 2.3 21.4 2.6 1.7 0.4 --- 3.4 46.2 
 (4.3-10.1) (5.1-10.5) (0.8-6.1) (13.7-29.6) (1.6-3.9) (0.5-4.3) (0.1-0.8) --- (1.8-7.7)  
Overall 
 
prop 0.28 0.32 0.07 0.18 0.06 0.02 0.01 0 0.06 1 
risk 8.3 9.4 2 5.4 1.9 0.4 0.1 0 1.9 29.5 
num 48.6 54.5 11.8 31.6 10.8 2.6 0.9 0 11 171.8 
 (37.3-63.0) (42.9-65.5) (8.0-22.1) (17.4-46.0) (5.9-19.7) (0.8-6.6) (0.1-5.6) (0.0-0.0) (6.2-20.7)  
Zimbabwe 
(high mort 
model) 
 
Early 
 
prop 0.37 0.35 0.07 0.1 0.06 0.01 0 --- 0.03 1 
risk 10.6 10.3 2.2 2.8 1.8 0.4 0.1 --- 0.9 29 
num 47 45.3 9.6 12.3 7.9 1.7 0.4 --- 4 128.1 
 (36.9-55.1) (36.7-51.3) (5.7-16.4) (4.7-18.8) (4.1-15.4) (0.6-4.3) (0.0-4.0) --- (1.9-12.7)  
Late 
 
prop 0.19 0.15 0.06 0.4 0.05 0.07 0 --- 0.07 1 
risk 2 1.6 0.6 4 0.5 0.7 0 --- 0.7 10.2 
num 8.7 7 2.7 17.9 2.3 3.2 0.2 --- 3.1 45 
 (4.9-14.1) (4.6-9.3) (1.0-6.7) (10.2-23.9) (1.4-3.5) (1.2-6.7) (0.1-0.4) --- (1.1-7.7)  
Overall 
 
prop 0.32 0.3 0.07 0.18 0.06 0.03 0 0 0.04 1 
risk 12.5 11.6 2.8 6.8 2.3 1.1 0.1 0 1.6 38.7 
num 54.8 50.6 12.2 29.8 9.9 4.7 0.5 0 6.9 169.3 
 (41.1-67.4) (40.7-59.2) (6.2-23.2) (14.3-42.5) (5.3-18.3) (1.7-10.5) (0.1-4.2) (0.0-0.0) (2.9-20.0)  
* prop = proportion; num = number of deaths (in 100s) 
 99 
 
Appendix P:  Comparison of different neonatal COD estimates for China 
As noted in the main text of the paper, we estimated the neonatal COD distribution for China 
using the low mortality model due to China’s relatlively low NMR (table S15a). While we 
have chosen to retain the low mortality model results for China, we have included two 
different estimates here for comparison.  The first are the most recent WHO estimates for 
China (table S15b) (89), based on single-cause models for the overall neonatal period, and 
the second are estimates for China using the high mortality model instead of low mortality 
model in our analysis (table S15c).  Note that the low and high mortality models have 
different cause categories, so some of the causes in table S15c are different from those in 
S15a and S15b.   
 
S15a: Proportional cause distribution estimated for China using the low 
mortality model 
 Intrapartum Preterm Congenital Sepsis Pneumonia Injuries Other 
2000 15.1 41.5 15.2 8.3 7.4 1.0 11.5 
2001 14.9 41.4 15.3 8.7 7.5 1.0 11.1 
2002 14.8 41.6 15.3 9.2 7.4 1.0 10.7 
2003 14.8 41.8 15.6 9.3 7.0 1.0 10.6 
2004 14.4 41.3 16.8 9.3 6.9 1.0 10.3 
2005 14.2 40.9 17.7 9.3 6.8 1.0 10.1 
2006 13.8 39.9 19.6 9.6 6.3 0.9 9.9 
2007 13.5 39.6 20.4 9.6 6.3 0.9 9.8 
2008 13.1 38.4 21.4 10.6 5.8 0.9 9.7 
2009 13.0 38.2 22.6 9.8 5.8 0.9 9.8 
2010 12.9 38.2 23.1 9.7 5.5 0.9 9.8 
2011 12.9 38.3 23.4 9.3 5.3 0.9 9.8 
2012 13.0 38.4 23.7 9.0 5.1 0.9 9.9 
2013 13.0 38.5 23.9 8.7 5.1 0.9 9.9 
 
S15b: Proportional cause distribution estimated for China by the WHO 
 Intrapartum Preterm Congenital Sepsis Pneumonia Injuries Diarrhoea Tetanus Other 
2000 0.35 0.25 0.08 0.07 0.09 0.04 0.02 0.01 0.09 
2001 0.34 0.24 0.09 0.06 0.09 0.04 0.02 0 0.11 
2002 0.33 0.24 0.09 0.06 0.09 0.04 0.02 0 0.13 
2003 0.32 0.24 0.09 0.06 0.09 0.04 0.02 0.01 0.14 
2004 0.31 0.23 0.1 0.05 0.08 0.04 0.02 0 0.15 
2005 0.3 0.23 0.1 0.05 0.08 0.04 0.02 0 0.17 
2006 0.29 0.23 0.11 0.05 0.08 0.04 0.02 0 0.18 
2007 0.28 0.23 0.12 0.05 0.07 0.04 0.02 0 0.18 
2008 0.28 0.23 0.12 0.04 0.07 0.04 0.02 0 0.19 
2009 0.27 0.23 0.13 0.04 0.07 0.04 0.02 0 0.2 
2010 0.26 0.23 0.14 0.04 0.07 0.04 0.02 0 0.2 
2011 0.25 0.23 0.14 0.04 0.07 0.04 0.02 0 0.21 
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2012 0.25 0.23 0.15 0.04 0.07 0.04 0.02 0 0.21 
2013 0.25 0.23 0.15 0.04 0.07 0.04 0.02 0 0.21 
 
S15c: Proportional cause distribution estimated for China using the high mortality model 
 Intrapartum Preterm Congenital Sepsis Pneumonia Tetanus Diarrhoea Other 
2000 0.18 0.42 0.13 0.09 0.03 0.01 0 0.13 
2001 0.18 0.41 0.14 0.1 0.03 0.01 0 0.13 
2002 0.19 0.4 0.15 0.1 0.03 0.01 0 0.14 
2003 0.19 0.39 0.16 0.1 0.03 0.01 0 0.14 
2004 0.19 0.37 0.18 0.1 0.03 0 0 0.14 
2005 0.19 0.36 0.19 0.1 0.03 0 0 0.13 
2006 0.18 0.35 0.21 0.1 0.03 0 0 0.13 
2007 0.18 0.35 0.22 0.1 0.03 0 0 0.13 
2008 0.17 0.34 0.24 0.1 0.02 0 0 0.13 
2009 0.17 0.33 0.25 0.1 0.02 0 0 0.12 
2010 0.17 0.33 0.25 0.1 0.02 0 0 0.12 
2011 0.17 0.33 0.25 0.1 0.02 0 0 0.13 
2012 0.17 0.33 0.25 0.1 0.02 0 0 0.13 
2013 0.17 0.32 0.25 0.1 0.02 0 0 0.13 
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